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Summary 
Historically, sperm has been considered merely as a carrier of genetic material at fertilisation. 
However, it is known that sperm supports embryonic development better than other cell types, 
suggesting that it might also have additional important, non-genetic contributions to embryonic 
development. The work described in this dissertation focuses on identifying the molecular 
determinants of developmental programming of sperm. 
First, the development of embryos derived from sperm and spermatids, immature precursors 
of sperm was compared. Sperm-derived embryos developed significantly better than spermatid-
derived embryos. Further research aiming to identify the reasons for the developmental advantage of 
sperm led to the identification of proteins that are present specifically in sperm and not in spermatids. 
Moreover, egg factors which are preferentially incorporated into the sperm, but not into the spermatid 
chromatin were identified with the use of egg extracts, suggesting that the chromatin of sperm could 
be programmed to interact with the components of the egg. 
Subsequently, the reasons for developmental failure of spermatid-derived embryos were 
investigated. By comparing the sperm with spermatids it was shown that the programming of sperm to 
support efficient development is linked to its special ability to regulate expression of 
developmentally-important embryonic genes, and not to its ability to support DNA replication or 
rRNA production. Further characterisation of the sperm and spermatid chromatin with the use of 
genome-wide sequencing allowed me to link the correct regulation of gene expression in the embryo 
with a certain combination of epigenetic marks in the sperm, but not in the spermatid chromatin. 
Finally, it is shown that enzymatic removal of epigenetic modifications at fertilisation leads to 
misregulation of gene expression. This therefore suggests that epigenetic information contained in 
parental genomes at fertilisation is required for a proper regulation of embryonic transcription. 
My results support the hypothesis that the sperm is not only a carrier of genetic material, but 
also provides the embryo with epigenetic information for regulation of transcription after fertilisation. 
I believe that these findings advance our current understanding of the nature and mechanisms of 
sperm programming for embryonic development, and are important contributions to the emerging 
field of transgenerational inheritance of epigenetic traits in general. 
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Chapter 1 
Introduction 
 
1.1. Stabilisation of the differentiated state by epigenetic mechanisms 
 
Vertebrate development starts when the sperm fertilises the egg. This leads to the 
formation of a totipotent zygote, which subsequently replicates its DNA and undergoes series 
of cell divisions. Later on embryonic cells start to differentiate to form multiple tissues and 
organs constituting the adult body. It is very important that such differentiated cells forming 
particular tissues do not de-differentiate and do not change their fates to other cell types, as 
this could lead to tissue malfunction and tumour formation. That is why a fully differentiated 
state is thought to be safe-guarded by several layers of stabilising mechanisms. Virtually all 
the cells in the body have the same genetic content, as evidenced by nuclear transfer 
experiments (see below) (Gurdon 1962, Gurdon & Uehlinger 1966, Hochedlinger & Jaenisch 
2002, Eggan et al. 2004, Sung et al. 2006). This means that differential expression of genes 
as cells specialise in their developmental pathways is not the result of gene loss or gain. In 
other words, features that make cells in a body different from each other are epigenetic. The 
word ‘epigenetic’ is derived from the Greek preposition ‘epi’ meaning ‘above, outside, 
besides’ combined with the word ‘genetic’, therefore meaning ‘outside genetic’. Currently 
this definition is used to describe heritable, non-genetic changes in cellular states (Bonasio et 
al. 2010). Interestingly, it has been observed that the DNA on chromosome (and in the 
nucleus) tends to be clustered according to its transcriptional activity: regions of chromatin 
which are transcriptionally active and decondensed are termed ‘euchromatin’ and regions 
which are transcriptionally repressed and densely packed are termed ‘heterochromatin’. 
Epigenetic mechanisms were proposed to be involved in the stabilisation and separation of 
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these two different states (Lamond & Earnshaw 1998, Noma et al. 2001). There are various 
epigenetic mechanisms that can contribute to transcriptional activation and silencing. The 
best characterised epigenetic mechanisms stabilising the expression states of genes are DNA 
methylation, post-translational histone modifications, presence of histone variants or density 
of nucleosomes itself. Such mechanisms can act cooperatively to achieve multiple layers of 
epigenetic mechanisms ensuring stable maintenance of chromatin states. All these 
mechanisms are briefly reviewed below. 
 
1.1.1. DNA methylation 
 
Methylation of cytosine is the best described epigenetic modification occurring on the 
DNA itself. Cytosines in DNA can be unmethylated or methylated (or be an intermediate 
between the two states, for example 5-hydroxymethylcytosine, which is however not 
discussed here). Methylation occurs by covalent modification of cytosine: by an addition of a 
methyl group to its fifth carbon, which creates 5-methyl-cytosine (5meC). Methylation can 
occur on cytosines in various contexts (Lister et al. 2009), but 5meC in CpG dinucleotides is 
the best described (Doerfler 2008). CpG dinucleotides are usually overrepresented in gene 
promoters. Methylation of cytosines in such CpG-rich promoters often leads to gene silencing 
(Boyes & Bird 1991, Boyes & Bird 1992, Hsieh 1994, Schubeler et al. 2000, Chen et al. 
2001a, Song et al. 2005). Conversely, the removal of methyl group from 5meC (DNA 
demethylation), leads to gene expression (Benvenuto et al. 1996, Papageorgis et al. 2010, 
Stengel et al. 2010). DNA methylation is implied in the establishment and/or the maintenance 
of correct gene expression patterns during development, differentiation and tissue 
specification (Maatouk et al. 2006, Song et al. 2009). Interestingly, comparison of DNA 
methylation profiles from 17 distinct adult mouse tissues led to identification of tissue-
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specific DNA methylation sites (Hon et al. 2013). This finding points towards important roles 
of DNA methylation during organism development and specialisation. It is therefore not 
surprising that alteration of these methylation patterns, on a genome-wide, or on a loci-
specific level, is associated with genomic instability and with cancers (Gaudet et al. 2003, 
Reddington et al. 2013). In support of this hypothesis, it has been well documented that 
during the germline specification in mouse, DNA methylation patterns are globally erased to 
allow reprogramming of the germ cells and to allow them to re-gain the pluripotency (Surani 
et al. 2007, Hajkova et al. 2010, Popp et al. 2010). 
 
1.1.2. Post-translational histone modifications 
 
Post-translational histone modifications are on the other hand not related to changes to 
DNA bases itself, but to histones – small basic proteins packing the DNA within the nucleus. 
There are four major types of histones which form the nucleosome – H2A, H2B, H3 and H4. 
Furthermore, inter-nucleosomal regions of DNA are bound by linker histone H1. All these 
histones can be subjected to post-translational modifications, which can affect the chromatin 
compaction and in turn lead to gene expression or repression or to stabilisation/destabilisation 
of these states (Strahl & Allis 2000, Jenuwein & Allis 2001, Godde & Ura 2008). For 
example, it is known that dimethylation or trimethylation of lysine 4 on histone 3 
(H3K4me2/3), methylation of argininie 17 or arginine 26 of histone H3 or histone acetylation 
are associated with transcriptional activation (Simpson 1978, Chahal et al. 1980, Turner et al. 
1992, Jeppesen & Turner 1993, Lee et al. 1993, Ogryzko et al. 1996, Noma et al. 2001, 
Bernstein et al. 2002, Santos-Rosa et al. 2002, Torres-Padilla et al. 2007, Wu et al. 2009). On 
the other hand, ubiquitination of lysine 119 of histone H2A (H2AK119Ub), di- or 
trimethylation of lysine 9 of histone H3 (H3K9me2/3) or trimethylation of lysine 27 of 
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histone H3 (H3K27me3) are associated with transcriptional repression (Lachner et al. 2001, 
Nakayama et al. 2001, Noma et al. 2001, Cao et al. 2002, Czermin et al. 2002, Muller et al. 
2002, Snowden et al. 2002, Plath et al. 2003, Wang et al. 2004, Richly et al. 2010). The 
effect of post-translational histone modifications on the chromatin state can be direct or 
indirect. It has been demonstrated that acetylation directly decreases the affinity of histones 
for DNA and therefore makes DNA more accessible to transcription factors (Cary et al. 
1982). Non-modified histones are positively charged, which facilitates their binding to 
negatively charged DNA. Acetylation brings a negative charge to the histone, which therefore 
decreases its affinity to DNA. Interestingly, post-translational histone marks can also 
indirectly affect the chromatin structure, by the recruitment of proteins that recognize such 
marks, known as chromatin ‘readers’. Acetylated histones are recognized by proteins 
containing bromodomains, for example Brd2, Brd3 or Brd4 (Bromodomain proteins 2, 3, 4), 
which, by various mechanisms, can in turn facilitate transcription (Dey et al. 2003, Kanno et 
al. 2004, LeRoy et al. 2008, Dey et al. 2009, Umehara et al. 2010a, Umehara et al. 2010b, 
Zhao et al. 2011, Draker et al. 2012). It has been shown that Brd4-bound acetylated histones 
can recruit transcription elongation factor P-TEFb, which leads to transcriptional elongation 
and gene activation (Jang et al. 2005, Yang et al. 2005, Hargreaves et al. 2009, Zippo et al. 
2009, Liu et al. 2013). Conversely, recognition and binding of repressive H3K9me2/3 mark 
by heterochromatin protein 1 (HP1) leads to heterochromatin formation and transcriptional 
repression (Bannister et al. 2001, Lachner et al. 2001, Motamedi et al. 2008). 
 
1.1.3. Histone variants 
 
There are also numerous histone variants that can compose the chromatin and 
presence of these variants instead of canonical histones also affects the chromatin 
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accessibility (Talbert et al. 2012). For example, H3 variant, histone H3.3 is associated with 
open chromatin state and active transcription and is preferentially incorporated into the 
paternal pronucleus after fertilisation (McKittrick et al. 2004, Loppin et al. 2005, Torres-
Padilla et al. 2006, Jullien et al. 2012). Interestingly, genome-wide analysis of H3.3 binding 
revealed that on top of being enriched at actively transcribed genes (transcriptional start sites 
and gene bodies), H3.3 was also enriched at transcriptional start sites (but not gene bodies) of 
repressed genes and was also shown to be important for the establishment of the 
pericentromeric heterochromatin mouse embryos (Goldberg et al. 2010, Santenard et al. 
2010). Another histone variant, H2A.Z, was shown to occupy developmentally-important 
gene promoters in embryonic stem cells (ES cells) and its downregulation led to 
overexpression of some of its target genes, suggesting that it is important for gene repression 
(Creyghton et al. 2008). Interestingly, presence of the very same histone variant H2A.Z in a 
combination with acetylated forms of histone H4, leads to recruitment of Brd2 and, in turn, to 
transcriptional activation (Draker et al. 2012). It has been also shown that presence of H2A.Z 
histone variant is essential for the removal of nucleosomes from the transcriptional start sites 
(TSSs) of tissue-specific genes during ES cells differentiation (Li et al. 2012) and that it 
generally facilitates transcription-coupled nucleosome removal from gene TSSs (Schones et 
al. 2008). These suggest that the presence of the very same histone variant can have different 
effects on transcription, depending on the chromatin context. Furthermore, combination of 
different histone variants can have additive effects on chromatin structure. It was shown that 
nucleosomes assembled with histone variants H3.3 and H2A.Z were more unstable than 
nucleosomes containing H3.3 and H2A or H3 and H2A.Z alone (Jin & Felsenfeld 2007). 
Instability of nucleosomes can then positively affect transcription, as discussed above. 
Besides, not only core histones have their variants. Linker histone H1 also has multiple 
variants. For example, there are 11 variants of histone H1 in humans and mice (Izzo et al. 
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2008), some of which are oocyte/early embryo-specific (H1foo) or testis-specific (H1t, H1t2 
or Hils1) (Seyedin & Kistler 1980, Tanaka et al. 2001, Yan et al. 2003, Martianov et al. 
2005, Tanaka et al. 2005). Interestingly, it has been shown that early embryonic variant of 
histone H1 (dBigH1) in Drosophila is crucial for regulation of zygotic gene activation 
(ZGA): deletion of this histone variant resulted in pre-mature ZGA and embryo death (Perez-
Montero et al. 2013). Oocyte and embryo-specific linker histone variant, B4, a homologue of 
the mammalian H1foo, has been also identified in frogs (Smith et al. 1988, Tanaka et al. 
2001). It was shown that the affinity of B4 histone for DNA is 6 times lower than that of a 
canonical, somatic-type H1. The incorporation of B4 instead of canonical H1 into chromatin 
facilitated transcription (Ura et al. 1996). Interestingly, the very same histone B4 was shown 
to be incorporated into chromatin of transplanted nuclei during the nuclear transfer procedure 
and to be necessary for transcriptional reprogramming (Teranishi et al. 2004, Jullien et al. 
2010). It is therefore not surprising that the embryonic-like linker histone variants are lost as 
embryos develop, probably in order to prevent promiscuous transcription and enable tissue 
specification (Smith et al. 1988). All these suggest that the mere composition of the 
nucleosomes can affect the susceptibility of chromatin to transcription. 
 
1.1.4. Nucleosome density 
 
The positioning of nucleosomes on DNA and, specifically, the density of 
nucleosomes at particular genomic sites, is also known to affect the accessibility of the 
chromatin. In general, the higher the nucleosome density, the more compact the chromatin 
structure and the less accessible for transcriptional machinery (Kwon et al. 1994, Bai & 
Morozov 2010). Comparison of genome-wide profiles of nucleosome occupancy in seven 
different human cell lines revealed the presence of nucleosome-free regions at TSSs of 
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transcriptionally active genes (Ozsolak et al. 2007). It was also shown that during ES cell 
differentiation, the activation of genes correlated with nucleosome depletion around their 
transcriptional start sites (TSSs) (Li et al. 2012). Furthermore, in yeast nucleosome 
occupancy is inversely correlated with transcriptional activity not only at gene promoters, but 
also across the gene body: nucleosomes are depleted at the promoters of highly transcribed 
genes and are more abundant at promoters and at gene bodies of repressed genes (Lee et al. 
2004). Interestingly, it was shown in zebrafish embryos that the canonical organisation of 
nucleosomes on chromatin is detected only from around the time of zygotic genome 
activation, suggesting that proper positioning of nucleosomes on chromatin is important for 
the regulation of gene expression (Zhang et al. 2014). All these results support the model that 
the mere presence of nucleosome modulates the accessibility of the underlying DNA 
sequence. 
 
1.1.5. Cooperative action of different epigenetic mechanism to achieve stable maintenance 
of a differentiated state 
 
It was demonstrated that various epigenetic mechanisms mentioned before can act 
cooperatively to achieve multiple layers of epigenetic stabilisation of chromatin states. For 
example, it has been shown that cytosine methylation is recognized by proteins that have 
methylated-cytosine binding domains (MBD): MeCP2, Mbd1, Mbd2, Mbd3 and Mbd4 
(Bogdanovic & Veenstra 2009). These proteins then recruit other factors, which can further 
induce heterochromatinization of the DNA-methylated region. For example, it has been 
shown that MBD domain-containing proteins can recruit histone deacetylases (HDACs) to 
chromatin. These are responsible for removing the acetyl groups from histones and therefore 
lead to chromatin compaction and transcriptional repression (Jones et al. 1998, Wade et al. 
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1999, Zhang et al. 1999, Le Guezennec et al. 2006). DNA methylation can be also 
reciprocally induced by the presence of certain histone marks. For example, HP1 protein that 
binds to H3K9me2/3 interacts with Dnmt1 and Dnmt3b, which are maintenance and de novo 
DNA methylases, respectively. This interaction is important for the induction of DNA 
methylation and gene repression (Lehnertz et al. 2003, Smallwood et al. 2007). Presence of 
DNA methylation can regulate the distribution of repressive histone marks also by restricting 
them. It has been shown that DNA methylation is mutually exclusive to H3K27me3 mark 
(Lindroth et al. 2008). Removal of DNA methylation leads to widespread accumulation of 
H3K27me3 at illegitimate regions (Hagarman et al. 2013, Reddington et al. 2013). In 
contrast, the removal of H3K27me3 results only in mild changes in 5meC distribution across 
the genome (Hagarman et al. 2013). Interestingly, it was shown that unmethylated CpG 
islands can be recognized and bound by Kdm2b, which is a histone H3 lysine 36 
demethylase. Kdm2b then recruits Polycomb repressive complex 1 (PRC1), which deposits 
H2AK119Ub, leading to gene repression (Farcas et al. 2012, He et al. 2013). Presence of 
certain histone variants in the nucleosome can also influence the deposition of epigenetic 
marks. For example, in mouse ES cells, the presence of H3.3 is necessary for proper 
establishment of H3K27me3 mark at promoters of developmentally-important genes 
(Banaszynski et al. 2013). 
Concluding, various epigenetic mechanisms can act independently or synergistically 
in several layers of regulation to ensure a stable maintenance of a differentiated state (Fig. 1). 
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Fig. 1. Epigenetic mechanisms stabilising a differentiated state. 
Example of a gene which is expressed in an undifferentiated cell and repressed in a 
differentiated cell. Repression of this gene is achieved and stabilised by several layers of 
epigenetic mechanisms: DNA becomes methylated, nucleosomes occupancy increases, 
histone variants associated with active transcription are replaced with canonical histone 
variants, activating post-translational histone marks are removed and repressive marks 
established.  
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1.2. Reprogramming as the reversal of differentiation 
 
Interestingly, epigenetically-stabilised differentiated states can be experimentally 
reversed back to embryonic-like pluripotent states. It has been shown that if a nucleus of a 
somatic cell is transplanted to an unfertilised, enucleated egg, this can lead to a development 
of a new embryo, which can subsequently differentiate into a an adult organism (Gurdon et 
al. 1958, Gurdon & Uehlinger 1966). It was also proved with the use of nuclear markers that 
the genetic material in such cloned adult organisms was derived exclusively from the donor 
cell nucleus and not from the recipient egg (Elsdale et al. 1960, Hochedlinger & Jaenisch 
2002). It means that a differentiated cell was able to de-differentiate to a totipotent state. 
However, it has been also shown that this process of de-differentiation is limited: the more 
differentiated the donor cell nucleus, the less frequent is the normal development of resulting 
nuclear transfer embryos. For example, it was shown in frogs that if donor cells for the 
nuclear transfer were derived from blastula or early gastrula stage embryos, up to 36% of 
successfully reconstructed embryos could reach a feeding tadpole stage, whereas if intestinal 
epithelium cell nuclei were used as donors, only 1.5% of embryos reached a feeding tadpole 
stage (Gurdon 1962). It has been further explained that the decreased susceptibility of 
differentiated cells to undergo reprogramming is related to the fact that multiple layers of 
epigenetic stabilisation of the differentiated state are acquired sequentially as the 
development progresses: the more differentiated the cell, the more epigenetic mechanisms 
safeguard the differentiated state and the more difficult it is to successfully de-differentiate 
such cells (Pasque et al. 2010, Pasque et al. 2011b). It was reported in mammalian systems 
that nuclear transfer-derived embryos exhibit abnormally high DNA methylation levels as 
compared with control, fertilised embryos. Moreover, these non-reprogrammable methylation 
abnormalities were memories of the methylation states in the donor cells used for the nuclear 
transfer: similarly high methylation pattern were also detected in the donor cells (Bourc'his et 
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al. 2001, Kang et al. 2001, Chan et al. 2012). This suggests that repressive marks acquired 
during differentiation were a barrier for reprogramming. It has been also shown that histone 
variants can be a barrier for reprogramming. Experiments using the transcriptional 
reprogramming system of nuclear transfer to Xenopus prophase-arrested oocytes (Fig. 2) 
demonstrated that mouse embryonic fibroblasts (MEFs) reprogram worse than less 
differentiated epiblast stem cells due to the presence of repressive histone variant macroH2A 
in MEFs (Pasque et al. 2011a). Post-translational histone marks themselves were also shown 
to be refractory to correct reprogramming after nuclear transfer and to be responsible for the 
retention of the donor cell-like characteristics in nuclear transfer embryos. For example, 
cloned bovine embryos ‘remembered’ the histone H4 lysine 5 acetylation levels from the 
donor cells, which was also correlated with levels of gene expression in such embryos. 
Interestingly, this memory of histone acetylation level was retained even when blastomeres 
derived from the first round of nuclear transfers were used as donors for the second round of 
nuclear transfers, suggesting persistence of the memory through generations (Wee et al. 
2006). The best documented and molecularly characterised phenomenon of the epigenetic 
memory in nuclear transfer embryos comes from experiments in frogs. It was shown that 
embryos derived from nuclear transfer with somite cells (muscle precursors) showed 
expression of MyoD gene (which is a gene normally expressed in somite tissues) in 
illegitimate regions of the embryo, in which this gene is not normally expressed (Ng & 
Gurdon 2008). This memory was dependent on the presence of lysine 4 of H3.3 histone 
variant at MyoD gene promoter (Ng & Gurdon 2008). This suggests that problems with 
resetting the epigenetic landscape apply not only to genes which are repressed and cannot be 
properly activated in the embryo, but also to those for which activating epigenetic 
environment inherited from the donor cell causes illegitimate gene expression in the resulting 
embryo. 
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Concluding, even though the process of cell differentiation can be reversed 
experimentally, nuclear reprogramming has its limitations and in general is inefficient; 
especially when highly differentiated cells are used as nuclear donors. 
 
 
 
 
Fig. 2. Transcriptional reprogramming system of the nuclear transfer to Xenopus prophase-
arrested oocytes. 
Somatic cells are first permeabilised and subsequently transplanted into the nucleus (germinal 
vesicle – GV) of a prophase-arrested Xenopus laevis oocyte. After the transplantation, nuclei 
of somatic cells reactivate gene transcription. This transcription can be measured by RT-
qPCR. 
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1.3. Sperm is a highly specialised cell 
 
 
1.3.1. Global changes occurring during spermiogenesis 
 
The sperm cell is highly specialised - designed to deliver genetic material to the egg at 
fertilisation. Spermatogenesis is the process in which a pluripotent germ cell differentiates 
into a mature spermatozoon. It starts when the germ cell precursors of the sperm, 
spermatogonia undergo a cell division, which can be either proliferative or differentiative. 
The first one produces more spermatogonial cells, the second one results in a formation of a 
spermatogonial cell and a more differentiated precursor – a primary spermatocyte (de Rooij 
2001) (Fig.3). Primary spermatocytes reduce their chromosome and DNA content in a 
meiotic division and eventually, as a result of meiosis, give rise to four haploid spermatids 
(Roosen-Runge 1969). Spermatids are immediate precursors of sperm, but in order to be 
transformed into mature spermatozoa, they have to complete a series of substantial structural 
and morphological changes, called spermiogenesis (Toshimori 2003) (Fig. 3). 
One of the most dramatic changes occurring during spermiogenesis is a global 
compaction of the chromatin. The molecular basis behind the compaction of the sperm 
nucleus is the best described in mammalian systems, so in this section I will review what is 
known about this process in mammalian systems. It has been calculated that the volume of 
chromatin in mature sperm in mammals is around six times smaller than the volume of 
mitotic chromosomes (Ward & Coffey 1991). Such a high compaction of the sperm nucleus 
is possible due to the presence of protamines. Protamines are small basic proteins, which 
have higher affinity for DNA than histones, allowing a tight packaging of sperm DNA 
(Balhorn 2007). They are incorporated into the sperm chromatin in place of core histones in a 
multi-step process. Initially, the chromatin in the sperm is globally hyperacetylated (Hazzouri 
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et al. 2000, Govin et al. 2004), which is thought to play at least two roles in promoting 
chromatin compaction. First, acetylated lysine residues of histones are recognized and bound 
by a protein called Brdt (Bromodomain-testis specific), which is suggested to be involved in 
histone eviction (Pivot-Pajot et al. 2003, Govin et al. 2006, Moriniere et al. 2009, Gaucher et 
al. 2012). Second, it has been recently shown that acetylation of core histones is also directly 
involved in their proteasome-mediated degradation during sperm maturation (Qian et al. 
2013). Core histones are replaced with testis-specific histone variants, such as hTSH2B, 
H2AL2 or H3t, which are thought to further increase the instability of the nucleosome 
structure (Li et al. 2005, Syed et al. 2009, Tachiwana et al. 2010). Subsequently, histones are 
replaced with transition proteins (Yu et al. 2000, Meistrich et al. 2003, Zhao et al. 2004), 
which are ultimately exchanged for protamines in the final stages of sperm maturation (Chen 
et al. 2001b, Cho et al. 2003, Balhorn 2007, Ravel et al. 2007, Steger et al. 2008). These 
nuclear changes are accompanied by cessation of transcription and disappearance of the basal 
transcriptional machinery – as opposed to spermatids, mature spermatozoa are 
transcriptionally silent (Monesi et al. 1978, Martianov et al. 2001, Zheng et al. 2008) (Fig.4). 
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Fig. 3. Spermatogenesis. 
The diagram depicts sequential stages of spermatogenesis. Spermatogenesis consists of 
meiotic maturation, in which the chromosome and DNA content is reduced and of 
spermiogenesis, in which immature spermatid maturates into spermatozoon. 
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Fig. 4. Major nuclear changes during spermiogenesis (as described in mammalian systems) - 
adapted from (Teperek & Miyamoto 2013). 
The round spermatid undergoes a series of chromatin remodelling events that lead to the 
formation of a fully mature spermatozoon. First, canonical core histones packing the 
chromatin in the round spermatid are replaced by histone variants, which, together with 
global histone acetylation, leads to instability of the nucleosome structure. Subsequently, 
transition proteins are incorporated in place of unstable nucleosomes in the elongating 
spermatid. Finally, transition proteins are replaced with protamines. The mature sperm 
chromatin is mainly composed of protamines, with interspersed histones and with tightly 
associated mRNAs and transcription factors (see chapter 1.4.2). All these processes are 
occurring in parallel with the cessation of transcription – round spermatids are 
transcriptionally active, whereas no transcription is detected in the mature sperm. 
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1.3.2. Epigenetic marks are retained in the chromatin of mature sperm 
 
Interestingly, it has been shown that not all the regions in the sperm chromatin are 
subjected to histone to protamine replacement. Regions which retain histones in the 
chromatin of mature sperm in human were shown to be endonuclease-sensitive and to be 
enriched for gene promoters and other regulatory sequences of the genome, such as enhancers 
(Arpanahi et al. 2009). It was also shown that among the genes that retain histones at their 
promoters in mature sperm in mouse and human, there is a significant overrepresentation of 
genes that are developmentally-important (Hammoud et al. 2009, Brykczynska et al. 2010). 
Furthermore, histones retained in sperm turned out to be post-translationally modified at 
specific regions of the chromatin in mouse and human. Some of the histone modifications, 
like acetylation of H4K12, (Paradowska et al. 2012), histone crotonylation (Tan et al. 2011) 
or H3K4me2 and H3K4me3 (Hammoud et al. 2009, Brykczynska et al. 2010) localise to 
genes which are highly active during spermiogenesis, suggesting that they are important for 
the regulation of expression of spermiogenesis-related genes. Therefore, the presence of these 
marks at the promoters of these genes in the chromatin of mature sperm likely reflects their 
expression at earlier stages. Strikingly however, other marks like H3K27me3, but also 
H3K4me2 and H3K4me3 (and a combination of H3K4me2/3 with H3K27me3), also marked 
promoters of genes that are developmentally-important, for example Hox genes, that are 
involved in embryo patterning (Hammoud et al. 2009, Brykczynska et al. 2010). 
Furthermore, comparison of sperm epigenetic landscapes with embryonic transcriptome 
revealed the following correlation: genes that have activating epigenetic marks in sperm tend 
to be expressed early in development, whereas those with repressive marks are activated late 
or silenced in early embryonic stages (Hammoud et al. 2009, Brykczynska et al. 2010). 
Surprisingly, similar observations were also made in zebrafish, which does not have 
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protamines packing the DNA in the mature sperm. In zebrafish sperm, developmentally-
important genes were enriched for histone variant H2AFV, for H3K4me2/3, H3K27me3 and 
for H3K36me3 at their promoter sequences (Wu et al. 2011). Genes bearing H3K4me3 
together with H3K14 acetylation (H3K14ac) in sperm were enriched at promoters of genes 
related to spermiogenesis and also for housekeeping genes (Wu et al. 2011). Analogically to 
what was observed in mammals, genes with activating marks at their promoters in sperm 
(H3K4me2/3 and H3K14ac) tend to be expressed early in embryonic development, whereas 
genes with repressive mark H3K27me3 or enriched for histone variant H2AFV, tend to be 
repressed at the earliest developmental stages in the embryo (Wu et al. 2011). Interestingly, a 
mass-spectrometry based study of post-translational histone and protamine marks in mouse 
sperm, revealed that not only histones, but also the protamines, are subjected to numerous 
post-translational modifications (Brunner et al. 2014). 
Similarly to histone marks, DNA methylation patterns also show uneven distribution 
in the genome of mature sperm. Overall, cytosine methylation patterns in gene promoters of 
sperm are very similar to those of embryonic stem cells (Farthing et al. 2008). Interestingly, it 
was shown that developmentally-important genes were hypomethylated in sperm in 
mammals, as well as in zebrafish (Hammoud et al. 2009, Brykczynska et al. 2010, Wu et al. 
2011). Importantly, experiments in zebrafish demonstrated that DNA methylation pattern of 
sperm, but not of oocytes, is recapitulated in the embryo at the time of zygotic genome 
activation. The oocyte methylation pattern had to be adjusted to match the sperm methylation 
pattern by a passive loss of DNA methylation (at loci methylated in an oocyte-specific 
manner) or by undergoing de novo methylation (for these loci, that were unmethylated in 
oocytes, but methylated in sperm) (Jiang et al. 2013, Potok et al. 2013). Experiments 
performed using in vitro egg extracts in Xenopus laevis showed that maintenance of the 
sperm-derived DNA methylation after replication is dependent on the recruitment of the 
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maintenance DNA methylase via UHRF1-mediated ubiquitination of lysine 23 on histone H3 
(Nishiyama et al. 2013). 
 
1.3.3. Chromatin composition of the mature sperm in Xenopus laevis 
 
Global condensation of the mature sperm nucleus is also observed in Xenopus laevis. 
Six protamine-like sperm basic proteins (Sps) have been identified in Xenopus: Sp1-6 (Abe & 
Hiyoshi 1991, Hiyoshi et al. 1991, Yokota 1991, Frehlick et al. 2007). Furthermore, it has 
been shown that mature Xenopus sperm cells are devoid of somatic type of linker histone H1, 
and instead have linker histone variants composing their chromatin, like H1fx and H1.sp 
(Abe & Hiyoshi 1991, Shechter et al. 2009). Interestingly, it has been also shown that the 
levels of somatic histone variants H2A and H2B, but not H3 and H4, are significantly 
reduced in Xenopus sperm (Abe & Hiyoshi 1991, Yokota 1991, Shechter et al. 2009). 
Furthermore, mass spectrometry and immunoblotting analyses in Xenopus laevis sperm 
identified the presence of various post-translational histone marks on the sperm chromatin 
(Nicklay et al. 2009, Shechter et al. 2009) (Table 1). However, nothing is known about the 
positioning of these marks on the sperm chromatin or about the function (if any) of these 
marks in the future embryo development. 
Table1. Histone variants and post-translational histone marks identified in Xenopus laevis 
sperm
* 
Histone variants H1fx, H1.sp, H2A.Z,  
Modifications on H3 Methylation: K4me1/2, K9me1/3, K27me1/2/3, K36me1/2, 
K79me1/2, R2me2a, R17me2a 
Acetylation: K18ac1, K23ac2,  
Modifications on H4 Acetylation: K5ac2/3, K8ac1/2/3, K12ac1/2/3, K16ac1/2/3 
Phosphorylation: S1ph 
Methylation: K20me1/2/3, K79me2, R3me1, R3me2s 
*
 - information from (Nicklay et al. 2009, Shechter et al. 2009). 
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1.4. Why is the sperm better than a somatic cell at supporting embryonic 
development? 
 
As mentioned before, the differentiation state of a somatic cell can be reversed back to 
pluripotency by reprogramming, for example by transferring the nucleus of such a 
differentiated cell to an unfertilised, enucleated egg, which in some cases can lead to a full-
term embryonic development. However, it was also mentioned that the nuclear transfer 
procedure is generally highly inefficient. This inefficiency remains in contrast to the high 
rates of successful embryonic development when the sperm fertilises the egg. There are 
definitely some similarities between events occurring after somatic cell nuclear transfer and 
after fertilisation. First, upon introduction into the egg cytoplasm, both the chromatin of the 
sperm and the chromatin of the somatic cell nucleus decondense and increase in volume 
(Gurdon 1976, Lassalle & Testart 1991, McLay & Clarke 2003). Global chromatin changes 
accompany the decondensation process. During fertilisation, sperm-specific protamines are 
replaced with histones deposited in the egg (McLay & Clarke 2003). In nuclear transfer, the 
oocyte-specific histone variants are also incorporated into the chromatin of somatic cells 
(Jullien et al. 2010, Jullien et al. 2012). Interestingly, it was shown that in mice the same egg-
specific linker histone variant – H1foo is incorporated into sperm chromatin upon fertilisation 
and into the nucleus of a somatic cell after somatic cell nuclear transfer (Gao et al. 2004, 
Becker et al. 2005). Moreover, it was shown that in Xenopus both processes are dependent on 
a protein called Nucleoplasmin, which is maternally deposited in the egg (Philpott et al. 
1991, Philpott & Leno 1992, Gillespie & Blow 2000, Tamada et al. 2006, Ramos et al. 2010, 
Inoue et al. 2011, Okuwaki et al. 2012). After reprogramming, the DNA of the sperm or of 
the somatic cell can be replicated and used as a template for RNA synthesis (Aoki et al. 1997, 
Bouniol-Baly et al. 1997). These observations would suggest that the embryos generated by 
both ways undergo similar changes leading to the same outcome – embryonic development. 
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However, embryos develop much better to the adulthood after fertilisation than after a 
somatic cells nuclear transfer. Does it mean that the sperm is somehow specialised to support 
embryonic development? 
There are numerous events occurring during spermiogenesis that transform the 
immature germ cell precursor into a mature sperm that is ready to fertilise the egg. It is 
possible that these events are important to somehow program the sperm to support embryonic 
development. Interestingly, ICSI (Intra Cytoplasmic Sperm Injection) experiments in mice 
showed that a spermatid (Fig. 3), when injected into an unfertilized egg, is a much less 
efficient donor cell at supporting normal embryonic development than a mature sperm cell 
(Kishigami et al. 2004). Moreover, experiments in mice also proved that when injected into 
eggs, spermatids that are more advanced in spermiogenesis are more efficient in producing 
normal embryos than the less advanced ones (Ohta et al. 2009). Both results could suggest 
that acquisition of specific sets of proteins and/or depletion of others may be responsible for 
the high efficiency of reprogramming and embryo generation upon fertilisation. Despite the 
fact that no factors directly responsible for differences in the efficiency of distinct sperm cell 
progenitors have been identified so far, there are some, which are more likely than the others 
to be involved in the sperm programming. Those include protamines, sperm-derived 
transcriptional regulators and sperm epigenetic marking. Each one of those is briefly 
discussed below in the context of its potential ability to confer to the sperm developmental 
advantage when compared with a somatic cell. 
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1.4.1. Protamines 
 
A striking difference between the sperm and the somatic cell is the packaging of their 
DNA. DNA in sperm is wrapped around protamines (at least in the majority of the vertebrate 
species), whereas histones are the core unit organising chromatin in somatic cells. Having the 
protamines instead of canonical histones as the main components of chromatin can provide 
the sperm with at least two developmental advantages. Firstly, upon fertilisation, protamines 
from the sperm are removed and subsequently, maternally-derived histones are assembled 
onto the paternal DNA to allow its chromatinisation (McLay & Clarke 2003, van der Heijden 
et al. 2005). The chromatin of a somatic cell is packed with histones instead of protamines, 
and therefore there may be no need to replace the somatic cell histones with the oocyte-stored 
histones. As mentioned before, somatic cells are differentiated and during the course of 
specialisation they acquire many epigenetic mechanisms stabilising the expression states of 
their own differentiation-specific genes, for example in the form of post-translational histone 
marks. If such epigenetic marks are not correctly erased at fertilisation (as could be the case if 
the oocyte would not remove the somatic cell-specific histones), the epigenetic memory of a 
donor cell can be carried over to the embryos, as demonstrated in the examples above 
(chapter 1.2). In support of this hypothesis it was shown that embryos generated by the 
injection of round spermatids, which do not have protamines on their DNA, had elevated 
levels of DNA methylation and of H3K9me3, as compared to embryos generated by sperm 
injection (Kishigami et al. 2006).  
Secondly, protamines on sperm DNA ensure the tight packaging of its chromatin. 
This can protect the DNA from any physical damage. Interestingly, in rabbits no offspring 
could be derived after the round spermatid injection and the developmental arrest of the 
reconstructed embryos was correlated with their abnormal ploidy (Ogonuki et al. 2005). The 
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nuclear transfer procedure involves numerous micromanipulations to the somatic cell 
nucleus. Since somatic cells do not have protamines, such procedures could lead to DNA 
damage. Indeed, it was suggested that a major cause of developmental failure of nuclear 
transfer embryos was DNA loss, which could be a result of DNA damage induced during the 
nuclear transfer procedure (Mizutani et al. 2012).  
On the other hand, experiments in mouse in which spermatids at different stages of 
spermiogenesis were used as the paternal DNA donors demonstrated that the highest 
difference in the ability of spermatids to support embryonic development was acquired during 
spermatid maturation from step 7-8 to step 9-10. Interestingly, at this stages protamines are 
not yet present in the spermatid nuclei, which argues against necessary roles of protamines in 
supporting embryonic development (Ohta et al. 2009). 
 
1.4.2. Sperm-derived transcriptional regulators and RNAs 
 
Interestingly, even though mature sperm is transcriptionally silent and devoid of basal 
components of transcriptional machinery, some transcription factors, like Oct-1, Ets-1, 
C/EBP and TBP are retained in the chromatin of the mature sperm, and are associated with 
the hypersensitive regions of the sperm chromatin (Fig. 4) (Pittoggi et al. 2001, Zheng et al. 
2008). Proteomic analysis of the mature sperm led to identification of several proteins 
involved in transcriptional regulation, for example, Bromodomain-containing protein 7 
(Brd7) or Polycomb protein Suz12 (de Mateo et al. 2011). If such factors were delivered to 
the oocytes at fertilisation, they could be involved in the regulation of embryonic gene 
expression. On the other hand, a somatic cell has its own transcriptional regulators important 
for the maintenance of its differentiated state. When the nucleus of such a cell is transplanted 
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to the oocyte, some of these differentiation-specific factors characteristic for a somatic cell 
transcriptional program would be delivered to the cytoplasm of the oocyte. This could be 
detrimental for the embryonic development, since it could interfere with the proper regulation 
of the embryonic gene expression. Indeed, it was shown that if fertilised embryos were 
injected with a cytoplasm derived from somatic cells, their development was impaired and 
such embryos had a decreased expression of pluripotency gene Oct4 (Van Thuan et al. 2006), 
suggesting that some components of a somatic cell cytoplasm may be indeed toxic for 
development. 
It was also hypothesised that sperm-derived RNAs may be needed for the future 
embryonic development. Despite the fact that mature sperm is transcriptionally silent and that 
it has almost no cytoplasm, it has been estimated that it contains about 10-100fg of RNA 
compared to 10-50pg of RNA typically found in a somatic cell (Pessot et al. 1989, Krawetz 
2005), some of which were shown to be delivered to the oocyte at fertilisation (Ostermeier et 
al. 2004). Of the RNAs delivered by the sperm to the oocyte at fertilisation, microRNA miR-
34c was shown to be required for the first embryonic cleavage division in mouse (Liu et al. 
2012). This led to the hypothesis that sperm-derived RNAs may be important for embryo 
development and that lack of such RNAs could explain the low developmental potential of 
somatic cells as donors in the nuclear transfer procedures (Miller 2007). However, the results 
of recent genome-wide analyses of sperm RNAs argue against this hypothesis. First, the great 
majority of the RNA contained in the sperm nucleus turned out to be fragmented to a variable 
extent (Sendler et al. 2013). Second, the comparison of RNA-seq profiles obtained from the 
purified sperm, from the whole testis and from various human tissues, revealed that there are 
only 102 transcripts (out of 37974 transcripts tested) that were expressed exclusively in the 
sperm and testis (or detected in other tissues at very low levels). All these transcripts were 
present throughout spermatogenesis and retained until the final stages of sperm maturation, 
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so no sperm-specific transcripts were detected (Sendler et al. 2013). This is not surprising 
taken into account the fact that sperm is transcriptionally silent, and thus all transcripts 
present in mature sperm must be a result of transcription occurring at earlier stages of 
spermiogenesis. Therefore, the presence of transcripts specific for testicular cells could 
perhaps explain the developmental advantage of sperm as compared to somatic cells; 
however, it cannot explain the fact that the mature sperm is better than a spermatid in 
supporting embryonic development. 
 
1.4.3. Sperm-derived epigenetic marks 
 
As mentioned before, it has been demonstrated in several species that mature sperm 
may also deliver to the oocyte information about the regulation of embryonic gene expression 
in the form of epigenetic marks on its chromatin. Promoters of developmentally-important 
genes in the sperm were shown to bear various post-translational epigenetic marks, which, if 
delivered to the oocyte at fertilisation, could instruct the embryo about the regulation of the 
future gene expression (Hammoud et al. 2009). Furthermore, it was also shown that the 
pattern of DNA methylation of the zebrafish sperm is retained in the embryo at the time of 
zygotic gene activation (Potok et al. 2013). Such epigenetic marking could therefore provide 
the sperm with a developmental advantage over a somatic cell nucleus. As discussed before, 
the chromatin of a somatic cell acquires various epigenetic marks in order to stabilise its gene 
expression. These multiple layers of epigenetic marks could be refractory to reprogramming 
after nuclear transfer and would result in the retention of the epigenetic memory of the 
previous state and interfere with embryonic development (Pasque et al. 2011b, Chan et al. 
2012). Furthermore, in support of the hypothesis for the importance of sperm-derived 
epigenetic marks for successful embryonic development, it was shown that abnormal histone 
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retention profiles or incorrect DNA methylation patterns in sperm correlated with idiopathic 
infertility cases in humans (Hammoud et al. 2010, Hammoud et al. 2011). However, due to 
the fact that the highly condensed sperm nucleus is not an easy material for experimental 
manipulations, so far there were no experiments proving this hypothesis. 
 
1.5. Evidence for the sperm developmental advantages 
 
After fertilisation, the embryo has to successfully accomplish several major 
developmental processes. First, the DNA from both parents needs to be faithfully replicated. 
Second, the embryo has to undergo successful zygotic genome activation (ZGA) and initiate 
the synthesis of both zygotic rRNA and mRNA. All these events need to be tightly regulated, 
as otherwise they may create a barrier for successful embryonic development (Newport & 
Kirschner 1982). Interestingly, it was suggested that the sperm may be advantageous as 
compared with a somatic cell in undergoing these processes (see below). 
 
1.5.1. DNA replication 
 
It was shown that a poor survival of nuclear transfer-derived embryos is correlated 
with chromosome loss during early embryonic division stages (Mizutani et al. 2012). It has 
been suggested that chromosome loss during cell division may result from incomplete DNA 
replication at the time of division (Laskey 2005). The use of egg extracts of Xenopus laevis, 
which are able to replicate DNA in vitro, demonstrated that the sperm, as opposed to a 
differentiated somatic cell (erythrocyte), can replicate DNA efficiently. DNA replication 
initiates from origins of replication. It was shown that during sperm replication, the median 
inter-origin distances were around 23.4kbp, whereas the median inter-origin distances for 
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replicating erythrocytes were around 120.9kbp (Lemaitre et al. 2005). Since, at least in early 
Xenopus development, early cell cycle phases are very rapid, and the first cell cycle last for 
only around 120mins (at 18°C), too sparsely positioned origins of replication in somatic cells 
could prevent the replication from being timely completed before the onset of the first cell 
division. Incompletely replicated chromosomes could then be either stretched and broken at 
the division or pushed towards one of the two resulting blastomeres, resulting in DNA loss 
(Gurdon & Laskey 1970). Interestingly, it was shown that pre-treatment of mouse embryonic 
fibroblasts (MEF) nuclei with Xenopus egg extracts before the nuclear transfer procedure 
increased the efficiency of replication (making it similar to what is observed for sperm 
nuclei) (Ganier et al. 2011). This pre-treatment of MEFs with Xenopus egg extracts also 
increased the frequency of normal nuclear transfer embryo development in mouse (Ganier et 
al. 2011). Therefore, the ability of undergoing efficient DNA replication was suggested to be 
one of the developmental advantages of sperm. Conversely, inefficient replication was 
suggested to be the cause of frequent developmental failures of embryos derived from a 
somatic cell nuclear transfer (Laskey 2005). 
 
1.5.2. rRNA synthesis 
 
Another challenge that the developing embryo has to face is a timely activation of 
rRNA synthesis. rRNA is a necessary component of ribosomes, which mediate protein 
translation. Series of experiments in mouse demonstrated that sperm-derived embryos, are 
significantly better at timely activating zygotic rRNA transcription than nuclear transfer-
derived embryos. First, reverse transcription, quantitative PCR (RT-qPCR) measurements of 
ribosomal RNA content revealed that nuclear transfer embryos (NT-embryos) have 
significantly lower levels of 18S, 28S and 5.8S rRNA than control sperm-derived embryos 
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(Suzuki et al. 2007). Second, inefficient rRNA activation, was also evidenced by a smaller 
amount of labelled RNA precursor incorporated into rDNA and by a significant delay in the 
appearance of markers of active nucleolar organising regions in NT-embryos, as compared to 
sperm-derived embryos (Bui et al. 2011). Finally, inefficient activation of rRNA synthesis 
was correlated with poor developmental outcomes of NT-embryos. First, NT-embryos 
developed worse than sperm-derived embryos, but also, NT-embryos which were more 
efficient at rRNA synthesis, developed better to adulthood than embryos less efficient at 
rRNA synthesis (Zheng et al. 2012). Interestingly, the ability to activate rRNA synthesis 
efficiently in NT-embryos was correlated with the levels of rDNA activity in the donor cells: 
the more active the donor cells at synthesising rRNA, the more efficient the resulting NT-
embryos at activating rRNA synthesis and the better the embryonic development. 
Furthermore, this phenomenon was also related to the DNA methylation levels of the rDNA 
loci in the donor cells, which were shown to be the most methylated in cells which were the 
less active at rRNA synthesis, and the less methylated in cells which were the most active in 
the rRNA transcription (Zheng et al. 2012). This is an important finding, as it again points 
towards the epigenetic memory of a previous state being a barrier for a successful 
reprogramming, and suggests that the inability of NT-embryos to correctly activate rRNA 
transcription may be the cause of their developmental failures. 
 
1.5.3. mRNA synthesis 
 
Finally, embryos need to initiate the synthesis of zygotic mRNAs in order to succeed 
in development (Newport & Kirschner 1982). There are reports indicating that NT-derived 
embryos do not properly initiate embryonic gene expression, as compared to sperm derived-
embryos. It was shown in mouse that NT-embryos often fail to induce correct expression of a 
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key pluripotency factor Oct4 and even if they succeed to induce its expression, they often do 
so abnormally and express it in ectopic tissues, in which Oct4 is not expressed in control 
sperm-derived embryos (Boiani et al. 2002). Again, correct activation of Oct4 correlated with 
successful development of NT-embryos (Bortvin et al. 2003). Microarray studies revealed 
that abnormal expression levels of 1633 genes was already detected at 2-cell stage in NT-
embryos in mouse (as compared with fertilised embryos). Furthermore, the largest group 
within these early abnormally expressed transcripts were transcription factors (Vassena et al. 
2007). Another microarray study in mouse in which 87 single blastocyst stage embryos 
derived from nuclear transfers with different donor cells were compared with control 
fertilised embryos revealed that gene expression profiles differed between nuclear transfer 
embryos and fertilised embryos and also that nuclear transfer embryos coming from the same 
donor cell type, were more similar to each other, than to the embryos coming from nuclear 
transfer of different donor cell types (Fukuda et al. 2010). The same conclusion has been 
drawn in an independent study, also using mouse nuclear transfer-derived embryos from 
different types of donor cells (Hirasawa et al. 2013). In the latter paper it was also showed 
that the donor-cell dependent aberrant gene expression was more pronounced in embryonic 
than in extraembryonic tissues (Hirasawa et al. 2013). All these results point towards the 
same conclusion, that the NT-derived embryos experience problems with initiation of 
embryonic gene expression and that the abnormalities in gene expression profiles are often 
correlated with the origin of the donor cell, suggesting persistent epigenetic memory in NT 
embryos. 
Concluding, the sperm, as opposed to a somatic cell, may be programmed for several 
aspects of embryo development: DNA replication, initiation of rRNA synthesis and zygotic 
mRNA transcription. 
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1.6. Work described in this thesis 
 
The experiments described in this thesis aim to answer the question of what is the 
nature of developmental programming of sperm. I started from establishing a model system 
in which the developmental potential of sperm can be compared to the developmental 
potential of another cell type. I concluded that a suitable cell to compare with sperm is a 
spermatid. A spermatid is an immediate precursor of sperm, has already completed meiotic 
division, and differs from sperm only in the degree of specialisation. Furthermore, a 
spermatid can be compared to sperm in the same assay. I then showed that sperm is better at 
supporting embryonic development than spermatids, suggesting that sperm is programmed to 
support proper embryonic development. Subsequently, I aimed to identify the molecular basis 
for the sperm programming. I started from the identification of proteins present in sperm and 
spermatids by mass spectrometry analysis, reasoning that sperm-specific factors could be 
responsible for the developmental advantage of sperm. I also used the mass spectrometry-
based approach to identify egg proteins which bind specifically to sperm or spermatid 
chromatin, since sperm programming could be also reflected in the ability to interact with the 
egg factors. Mass spectrometry analysis allowed me to identify several interesting candidate 
proteins, which I then functionally tested for their roles in the programming of the paternal 
nucleus. Unfortunately, none of these factors turned out to be beneficial for embryonic 
development. I have then changed my strategy for investigating the nature of sperm 
programming by characterising the developmental defects of spermatid-derived embryos. I 
showed that these defects are unlikely to be explained by inefficient DNA replication or by 
their inability to initiate zygotic rRNA transcription. Interestingly, RNA-seq analyses allowed 
me to identify 100 developmentally-important mRNAs which were misexpressed in 
spermatid-derived embryos as compared with sperm-derived embryos. Interestingly, the 
majority of them (82/100) were upregulated in spermatid-derived embryos. Further analysis 
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revealed that orthologues of these genes are modified by a repressive H3K27me3 mark in 
human sperm. These results encouraged me to test the hypothesis that perhaps the sperm is 
epigenetically programmed to regulate embryonic gene expression after fertilisation. Indeed, 
the enzymatic removal of H3K27me3 marks from the parental chromatin in embryos at the 
time of fertilisation resulted in gene misexpression. This led to the hypothesis that perhaps 
spermatids lack the repressive H3K27me3, as compared with sperm, which causes 
upregulation of genes in spermatid-derived embryos. Surprisingly, ChIP-seq analyses on the 
chromatin isolated from sperm and spermatids revealed that spermatids, similarly to sperm, 
already have repressive H3K27me3 marks at misregulated genes. Therefore, H3K27me3 
itself could not explain the difference in gene expression between sperm- and spermatid-
derived embryos. Interestingly, further ChIP-seq analyses for activating histone marks 
revealed that spermatids have more of H3K4me2/3 marks than sperm. Interestingly, the 
presence of these activating marks at misregulated genes in spermatids correlated with their 
upregulation in spermatid-derived embryos. All these results support the hypothesis that the 
sperm, as opposed to the spermatid, is epigenetically programmed to regulate embryonic gene 
expression after fertilisation. 
The results presented in this thesis are divided into 5 separate chapters (Chapters 3-7). 
Each of these chapters has a brief introduction that explains the rationale for the experiments 
conducted, followed by a detailed report of the results and a subsequent short 
summary/discussion. Since all the chapters have their own short summary/discussion 
sections, when writing the final discussion of the thesis (Chapter 8) I took the advantage of 
the writer’s freedom and I do not discuss the results one by one in the order of appearance in 
the thesis. Instead, I took the pleasure of talking about the most exciting results; therefore I 
sometimes shuffle the results and discuss them according to the common connecting theme. 
In the discussion section I also propose new experiments, which are based on the results 
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described, that are either currently conducted in the laboratory or are in the future plans. 
Finally, I put the obtained results in the broader context and I explain how they advance the 
current knowledge of the subject.  
In the appendices section of the thesis I attach publications that arose as a result of 
this work. There are two review articles, one book chapter and a research article by a 
colleague from my laboratory, Dr Kei Miyamoto, with whom I collaborated on some parts of 
his project (which is not connected to the work described in this thesis and therefore is not 
separately described here). The manuscript describing the work presented in this thesis is 
currently in preparation. 
Supplementary tables S1-S6 are Excel files with long protein/gene lists, and they are 
therefore provided electronically as separate attachments to this thesis. 
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Chapter 2 
Experimental procedures 
 
All the experiments involving the use of animals comply with the Home Office 
regulations as set out in the Animals (Scientific Procedures) act 1986 (Establishment Code 
8002802). 
All the animal care (tadpole and frog husbandry, hormonal injections (PMSG/hCG), 
sacrifice and dissections) was done by David Simpson at the Frog Facility at the Gurdon 
Institute. 
All the bioinformatic analyses described are written and kindly shared by Dr Angela 
Simeone, Dr George Allen and Dr Charles Bradshaw. 
Experimental procedures are described in order of their appearance in the ‘Results’ 
section of the thesis (Chapters 3-7), apart from all the bioinformatic analyses, which are 
described altogether as the last section. 
 
2.1. Separation of sperm and spermatids 
 
Testes from 6 adult Xenopus laevis males were isolated and manually cleaned from 
blood vessels and fat in 1XMMR (100mM NaCl, 2mM KCl, 2mM CaCl2, 1mM MgCl2, 5mM 
HEPES pH 7.4) using forceps and paper tissues. It is crucial to clean the testes well from any 
non-testicular tissues, as otherwise the cells released from the tissues may negatively affect 
the final purity of the isolated cells. Subsequently, testes were torn into small pieces with 
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forceps and homogenised with 2-3 strokes of a Dounce homogenizer (tissue from 1 testis at a 
time). The cell suspension was then filtered (50um pore size, CellTrics, cat. 04-0042-2317) to 
remove tissue debris and cell clumps and spun down at 800rcf, 4°C, 20 minutes. Supernatant 
was discarded and the cell pellet was resuspended in 12ml of 1XMMR. If any red blood cells 
were visible at the bottom of the pellet (a result of incomplete removal of blood vessels), only 
the uncontaminated part of the pellet was recovered, taking extreme care not to disturb the 
red blood cells. Subsequently, six (1 per testes from each frog) step gradients of iodixanol 
(Optiprep – Sigma, D1556, is 60% iodixanol in water) in 1XMMR were manually prepared 
in pre-chilled 14ml ultra-clear centrifuge tubes (Beckman Coulter, 344060) in the following 
order from the bottom to the top of the tube: 4ml of 30% iodixanol, 1ml of 20% iodixanol, 
5ml of 12% iodixanol and 2ml of cell suspension in 1XMMR. Gradients were spun down in 
pre-chilled SW40Ti rotor at 7500rpm (10000g), 4°C, 15 minutes, deceleration without break 
(Beckman Coulter Ultra-centrifuge, Optima L-100XP). The top interface fraction (between 
1XMMR and 12% iodixanol), containing spermatids, and the pelleted fraction, containing 
mature sperm, were collected. Collected fractions were diluted six times with 1XMMR and 
collected by spinning first at 805 rcf, 4°C, 20 minutes and re-spinning at 3220 rcf, 4°C, 20 
minutes to pellet the remaining cells. Pelleted cells were subjected to nuclei preparation (see 
below). 
 
2.2. FACS analysis 
 
All the cell cycle analyses were performed by Dr Rachel Walker at the Flow Cytometry 
facility of Cambridge Stem Cell Institute, Cambridge, UK (samples were provided to Dr 
Walker after fixation and labelling). 
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Cells were fixed in cold 70% EtOH for 30mins at 4°C, washed twice in 1XMMR, 
spun at 850g and resuspended in 50ul of 1XMMR supplemented with 100ug/ml of DNase-
free RNase. DNA was stained by the addition of 200ul of 50ug/ml propidium iodide solution. 
 
2.3. Sperm and spermatid nuclei preparation, intra-cytoplasmic sperm 
injections (ICSI) to non-enucleated and to enucleated eggs, and embryo 
culture 
 
Sperm and spermatids nuclei have been permeabilised with digitonin (Smith et al. 
2006) and stored at -80°C. Injections were performed using Drummond Nanoject 
microinjector (NanojectII Auto Nanolitre Injector, Biohit, 3-00-206A) and glass caplillaries 
(Biohit, 3-00-203-G/XL) pulled using a Flaming-Brown micropipette puller (settings: heat 
700, pull 100, velocity 100, time 10). Cell suspension in sperm dilution buffer (SDB) (Smith 
et al. 2006) was sucked into the injection needle filled with mineral oil. Cell concentration 
was adjusted by doing mock injections on a microscope slide to deliver 1 cell per 4.6nl 
injection. The eggs were placed in batches of 20-25 on a blotting paper. If they were to be 
enucleated, they were placed with animal pole facing upwards, whereas if they were not 
subjected to enucleation, they were placed on a side (with the marginal zone upwards). For 
enucleation, eggs were treated for 30s with a UV mineralite lamp (Gurdon 1960) (this step 
was omitted for non-enucleated eggs). The jelly of the egg was removed by a minimal length 
of the Hanovia lamp treatment that allows for the needle penetration. The eggs were 
immediately injected with sperm or spermatid solution and moved to 1XMBS (Gurdon 1976) 
supplemented with 0.2% bovine serum albumin (BSA). Cell suspension in the needle was 
replaced every 20-25 eggs injected. At 4-cell stage embryos were sorted (all the non-cleaved 
embryos or those with irregular cleavage furrows were discarded) and the culture media was 
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replaced with 0.1MBS, 0.2% BSA. Embryos were cultured in 0.1MBS, 0.2% BSA (changed 
daily) at 16-18°C incubator. Assessment of developmental stages was performed according to 
Nieuwkoop and Faber (Nieuwkoop & Faber 1994). 
 
2.4. Nuclear transfer 
 
Nuclear transfers were performed as described (Elsdale et al. 1960, Gurdon 1960), 
with a modification: donor cells were dissociated in 2mM EDTA. Donor cells were derived 
from animal caps of early gastrula (stage 10.5) embryos. Eggs were enucleated by a 30s 
treatment of Mineralite UV lamp and dejellied by a treatment with a Hanovia UV lamp 
(minimal length required to allow for the needle penetration). 
 
2.5. Protein preparation for the mass spectrometry analysis 
 
 
All the methods were obtained from the Cambridge Centre for Proteomics (CCP), at the 
Biochemistry Department, University of Cambridge. I have performed all the steps of protein 
isolation, quantification and labelling under the supervision of Renata Feret from the CCP. 
All the subsequent steps of the analysis were carried by Renata Feret and colleagues at the 
CCP. 
Proteins from pelleted sperm and spermatids were extracted in Urea/Thiourea buffer 
(4% Chaps, 2M Thiourea, 6M Urea; Sigma: C9426, T7875, respectively and Fisher 
Chemicals, U/0500/53) supplemented with protease inhibitors (Roche, 11873580001) by 
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keeping on ice for 1h and vortexing from time to time until the pellet disappeared. 
Subsequently, the solution was sonicated with a probe sonicator (3s, Amplitude 40, 
sonication over an ice bath) in four separate rounds. The protein concentration was quantified 
with a Quick Start Bradford Protein Assay (Bio-Rad, 500-0202), following manufacturer’s 
recommendations. Fifty micrograms of protein lysate was subsequently labelled with Cy3 or 
Cy5 dye (Cy dyes label the lysine residues of proteins) by adding 1ul of 0.2mM dye. 
Labelling reaction was carried at 4ºC for 30mins in the dark and quenched by the addition of 
1ul of 1mM lysine. Quenching was performed for 10mins at 4ºC in the dark. After the 
labelling was completed, labelled protein lysates were mixed. Reciprocal labelling was 
performed to rule out any abnormalities or biases in labelling (none were noticed). Further 
processing of the samples (1
st
 and 2
nd
 dimension electrophoresis, scanning, staining, spot 
excision, protein digestion and the mass spectrometry analysis) were performed by the staff at 
the CCP according to the methods used at the CCP. 
 
2.6. Interphase egg extract preparation 
 
Eggs were collected in 1XMMR, dejellied with 0.2XMBS, 2% cysteine (pH 7.8-7.9) 
(Sigma, W326305) and washed with 0.2XMMR. Subsequently, eggs were activated for 3 
minutes at RT with 0.2XMMR supplemented with 0.2ug/ml calcium ionophore (Sigma, 
C7522). Eggs were rinsed with 0.2XMMR and subsequently all abnormal or not activated 
eggs were removed. Eggs were washed with 50ml of ice-cold extraction buffer (EB) (5mM 
KCl, 0.5mM MgCl2, 0.2mM DTT, 5mM Hepes pH 7.5) supplemented with protease 
inhibtiors (PI) (Roche, 11873580001), transferred into centrifugation tube (Thinwall, Ultra-
Clear™, 5mL, 13 x 51 mm tubes, Beckman, 344057) and supplemented with 1ml of EB 
buffer with PI and 100ug/ml of cytochalasin B (Sigma, C2743) and placed on ice for 10 
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minutes. Subsequently, eggs were spun briefly at 350g for 1 minute at 4°C (SW55Ti rotor, 
Beckman Coulter Ultra-centrifuge, Optima L-100XP) and excess buffer was discarded. Eggs 
were then spun at 18000g for 10 minutes at 1°C, the extract was collected with a needle, 
transferred to a fresh, pre-chilled tube, supplemented with PI and 10ug/ml of cytochalasin B 
and re-spun using the same conditions. Extract was collected with a needle and used: frozen 
(on liquid nitrogen, in 100ul aliquots) for the analysis of proteins bound to the chromatin 
followed by the proteomic analysis; or fresh, for replication assays (see below). 
 
2.7. Egg extract treatment and protein isolation for mass spectrometry 
analysis of egg proteins incorporated into sperm or spermatid chromatin. 
 
Sperm and spermatids were collected and permeabilised as described above. Egg 
extracts were prepared as described above. Twenty millions of permeabilised sperm or 
spermatids were treated with 3650ul of egg extract, supplemented with the 1X final energy 
regeneration mix (20X energy regeneration mix is prepared and stored in aliquots at -80ºC: 
2mg/ml Creatine Kinase (Roche, 10127566001), 150mM Creatine Phosphate (Roche, 
10621714001), 20mM ATP (Roche, 10519979001), 2mM EGTA, 20mM MgCl2). Control 
permeabilised cells were treated with EB buffer and the energy regeneration mix alone. Cells 
were incubated in the extract/buffer for 1h at room temperature with frequent tapping. After 
that, cells were washed with 15 volumes of Buffer D (10mM Hepes pH 7.7, 10mM KCl, 
1.5mM MgCl2, 1mM DTT) (spin at 3220 rcf, 4°C, 20mins). Pellets of black colour were 
observed in the egg extract-treated samples. Subsequently, pellets were resuspended in 15ml 
of Buffer E (250mM Sucrose, 10mM Tris-HCl pH 8.0, 5mM MgCl2, 1mM DTT, 0.1% Triton 
X-100) and spun at 3220 rcf, 4°C, 20mins. Subsequently, pellets were resuspended in 1ml of 
Buffer E each and transferred to a 1.5ml tubes and washed 6 more times with Buffer E (each 
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time spun at 1000rcf, 5mins, 4°C). The final pellet contained proteins bound to chromatin, 
which were isolated and processed for 2-DIGE and proteomics analysis as described in 
chapter 2.5. 
 
2.8. Immunoblotting analysis. 
 
All the immunoblotting analyses were performed according to standard 
immunoblotting protocols (Green & Sambrook 2012). For the validation of mass 
spectrometry results, equal amount of proteins isolated in Urea/Thiourea buffer were loaded 
on each blot (see chapter 2.5). For the immunoblotting on oocytes, embryos or GVs, 
equivalents of 1 oocyte, cytoplasm or embryo or an indicated number of GVs were loaded on 
each lane of a gel. Isolations of cytoplasmic proteins from oocytes/embryos were performed 
using a mild lysis buffer (10mM Tris pH 8.0, 150mM NaCl, 1%NP-40, 1mM EDTA and 
protease inhibitors): oocytes/embryos were disrupted in the lysis buffer, kept on ice for 
10mins, vortexed from time to time, spun at 16100 rcf, 4ºC, 1min and the supernatant was 
used for immunoblotting. Isolations of nuclear proteins (from somatic cells, sperm, 
spermatids or from embryos) were performed using Emilie’s Buffer (500mM Tris pH 6.8, 
500mM NaCl, 1% NP40, 0.1% SDS, 1% b-Mercapthoethanol and protease inhibitors). If 
nuclear proteins were isolated from embryos, then first the nuclei were isolated (to remove 
contaminating yolk, see below) and only then the Emilie’s buffer was used to extract the 
proteins from the pelleted nuclei. Nuclei were isolated from embryos with the following 
method: up to 5 embryos were homogenised by pipetting up and down in 50ul of buffer E1 
(50mM Hepes-KOH pH 7.5, 140mM NaCl, 1mM EDTA pH 8.0, 10% glycerol, 0.5% Igepal 
CA-630, 0.25% Triton X-100, 1mM DTT and protease inhibitors) and spun at 1100rcf, 
2mins, 4ºC (all the following centrifugations were performed in the same conditions). The 
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supernatant and the lipids attached to the walls of the tube were discarded and the pellet was 
resuspended in 2ml of buffer E1. The spin was repeated and the pellet was again resuspended 
in 2ml of buffer E1 and incubated on ice for 10mins.  After another spin, the pellet was 
resuspended in 2ml of buffer E2 (10mM Tris pH 8.0, 200mM NaCl, 1mM EDTA pH 8.0, 
0.5mM EGTA pH 8.0 and protease inhibitors) and centrifuged. This procedure was repeated 
twice (the last wash in E2 was preceded by 10mins incubation in E2 on ice). Finally, the 
pellet (containing the isolated nuclei) was resuspended in the desired volume of Emilie’s 
buffer). 
Polyacrylamide gels were cast at the percentage appropriate for the separation of the 
desired protein size (Green & Sambrook 2012). Gel electrophoresis, transfer of proteins, 
immunoblotting and washes were performed according to the standard protocols (Green & 
Sambrook 2012). PVDF membranes with 0.45uM pore size were used (Immobilon, 
Millipore, IPFL00010) with a semi-dry transfer system (Trans-Blot® SD Semi-Dry Transfer 
Cell, BioRad, 170-3940) transferring for 30mins, at room temperature (25V). 
All the protein detections were performed using immunofluorescence with the use of 
the LI-COR Imaging System. Primary antibodies were used at 1:1000 dilutions, unless stated 
otherwise and blots were incubated with the primary antibodies overnight at 4°C. Primary 
antibodies against the following proteins were used in this thesis: Hdac1 (rabbit polyclonal; 
Abcam, ab33278), Hdac2 (rabbit polyclonal; Epitomics S2398), Mbd3 (1:250; mouse 
monoclonal; Abcam, ab45027), Hp1γ (goat polyclonal; Abcam, ab40827), HA-tag (1:2500, 
mouse monoclonal; Sigma, H9658), Rbbp4 (rabbit polyclonal; Abcam, ab1765), Rbbp7 
(rabbit polyclonal; Abcam, ab3535), Lsf (rabbit polyclonal; Abcam, ab80445), actin (1:2500, 
rabbit polyclonal; Sigma, A2103), beta-actin (1:2500; mouse monoclonal; Abcam, ab6276), 
H3K27me3 (rabbit monoclonal; Cell Signalling Technology, 9733), H2A (rabbit polyclonal; 
Millipore, 07-146), H2B (1:2000, rabbit polyclonal; Abcam, ab1790), H3 (rabbit polyclonal; 
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Abcam, ab18521) and H4 (1:500, rabbit polyclonal; Abcam, ab10158). To detect the primary 
antibodies, the following secondary antibodies were used (all at 1:25000 dilution): goat anti-
mouse IRDye 800 (Licor, 926-32210), Goat anti-Rabbit IRDye 800 (Licor, 926-32211), goat 
anti-rabbit Alexa 680 (Invitrogen, A-21109), goat anti-mouse Alexa 680 (Invitrogen, A-
21057), donkey anti-goat Alexa 680 (Invitrogen, A-21084). Blots were incubated with the 
secondary antibody solution for 1h at RT. To reveal the proteins, blots were scanned using a 
LI-COR detection system (Odyssey laser scanner, LI-COR Biosciences). 
 
2.9. Molecular cloning of candidate sperm factors and mRNA synthesis 
 
cDNA from testis isolated from Xenopus laevis was generated with the use of 
oligodT(15) primer. NCBI-deposited sequences were then used to design primers to amplify 
the sequences of candidate sperm factors: Sp1 (NM_001137586.1), Sp4 (NM_001087761.1), 
Sp5 (S71764.1), H1fx (BC041758.1), Mlf1 (NM_001095375.1). Primers used to amplify the 
candidate factors cDNA sequences and to allow their cloning into the pEntry vector are listed 
in Table 2. Clonings were performed using pENTR™/D-TOPO® Cloning Kit (Life 
Technologies, K2400) and Gateway® LR Clonase® II enzyme mix (Life Technologies, 
11791-020) according to the manufacturer’s instructions. Directional cloning was performed 
into the C-terminus (destination vector used was pCS2+ with a C-terminal HA-tag). Clones 
were first checked by a directional colony PCR screen (using M13 forward primer: 
GTAAAACGACGGCCAGT and the insert-specific reverse primer) and second, by 
restriction enzyme digestion and Sanger sequencing (Sanger sequencing reactions were 
performed at the sequencing facility at the Department of Biochemistry, University of 
Cambridge). mRNA was synthesized in vitro using MEGAscript® SP6 Kit (Ambion, 
AM1330M) following the manufacturer’s instructions. mRNA concentration was measured 
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with a Nanodrop, adjusted to a final concentration of 1mg/ml with DEPC H2O, aliquoted 
(aliquots of 2ul) and frozen at -80ºC. Clones of mouse K6B (amino acids 1025-1642) and its 
catalytically inactive mutant (K6B-mut) were in pCS2+ destination vector with a C-terminal 
HA-tag and NLS-tag and were a kind gift from Dr Jerome Jullien. 
Table 2. Sequences of primers used for the cloning of candidate sperm factors 
Name of primer Sequence 
XL_SP1_Entry_F CACCATGGCACTGCCCTCCGAGACC 
XL_SP1_Entry_R CACTATCATGGTTCTGGGAACCCTGCGCTTG 
XL_SP4_Entry_F CACCATGAGCAAAGTGAGTGGCGGG 
XL_SP4_Entry_R ACTGCGATAATCTGAGCCATAGTCTCTTGCC 
XL_SP5_Entry_F CACCATGAGCAAAATGAGAGGCGGG 
XL_SP5_Entry_R ACTGCGATATTCTGACCCATAGGC 
XL_H1fx_Entry_F CACCATGGCTCTAGAGCTGGAAGAGAATTTACACAGC 
XL_H1fx_Entry_R CGCTTTCTTGGATTTAGGCGCTTTGCGGACGC 
XL_MLF1_Entry_F CACCATGTTCCGCAGTTTGCTGAGAGACTTTGACG 
XL_MLF1_Entry_R TTTCTCCCTTGCCGGCAACTGCAGCTG 
 
 
2.10. Cell culture, transfection, immunostaining and microscopic analysis 
 
Mouse C2C12 cells were cultured in DMEM (GIBCO, 41965-062) supplemented 
with 10% FBS and 100u/ml of penicillin/streptomycin at 37ºC, 5% CO2. Xenopus laevis XL 
177 cells were cultured in the same medium, but diluted to 60% with a ddH2O at 23ºC. Cells 
were split whenever the confluence was reached. Transfections were performed with 
lipofectamine 2000 (Invitrogen, 11668027), following the manufacturer’s protocol. For the 
immunostaining procedure, cells were fixed with 4% PFA in1XPBS, permeabilised with 
0.1% Triton X-100 in 1XPBS and blocked with 5% BSA in 1XPBS. Antibody against the 
HA-tag (mouse monoclonal; Sigma, H9658) was diluted 1:500 and detected with a secondary 
antibody conjugated with Alexa 488, diluted 1:500 (donkey anti-mouse, Invitrogen, A21202). 
Samples were mounted on a microscope slide in Vectashield mounting medium with DAPI 
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(Vector Labs, H-1200) and sealed with nail polish. Microscopic analyses were performed 
using Zeiss 510 META confocal LSM microscope. 
 
2.11. Cell squashing for ploidy assessment 
 
Early tadpoles (stage 30-36) were anaesthetised and decapitated. Subsequently, 
tadpoles were transferred on a microscope slide and the yolky tissues were removed. The 
remaining tissues of the tadpole were then squashed with the coverslip and observed under a 
phase contrast microscope. 
 
2.12. Injection of 1-cell embryos with mRNA 
 
Eggs were in vitro fertilised and dejellied using 2% cysteine solution in 0.1XMMR. 
Injections into 1-cell stage embryos were performed in injection solution (Smith et al. 2006) 
using a Drummond Nanoject microinjector, delivering 9.2ng of mRNA per injection (mRNA 
at 1mg/ml in DEPC H2O). Embryos were cultured at 18°C and collected for qRT-PCR 
analysis (chapter 2.14) at the stage indicated in the text (see Chapter 3.7). Expression of K6B 
and K6B-mut proteins in embryos, as well as the removal of H3K27me3 by K6B were 
confirmed by immunoblotting. 
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2.13. Injection of mRNA or oligonucleotides into the oocytes 
 
 
Oligonucleotides and qPCR primers for HP1γ were designed by Matthew Jones, a 4-year 
PhD rotation student during his rotation in the Gurdon laboratory. 
 
Ovaries were isolated from frogs pre-primed with PMSG at least 48h before use. 
Oocyte defolliculation was performed enzymatically with a liberase treatment (Halley-Stott et 
al. 2010). For in vitro maturation experiments, oocytes were liberated for a maximum time of 
1h 15mins and the remaining defolliculation was done manually (Miyamoto et al. 2013). 
Oocytes were cultured in 1XMBS medium (88mM NaCl, 1mM KCl, 2.4mM NaHCO3, 
0.82mM MgSO4, 0.41mM CaCl2, 0.33mM Ca(NO3)2, 10mM HEPES pH7.4, 10ug/ml 
streptomycin sulfate and 10μg/ml penicillin). mRNA was injected as described above, with 
the difference that the use of injection solution was omitted (oocytes were injected directly in 
the culture medium). Oligonucleotide design was performed according to the guidelines 
published (Hulstrand et al. 2010). Sequences of the oligonucleotides used are listed in Table 
3. The oligonucleotide injection and in vitro maturation and ICSI (for the K6B/K6B-mut) 
experiments were conducted as described before (Miyamoto et al. 2013). Sequences of 
primers used for the assessment of the knockdown are listed in Table 4. 
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Table 3. Sequences of oligonucleotides used for the knockdown of candidate egg factors 
Name of oligonucleotide Sequence 
HP1g #1 C*T*T*CCTCCACCTTCT*T*G*C 
HP1g #2 A*C*C*TTTCCATTTACTAC*A*C*G 
HP1g #3 T*T*C*AATCAACTCTGGACA*G*T*C 
Hdac1 #1 C*C*A*ACATCACCATCA*T*A*G 
Hdac1 #2 C*C*A*TAGTTGAGCAGC*A*G*G 
Hdac1 #3 T*G*T*CTGGTCGTATGG*A*G*C 
Hdac2 #1 G*A*C*CTTCTTCTTGGC*A*C*C 
Hdac2 #2 C*A*C*CATCATAATAGT*A*G*C 
Hdac2 #3 C*G*G*ATTCTGTGAGGC*T*T*C 
Mbd2/3 #1 C*T*G*AGGCTTACTGCG*G*A*A 
Mbd2/3 #2 T*C*C*TAAGTAACGAGC*A*A*G 
Mbd2/3 #3 C*C*G*CATTCGCTGTCT*G*T*T 
LSF #1 T*G*C*CAGCGGTAACTT*C*A*G 
LSF #2 T*C*C*ACCTCCATCCTT*C*T*A 
LSF #3 T*A*T*TCTGTCTCCAGG*T*C*T 
Rbbp4 #1 T*A*T*GACTCGTTCCTC*C*A*C 
Rbbp4 #2 G*A*G*CATCATCATTAG*G*A*A 
Rbbp4 #3 A*G*G*TTGCCACTTAGG*T*T*G 
Rbbp7 #1 C*T*T*CCACTGTATCCT*C*A*A 
Rbbp7 #2 C*A*T*AACCAGGTCATA*C*A*G 
Rbbp7 #3 G*G*A*ACCTGGACACGA*G*C*C 
*  denotes a phosphorothioate bond 
 
Table 4. Sequences of primers used for qRT-PCR assays 
Name of the primer Sequence 
Hdac1_F1 CGCTCCATACGACCAGACA 
Hdac1_R1 GCCATCAAACACAGGACAGT 
Hdac2_F1 TCTGTAGCTGGTGCTGTAAAACTCA 
Hdac2_R1 CCTGCCCAGTTAACAGCCATA 
HP1g_F1 GGGAGCCTGAGGAAAACTTAG 
HP1g_R1 CAAATCCCCGTGGTTTATCA 
Rbbp4_F1 GGAGAGTTTGGAGGCTTTGG 
Rbbp4_R1 TGGAGTTTTGGTGGCAATAA 
Rbbp7_F2 GTGTCCAGGTTCCCAATGAT 
Rbbp7_R2 CAAAGCCACCAAACTCTCCT 
PWP1_F GACTTCGAAAATCTGGCATCTCA 
PWP1_R GGGACTTTCACCATTGACTTAAACA 
GATA3_F2 CACAGGATCTCCATTGGCATT 
GATA3_R2 CCTGTGCAAACTGTCAAACCA 
SFRP2_F1 GGAATAAGAAGAGACAGGCCCAAT 
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SFRP2_R1 TTACCAAAGCCACCCCAGAA 
C19ORF26_tr_F2 GCCATCAACCCCTTCTTCATC 
C19ORF26_tr_R2 ACACGTTACCACAGCACTTTGC 
PLOD2_F2 CACATTCTTTATTCTGCCGACAGAT 
PLOD2_R2 AAGAGCCAATCACGCAAGCT 
NA_F1 GATGCTCAGCTTTGGATCTTGA 
NA_R1 CCACACGGGCCTGATCTG 
MN1_F2 TGCCTTCAGCTAGGGACACA 
MN1_R2 CACCCAGTCGTGATAAAGCAGTAG 
XL_HES1_F1 TGAGCAATACCCCGGATAAG 
XL_HES1_R1 TCCAGGATGAGGGTTTTGAG 
WAVE1_F2 AGGAATCCAGCTTCGCAAAG 
WAVE1_R2 ACGCGCTCGTGTTTTGCT 
HOXB1_F CCCCACAAAATTGCAACCA 
HOXB1_R TCTGCTTCTTGGCTGGCATA 
HES7_F1 TCCTCTCCCTCCGCCTTTT 
HES7_R1 CCATGGAAACCCATAGAAAGCT 
DOLPP1_F GGGCATTCGCTATGCTCTCT 
DOLPP1_R GCCTGAAATCCCTCAACCAA 
ZNF33A_F2 GGTCTGTCTCATCCTGAATGCTT 
ZNF33A_R2 AATAGGTGTGGATTCTGCTGTTGA 
SOX21_F1 CCCACATTGGGTTCCAACTG 
SOX21_R1 GGCATGACAGCCCGACTAAG 
XL_GJB1_F1 GCATCAGCAAAGAGCATCAA 
XL_GJB1_R1 CAGGGAGCCGTGAGAGTTAG 
FOSL2_F1 TGTGTGATAAAGTAGACCAGAGGATTTT 
FOSL2_R1 GTCGCTTGTTTCCTTTTCAACA 
FOS_F2 AGTCCTGGATCGCCGAGTT 
FOS_R2 TCACAGTAACCGCAACGATCTATT 
CHD3_F2 GTTCCCACGCACGTTTGTT 
CHD3_R2 TGGCTGCTGCATCCATAATG 
MIX1b_F2 AGGATGGAGTGGAGGATCTGAA 
MIX1b_R2 GGTTCTCCGGGAAGGTAAAGG 
XL_18srRNA_F1 ATGGCCGTTCTTAGTTGGTG 
XL_18srRNA_R1 TATTGCTCGATCTCGTGTGG 
XL_28srRNA_F1 TCATCAGACCCCAGAAAAGG 
XL_28srRNA_R1 GATTCGGCAGGTGAGTTGTT 
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2.14. RNA extraction and qRT-PCR analysis 
 
 
Oocytes or embryos were collected and frozen at -80°C. RNA extractions were 
performed using Qiagen RNeasy Mini kit (Qiagen, 74106) according to the manufacturer’s 
protocol, unless stated otherwise. RNA was eluted in 50ul DEPC H2O and was used for 
cDNA synthesis and for RT-qPCRs, as described before (Halley-Stott et al. 2010). For all the 
experiments described, apart from rRNA levels assessment, cDNA synthesis was performed 
using oligo dT(15) primer (0.5ul of 100uM primer/reaction). For rRNA levels measurement, 
gene-specific primers were used for cDNA synthesis. qPCRs were performed with gene 
specific primers (Table 4) using a SybrGreen detection system (Sigma, S9194) and ABI 7300 
machine (Applied Biosystems) as detailed before (Halley-Stott et al. 2010). Results were 
exported to Microsoft Excel for analysis. Gene expression was normalized to pwp1 or dolpp1 
transcripts. Subsequently, a Grubb’s test was used to identify and exclude any potential 
outliers in the datasets with a p-value cut-off < 0.05: 1 out of 15 samples for spermatid-
derived embryos for rRNA expression analysis was identified as outlying, 1 out of 6 
sperm/spermatid embryos was outlying for mn1 and 1 out of 6 for chd3 transcript for RNA-
seq validation analysis. Statistical significance was assessed using a t-test. 
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2.15. Analysis of DNA replication 
 
The protocol described here is a modification of the original protocol kindly provided by Dr 
Vincent Gaggioli. 
 
Replication on single DNA fibres was performed as described before (Gaggioli et al. 
2013) with slight modifications. Freshly prepared egg extracts were supplemented with 
energy regeneration mix (components as mentioned in chapter 2.7) and with 20uM biotin-16-
dUTP (Roche, 11093070910). Permeabilised cells were added to a final concentration of 200 
nuclei/ul of extract and incubated at RT for 30mins, 40mins or for 2h (tapping every 10 
minutes). Reaction was stopped by adding 10 volumes of ice-cold 1XPBS (Phosphate Buffer 
Saline: 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4x2H2O, 2mM KH2PO4) and cells were 
spun down at 1000g, 4°C, 7 minutes. Cells were resuspended in 50ul of 1XPBS and mixed 
immediately with 50ul of melted (at 65°C) 2% low melting point agarose (Invitrogen, 
16520050) in 1XPBS. After solidification, the agarose plug was incubated overnight (O/N) at 
50°C with 1ml 0.5M EDTA pH8.0, 100uL 10% sarkosyl (Sigma, L5125), 1mg/mL 
Proteinase K (New England Biolabs, P8102S) followed by three washes in TE pH 6.5. 
Subsequently, the plug was incubated twice in TE supplemented with 0.1mM PMSF (Sigma, 
93482) for 30 minutes at 50°C and washed four times with 1ml of 50mM MES (Sigma, 
69889) pH 6.35, 1mM EDTA (1h at RT each wash). Then the solution was removed; the plug 
was melted in 400ul of MES pH 6.35, 1mM EDTA at 68°C for 20 minutes and the agarose 
was digested with 2 units of β-agarase (New England Biolabs, M0392S) O/N at 42°C. 
Silanised coverslips were prepared as described before (Labit et al. 2008). Thirty 
microliters of replicated DNA solution was pipetted onto a silanised coverslip, covered with a 
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non-silanised coverslip and incubated for 5 minutes at RT. Subsequently, the top coverslip 
was slid away to stretch DNA fibres and the silanised coverslip with stretched fibres was 
fixed in 3:1 solution of Methanol:Glacial Acetid Acid for 10 minutes, RT. The fibres were 
then denatured with 2.5M HCl (1h, RT) and dehydrated by washes in 70% ethanol, 90% 
ethanol and 100% ethanol (1 minute for each wash). Subsequently, the coverslip was dried, 
washed 3 times in 1XPBS, 0.1% Tween (Sigma, P5927) (5 minutes for each wash) and 
blocked in 3%BSA in 1XPBS (1h, RT). All antibodies were diluted in 1XPBS, 3%BSA, 
0.1% Tween. Total DNA and replicated DNA were simultaneously detected using the 
following primary antibodies: anti-DNA antibody (Millipore, MAB3034) 1:300 dilution and 
streptavidin-Alexa 594 antibody 1:50 to detect biotin (Invitrogen, S-11227) for 30 minutes at 
37°C. Slides were washed with 1XPBS, 0.1% Tween (4 washes) and secondary antibodies 
(diluted 1:50) were added: chicken anti-mouse Alexa 488 (Invitrogen, A-21200) and 
biotinylated antibody anti-streptavidin (Vector Labs, BA-0500) (incubation for 30 minutes, 
37°C). After four washes in 1XPBS, 0.1% Tween, a tertiary detection was performed with 
antibodies diluted 1:50: goat anti-chicken Alexa 488 (Invitrogen, A-11039) and streptavidin-
Alexa 594 (for 30 minutes, 37°C). The coverslip was washed three times with 1XPBS 0.1% 
Tween, three times in 1XPBS, mounted on a microscope slide with a mounting medium (50% 
glycerol in 1XPBS), and sealed with nail polish. Images were acquired with a Zeiss 510 
META confocal LSM microscope. Image analysis was performed in ImageJ; the amount of 
replicated DNA and total DNA was measured individually on single DNA fibres. The data 
was analysed in Microsoft Excel with a macro kindly provided by Dr Vincent Gaggioli. 
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2.16 Pulldown of BrUTP-labelled RNA from haploid sperm- and 
spermatid-derived embryos 
 
 
Sperm- and spermatid-derived haploid embryos were generated as described above, 
but using SDB buffer containing 100mM BrUTP (Sigma, B7166). Single embryos were 
harvested at stage 10.5-11.5 and total RNA was isolated with Qiagen RNeasy Mini kit 
(Qiagen, 74106) according to the manufacturer’s protocol (elution in 50ul DEPC H2O). For 
each embryo 20ul of agarose-conjugated beads with antibody against BrdUTP (Santa Cruz 
Bioechnology, sc-32323) were washed twice in 1ml of 0.5XSSPE (wash buffer) (1XSSPE: 
300mM NaCl, 20mM NaH2PO4xH2O, 2mM EDTA), 0.05% Tween 20, 0.1% PVP (Sigma, 
P5288) by centrifugation for 2 minutes at 2000g, RT. Subsequently, beads were blocked O/N 
on a rotating wheel at 4°C in wash buffer supplemented with 1mg/ml of RNase-free BSA 
final (New England Biolabs, B9000S). Next, 20ul of beads were resuspended in 500ul of 
0.5XSSPE supplemented with 0.05% Tween and RNase Inhibitor (New England Biolabs, 
M0314S), mixed with 30ul of purified RNA and incubated for 4 hours on a rotating wheel at 
4°C. Subsequently, beads were washed for 10 minutes on a rotating wheel at 4°C with the 
following solutions: once with 0.2XSSPE, 0.05% Tween; twice with 0.5XSSPE, 0.05% 
Tween, 150mM NaCl and once with 1XTE (10mM Tris, 1mM EDTA, pH 8.0), 0.05% Tween 
(spins 2000g, RT for 2 minutes). RNA was eluted four times for 5 minutes at RT with 100ul 
of elution buffer (300mM NaCl, 5mM Tris, 1mM EDTA, 0.1%SDS, 2mM DTT); the eluates 
were pooled, extracted with phenol:chloroform, precipitated by adding 1ml of EtOH, 40ul of 
3M NaAcetate and 1ul of 10mg/ml tRNA (Sigma, R8759) and resuspended in 15ul DEPC 
H2O. 
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2.17. Preparation of cDNA library for sequencing 
 
Embryos were collected and frozen at -80°C (pools of 5 embryos) at stage 10.5-11.5. 
RNA extractions were performed using Qiagen RNeasy Mini kit (Qiagen, 74106) according 
to the manufacturer’s protocol. RNA was eluted in 50ul DEPC H2O and was used to generate 
a cDNA sequencing library with Illumina TrueSeq kit (RS-122-2001), according to the 
manufacturer’s protocol. Quality and the size of libraries obtained were validated using 
Tapestation equipment and software (Agilent). 
 
2.18. Preparation of ChIP-seq samples 
 
Sperm and spermatids were separated as described above. Chromatin fractionation 
and chromatin immunoprecipitation (ChIP) were performed as described before (Erkek et al. 
2013, Hisano et al. 2013) with slight modifications. Pre-treatment of cells with DTT was 
omitted and chromatin was digested with 2.5U of MNase/1 million of cells (Roche, 
12533700) for 30 minutes at 37°C. Following the digestion, antibodies against histone marks 
were added: anti-H3K4me2 (Millipore, 07-030), anti-H3K4me3 (Abcam, ab8580), anti-
H3K4me3 (Millipore CS200580), anti-H3K27me3 (Millipore, 07-449), anti-H3K27me3 
(kind gift from Dr Thomas Jenuwein). Before ChIP, primary antibodies were bound to 
magnetic beads conjugated with secondary antibodies (Invitrogen, 11204D) according to the 
manufacturer’s protocol and all wash steps in the protocol were performed using a magnet, 
instead of centrifugation. Bound DNA was isolated, separated by electrophoresis and 
mononucleosomal bands from sperm and spermatids were excised (Hisano et al. 2013) and 
subjected to library preparation with TruSeq DNA kit (Illumina, FC-121-2001), according to 
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the manufacturer’s protocol. Quality and the size of libraries obtained were validated with the 
use of Tapestation equipment and software (Agilent). 
 
2.19. Bioinformatic analyses 
 
All the methods in this section were written and kindly shared by Dr Angela Simeone, Dr 
George Allen and Dr Charles Bradshaw. 
 
2.19.1. Sequencing of libraries 
 
 
RNA-Seq and ChIP-Seq libraries were sequenced on an Illumina HiSeq 2000 
instrument in single read mode at 36 base length or paired read mode at 50 or 100 base 
length. The resulting fastq files were filtered and mapped against the Xenopus laevis genome 
(JGI version 6.1) using BWA 0.6.2 (ChIP-Seq) or TopHat 2.0.6 (RNA-Seq) (Li & Durbin 
2009, Trapnell et al. 2009, Kim et al. 2013).  
 
2.19.2. Xenopus laevis transcriptome 
 
The 553,960 assembled transcripts were provided by the International Xenopus 
Genome Project (http://www.marcottelab.org/index.php/Xenopus_Genome_Project) in 
October 2012. This assembly was augmented with Xenopus laevis sequences from the NCBI 
RefSeq database downloaded in Feburary 2012 (30,611 sequences). The combined transcript 
sequences were filtered with cd-hit-est 4.5.7 (Li & Godzik 2006) with a similarity score of 
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95% to remove redundant sequences. This resulted in a final set of 39,384 transcripts. To 
provide gene names, orthologues were found against the M. musculus proteome (downloaded 
in January 2013 – NCBI RefSeq) using Inparanoid 4 (Alexeyenko et al. 2006) on predicted 
ORFs from the Trinity Suite (Grabherr et al. 2011). The sequences were further annotated 
using InterProScan 4.8 (Zdobnov & Apweiler 2001) to provide both InterPro Domains 
(Release 35) and Panther 7.2 ontology terms (Thomas et al. 2003). Xenopus laevis NCBI 
descriptions were provided for transcripts that originated from the NCBI. 
 
2.19.3. Filtering sequencing data 
 
Fastq files were filtered for low quality reads (<Q20) and low quality bases were 
trimmed from the ends of the reads (<Q20). Reads of good quality where a paired read was of 
low quality were kept. Adapter sequences were removed from both pairs using cutadapt 
(Martin 2011). 
 
2.19.4. Genome based RNA-Seq mapping  
 
Xenopus laevis draft genome (JGI version 6.1) from the International Xenopus 
Genome Project was used as a reference genome 
(ftp://ftp.xenbase.org/pub/Genomics/JGI/Xenla6.1/). Transcript sequences obtained from the 
assembly were assigned to genome using BLAT (Kent 2002). The resulting mappings were 
filtered by a mismatch threshold (2%) as well as requiring 90% of the transcript to match to 
the genome and all exons to match to a single scaffold. To prevent spurious matching, the 
genome was filtered to only include scaffolds with length > 100kb. This resulted in 34,373 
transcripts mapping to the genome. This mapping was used as a junction file for Tophat 2.0.6 
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(Trapnell et al. 2009, Kim et al. 2013) which was used to map the RNA-Seq reads to the 
genome. Read counts were then generated for each of the transcripts. 
 
2.19.5. Differential expression 
 
RPKMs were calculated by normalizing read counts for each transcript by the 
transcript length and the total number of reads in the corresponding sample. Zeros were 
replaced with values obtained by randomly sampling from all RPKM values greater than zero 
and less than 0.2. These were converted back to raw counts, rounding up to the nearest 
integer, and then normalized using the Bioconductor package EdgeR (Robinson et al. 2010). 
Transcripts were kept in the analysis if they had at least one count per million in all of the 
sperm-derived embryo samples or all of the spermatid-derived embryo samples, leaving 
18,340 transcripts post-filter. Differentially expressed transcripts were then called using 
EdgeR, taking into account the pairing of sperm- and spermatid-embryos in the design matrix 
of the model. Gene ontology terms over-represented among the differentially expressed genes 
were found using topGO (Alexa et al. 2006). 
 
 
2.19.6. Heatmaps for differentially expressed genes 
 
For each differentially expressed gene, log2 fold changes were calculated pairwise for 
each spermatid/sperm-derived embryo pair. Genes were filtered out if they were not 
consistently upregulated in at least 6 of 7 pairs or consistently downregulated in 6 of 7 pairs. 
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These log2 fold change values were then plotted for each remaining gene, ordered by mean 
fold change, using heatmap.2 from the gplots library in R. 
 
2.19.7. Genome-wide correlation analysis of ChIP-seq data 
 
For each ChIP experiment, reads in the bound (IP) and in the input samples (input) 
were normalised to the total number of reads aligned and scaled by a factor of 10
6 
(i.e. values 
represent count per million, cpm). The entire genome was binned into 200bp wide windows. 
The coverage was computed as the number of reads in each window normalised by the total 
number of reads in the experiment. For each mark in each cell type the reproducibility was 
evaluated by estimating the Pearson correlation coefficient between ChIP-Seq replicates. 
 
2.19.8. Histone methylation level analysis 
 
 
The methylation level was computed as: 
 
                   
          
   
    
             
      
    
 
where NIP is the total number of aligned reads in the IP experiment and Ninput is the total 
number of aligned reads in the input experiment. 
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For H3K4me2/3 the methylation level was computed in a window around the TSS 
[TSS-10kb, TSS+2kb]. For H3K27me3 the window considered for estimating the 
methylation level included the 10 kb upstream region together with the gene body. 
Methylation levels across replicates were averaged. Heatmaps for methylation levels at 
misregulated genes were generated in the same way as for differentially expressed genes. 
 
2.19.9. Peak calling for histone marks 
 
The detection of highly methylated histone regions (peaks) was performed with 
MACS2 2.0.9 (Zhang et al. 2008) using the broad-region option and a q-value of < 0.01. The 
list of confirmed peaks for each histone mark analyzed consisted of the peaks with a p-value 
of < 0.01 detected in at least two out of three replicates. 
 
2.19.10. Statistical testing of ChIP-seq data 
 
Statistical analysis was conducted in R (http://www.R-project.org). The comparison 
of the methylation levels between promoter regions of 100 misregulated genes and promoter 
regions in the entire genome was performed using Kolmogorov-Smirnov test (R function 
ks.test()). The difference between methylation levels of promoter regions between cell types 
(sperm, spermatids) was tested in the same way.  
The enrichment in the proportion of misregulated genes positive for H3K27me3 in 
sperm and spermatid was tested by the non-parametric Chi-squared test for proportions (R 
function prop.test()). 
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Chapter 3 
Sperm-derived embryos develop better 
than nuclear transfer-derived and 
spermatid-derived embryos 
 
 
3.1. Introduction 
 
The goal of my PhD is to understand the mechanisms of sperm programming for 
embryonic development. To be able to investigate these mechanisms, firstly a good system is 
needed in which the developmental capacity of sperm, and of other cells, could be tested and 
compared. One would ideally want to compare the developmental potential of embryos 
generated with sperm or with a somatic cell. However, a typical somatic cell is not 
appropriate for such comparison, for the reason that it is diploid. Therefore, if embryos are to 
be generated with a diploid cell (by a nuclear transfer to unfertilised egg), the egg would need 
to be enucleated. By contrast, fertilisation of an egg by a sperm naturally gives rise to a 
diploid embryo with no need for egg enucleation. Thus, comparison of somatic cell nuclear 
transfer with fertilisation is limited by technical differences in embryo generation; one would 
need another haploid cell for fair comparisons with sperm. Therefore, it was reasoned that 
spermatids, immature precursors of sperm, could be appropriate for such comparisons. First, 
the same ploidy would enable their comparison in the same assay and second, the fact that 
they come from the same lineage, reduces the differences between the two cells. Too many 
differences, for example between sperm and somatic cells, would make it difficult to identify 
those differences, which are developmentally-relevant. 
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In this chapter I first described how I isolated sperm and spermatids from Xenopus 
laevis testicular cells. Second, I described the results of the comparison of the developmental 
potential of sperm- and of spermatid-derived embryos. Last, I described the results of the 
comparison of the developmental ability of spermatid-derived embryos and nuclear transfer-
derived embryos. 
 
3.2. Separation of Xenopus laevis sperm and spermatids 
 
To compare the abilities of sperm and spermatids to support embryonic development I 
first needed to establish a method allowing their separation from Xenopus leavis testes. I have 
achieved this by adapting and modifying a previously described method using a density 
gradient centrifugation in a Metrizamide gradient (Risley & Eckhardt 1979). Metrizamide 
was unfortunately no longer commercially available, therefore I have found another non-ionic 
solution, Optiprep (Sigma, D1556), with a similar density. The density of 60% Metrizamide 
solution used in (Risley & Eckhardt 1979) was 1.33g/cm
3
, whereas the density of Optiprep 
solution (which is 60% solution of iodixanol in water) was 1.32g/cm
3
. I have therefore used 
Optiprep in my attempts to separate Xenopus testicular cells. 
Briefly, a mixture of testicular cells was isolated from testes (see Experimental 
procedures) and overlaid on an Optiprep step gradient prepared in a centrifuge tube. A step 
gradient was prepared as described (Risley & Eckhardt 1979), with a slight modification: an 
additional 1ml of 20% step was introduced between the 30% and 12% steps (Fig. 5). 
Centrifugation was performed in the same conditions as described in (Risley & Eckhardt 
1979) and this allowed separation of testicular cells into two different fractions: spermatids 
(collected from the top interface fraction) and mature sperm (pelleted at the bottom of the 
tube) (Fig. 5). 
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Fig. 5. Separation of sperm and spermatid by density gradient centrifugation 
The diagram explains the procedure of separating sperm and spermatids from Xenopus laevis 
testis. First, step gradients of Optiprep are prepared in a centrifuge tube. Percentages of 
Optiprep in 1XMMR in each step are indicated in the diagram (see also Experimental 
procedures). Testicular cells isolated from the testis are overlaid on top of the prepared 
gradient. After centrifugation, spermatids are recovered from the interface between the 
1XMMR and 12% Optiprep fraction, and the sperm is recovered from the bottom of the tube 
(pelleted cells). 
 
Morphological observations under a phase contrast microscope, as well as DAPI 
staining of these two cell populations confirmed their successful separation (Fig. 6A and 6B). 
The mature sperm population was 95-99% pure, and it was possible to assess the purity of the 
sperm by microscopic observations, due to the fact that mature sperm in Xenopus laevis have 
a characteristic, snake-like shape (Risley & Eckhardt 1979, Risley et al. 1982). It is however 
not possible to judge the purity of the spermatid population by simple microscopic 
observations, due to the fact that spermatids at many stages of their maturation, have a round 
or elongated shape. Spermatids can therefore be misassigned as another cell types by an 
inexperienced researcher (Abe 1988, Abe & Hiyoshi 1991). To circumvent this problem, the 
purity of the spermatid fraction was assessed by flow cytometry analysis. Spermatids have 
already completed meiosis and are haploid with a reduced DNA content, so they can be 
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distinguished from other round-shape diploid and tetraploid testicular cells by DNA staining 
and ploidy assessment. Flow cytometry assessment estimated the spermatid content to be 
around 80% (Fig. 6C). 
These two purified populations were used in all the subsequent experiments in which 
sperm and spermatids are compared. 
 
3.3. Sperm-derived embryos develop better than spermatid-derived 
embryos 
 
Next, I needed to develop an experimental setup in which the developmental potential 
of sperm and spermatids can be compared. As opposed to sperm, spermatids are not motile 
and therefore cannot swim to the egg for fertilisation. I therefore reasoned that a fair 
comparison between the two cells would be to inject them directly into the cytoplasm of the 
egg. For that, a protocol for intra-cytoplasmic sperm injection (ICSI) was adapted from 
(Smith et al. 2006). The technique relays on injecting single permeabilised sperm cells into 
unfertilised eggs (Fig. 7A). I confirmed that embryos obtained in such way can develop into 
healthy adult organisms (Fig. 7B).  
For the purpose of comparing the developmental capacity of sperm and spermatids, 
sperm and spermatids were permeabilised and subsequently injected into unfertilised 
Xenopus eggs. The embryo development was assessed at two different stages: at an early 
gastrula stage and at a swimming tadpole stage and the embryos were scored as the 
percentage of those reaching a gastrula/swimming tadpole stage to the total number of 
cleaved embryos (Fig. 7C). 
 Chapter 3: Results 
 
61 
 
Both sperm- and spermatid-derived embryos reached the gastrula stage with a similar 
efficiency. However, sperm-derived embryos developed significantly better to the swimming 
tadpole stage than spermatid-derived embryos (p-value < 0.05) (Fig. 8A and 8B). 
 
Fig. 6. Purity assessment of the spermatids and sperm populations 
(A) Observations of sperm and spermatids population with a phase contrast microscope 
reveals that the two populations isolated are morphologically different. Sperm cells have a 
characteristic snake-like shape (left panel), whereas spermatids are round cells with a dense 
interior structures (right panel). Scale bar = 10um. (B) DNA staining with DAPI of sperm and 
spermatids confirms their morphological (nuclear shape) differences. Scale bar = 10um. Due 
to the fact that the sperm cells have a distinct morphology, microscopic observations (A and 
B) allow the estimation of the purity of sperm population to be around 95-99%. (C) Flow 
cytometry-based assessment of the purity of the spermatid population. Spermatids (haploid 
cells) consist around 80% of all the cells. 
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Fig. 7. ICSI with sperm and spermatids 
(A) Diagram explaining the principles of the ICSI procedure. The sperm is injected directly 
into the cytoplasm of the unfertilised egg. Successfully injected eggs can subsequently 
develop into tadpoles. (B) Healthy frogs obtained by ICSI procedure. (C) Diagram explaining 
the design of ICSI experiment to compare the developmental potential of sperm and 
spermatids. Sperm or spermatids are injected into unfertilised egg. Such egg develops and 
embryos are scored at two stages: at an early gastrula stage and at a swimming tadpole stage. 
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Fig. 8. Sperm-derived embryos develop better than spermatid-derived embryos 
(A) Graph summarising the results of ICSI experiments with sperm and spermatids. Embryos 
were scored at two different developmental stages: at a gastrula stage and at a swimming 
tadpole stage. Sperm- and spermatid-derived embryos developed similarly to the gastrula 
stage, but the sperm-derived embryos developed significantly better to the swimming tadpole 
stage. * - p-value = 0.000002 (z-test). N = 6 independent experiments. Error bars show 
±SEM. Numbers above each bar represent the number of embryos tested. (B) Shows 
representative images of sperm-derived and spermatid-derived embryos. Note that 
developmental abnormalities of spermatid-derived embryos are not visible before stage 12. 
Timescale below the images indicates average developmental time for embryos cultured at 
18ºC. Scale bar = 1mm. 
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3.4. Nuclear transfer-derived embryos develop with a similarly low 
efficiency as spermatid-derived embryos and worse than sperm-derived 
embryos. 
 
Developmental potential of somatic cells cannot be directly compared to that of sperm 
and spermatids, due to differences in ploidy of these cells and therefore different technical 
manipulations required to generate the embryos. However, to get an idea as to whether 
development of somatic cell-derived embryos is more similar to the development of sperm-
derived or spermatid-derived embryos, nuclear transfer experiments were performed and 
compared to the results of ICSI experiments obtained above. 
Late blastula/early gastrula stage cells were used as nuclear donors for the somatic 
cell nuclear transfer experiments, as these cells proved to be efficient at supporting 
embryonic development (Gurdon 1962). Optimisation of the nuclear transfer procedure is 
described in the chapter 5.2.3. Cell membranes were mechanically disrupted and single nuclei 
were then transferred into enucleated eggs (Fig. 9A). Resulting embryos were scored as 
before: at an early gastrula and at a swimming tadpole stage (as a percentage of the cleaved 
embryos). Subsequently, the results were compared to the results obtained with ICSI with 
sperm and spermatids. 
Nuclear transfer-derived embryos developed to the gastrula stage with a similar 
frequency to sperm- and spermatid-derived embryos. Interestingly, nuclear transfer-derived 
embryos developed to a swimming tadpole stage less efficiently than sperm-derived embryos 
(p-value < 0.05) and with a similar efficiency to spermatid-derived embryos (p-value > 0.05) 
(Fig. 9B). 
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Fig. 9. Sperm-derived embryos develop better than nuclear transfer-derived embryos 
(A) Diagram explaining the procedure of nuclear transfer to Xenopus laevis eggs. The egg is 
enucleated by UV radiation and subsequently injected with an embryonic cell nucleus. 
Successfully reconstructed embryos can develop to a swimming tadpole stage. (B) 
Comparison of the developmental potential of sperm-, spermatid- and nuclear transfer-
derived embryos. Scoring was performed as described in Fig. 8. Note that the data for sperm- 
and spermatid-derived embryos come from the experiments described in Fig. 8. Nuclear 
transfer embryos are from 4 independent experiments. Error bars show ±SEM. Numbers 
above each bar represent the number of embryos tested. * indicates p-value=0.002; ** 
indicates p-value=0.000002 (z-test). 
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3.5. Summary 
 
The results obtained so far show that sperm-derived embryos developed significantly 
better than spermatid-derived embryos. Furthermore, the developmental potential of nuclear 
transfer-derived embryos was as low as that of spermatid-derived embryos (as compared with 
sperm-derived emrbyos). This suggests that the sperm is better suited to support embryonic 
development than a spermatid and a somatic cell. 
Since a direct comparison between sperm and somatic cells is not possible and since 
spermatids were similarly inefficient at supporting development as somatic cells, in all 
subsequent analysis the sperm is compared with spermatids. 
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Chapter 4 
Identification of proteins present in sperm, 
spermatids and incorporated into sperm 
and spermatids from the egg extract 
 
 
4.1. Introduction 
 
Results obtained so far suggest that the sperm, as opposed to the spermatid, is 
programmed to support efficient embryonic development. Spermiogenesis is a complex, 
multistep process, involving numerous molecular changes to the maturing spermatid nucleus. 
Many proteins are lost and gained during sperm maturation (Gaucher et al. 2010). It is 
therefore possible, that the loss or gain of particular proteins in the course of spermiogenesis 
is responsible for the acquisition of the developmental advantage of sperm, as compared to 
the spermatid. Such proteins could have a direct or indirect effect on embryonic development. 
For example, if sperm was delivering transcription factors to the embryo, they could directly 
influence the embryonic development. On the other hand, sperm factors could also have 
indirect effect on development if they were recognised by egg-derived effector proteins. For 
example, sperm-derived protamines are recognised and processed by egg-derived 
Nucleoplasmin (Philpott et al. 1991, Philpott & Leno 1992), which could help the sperm 
nucleus to acquire a chromatin state compatible with early development. I therefore aimed to 
identify proteins that: 1) are present in the sperm nucleus itself, or 2) are egg factors that are 
specifically attracted to the sperm chromatin. To identify the first factors, I have compared 
proteins present in sperm and spermatids. To identify the second type of factors, I have 
incubated sperm and spermatids in egg extracts and compared the proteins bound to each type 
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of chromatin. In both cases the identification of differences in protein composition between 
the two samples was performed with the use of 2-DIGE electrophoresis (2-D Fluorescence 
Difference Gel Electrophoresis) followed by mass-spectrometry analysis of selected protein 
spots. This approach led to the identification of 51 sperm-specific proteins, 47 spermatid-
specific proteins and also 107 egg proteins binding specifically to sperm upon egg-extract 
treatment and 20 egg proteins incorporated specifically into spermatid chromatin upon egg 
extract incubation. 
 
4.2. Sperm and spermatids differ in their nuclear protein composition 
 
First, the nuclear composition of sperm and spermatids was compared. For that, the 
cells were prepared in the same way as for ICSI experiments (see Experimental procedures). 
Proteins were extracted with Urea/Thiourea buffer (see Experimental procedures). 
Subsequently, equal amount of proteins isolated from sperm and spermatids were labelled 
with fluorescent Cy3 and Cy5 dyes and separated in two dimensions (Fig. 10A and B). 
During spermiogenesis, the protein composition of the nucleus of the maturing spermatid 
undergoes numerous changes (Gaucher et al. 2010). For example many proteins that become 
incoportated into the sperm chromatin in Xenopus laevis, are highly basic (Abe & Hiyoshi 
1991, Hiyoshi et al. 1991). Therefore, in order to allow an appropriate separation of all 
proteins and of nuclear proteins, amongst which many are highly basic, the first dimension 
electrophoresis (separating proteins according to their isoelectric point) was performed 
separately in two different pH ranges: 3-10 (to better separate the majority of the proteins) 
and in pH range 7-11 (to specifically separate the basic proteins). Subsequently, all the 
proteins were separated by electrophoresis in the second dimension, according to their 
molecular mass. Gels were imaged using a laser scanner to identify protein spots which were 
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present specifically in sperm, spermatids and those which were common between the two 
samples (manual identification) (Fig. 11A and B). Afterwards, gels were silver-stained in 
order to allow visualisation and excision of selected protein spots (Fig. 12A and B). 
Subsequently, proteins isolated from each spot were subjected to mass spectrometry analysis. 
Only those proteins which had an overall protein probability score (calculated by Mascot: 
http://www.matrixscience.com/help/scoring_help.html) above 100 (the higher the score, the 
more probable the correct identification of the protein), or a score below 100, but at least two 
different peptides confirming their identity, were included in the final list of identified 
proteins. In total 51 sperm-specific, 47 spermatid-specific and 38 proteins present in both cell 
types were identified (Table S1). Amongst the sperm-specific proteins identified, proteins 
previously reported to be present in Xenopus laevis sperm were found, for example sperm 
basic protein 1 (Sp1), sperm basic protein 4 (Sp4) (Sp1-6 proteins are functional orthologues 
of mammalian protamines) and histone 1 variant H1fx (Shechter et al. 2009), which confirms 
that the approach used to identify these proteins is valid. Similarly, in the list of spermatid-
specific proteins a homologue of a human spermatid-specific protein, Rsb-66, was found 
(Yang et al. 2003, Chen et al. 2008), which confirms a successful separation of a spermatid 
population and also indicates that the approach used can successfully identify spermatid-
specific proteins. Proteins that were found in both cell types contained mainly basic 
metabolism and structural proteins, for example actin, tubulin or ATP synthase (Table S1). 
Within the sperm-specific proteins there are several proteins which can be implicated 
in rendering the sperm susceptible to egg reprogramming. For example, I have identified 
Wdr5 protein in the sperm nuclei. Wdr5 has been shown to recognise and bind to 
dimethylated and trimethylated lysine 4 of histone H3 (H3K4me2/3). Wdr5 then recruits 
histone H3K4 methylase (via a direct interaction with the methylase), which results in further 
spreading of the activating H3K4me2/3 epigenetic mark and leads to a transcriptional 
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activation (Wysocka et al. 2005, Wysocka et al. 2006, Zhang et al. 2012). It has been shown 
that in Xenopus laevis embryos, knockdown of Wdr5 leads to abnormal expression patterns 
of developmentally important Hox genes. Furthermore, Wdr5 was shown to be required for 
the self-renewal of embryonic stem cells (ES cells) and also for the induction of pluripotency 
during the derivation of induced pluripotent stem cells (iPS cells) (Ang et al. 2011). 
Therefore, the presence of Wdr5 protein in the sperm, but not in the spermatid nucleus, could 
be advantageous for the sperm, as Wdr5 protein was directly shown to be involved in the 
regulation of transcription. Another example of a sperm-specific protein identified in this 
study, which could also explain the developmental advantage of the sperm is Mlf1. Mlf1 is a 
transcription factor that has been shown to regulate both gene transcription and cell cycle 
progression (Winteringham et al. 2004, Yoneda-Kato et al. 2005, Yoneda-Kato & Kato 
2008). Therefore, Mlf1 could be important for the early phases of the embryonic 
development, and could potentially explain the developmental advantage of sperm over the 
spermatids. Conversely, proteins named Prohibitin and Prohibitin 2 were identified as being 
present specifically in spermatids. They are highly conserved proteins, with 90% and 88% 
amino acids identity between Mus musculus and Xenopus laevis, respectively. They were 
shown to have anti-proliferative functions, but also to be involved in differentiation and 
morphogenesis (Chowdhury et al. 2013). It is thus also possible that the presence of certain 
proteins in the spermatids, but not in sperm, such as anti-proliferative Prohibitins, could 
impair the development of spermatid-derived embryos. 
I also tested whether any particular types of proteins are enriched in sperm and 
spermatids. For that I have performed gene ontology (GO) analysis using the online Database 
for Annotation, Visualization and Integrated Discovery (DAVID; 
http://david.abcc.ncifcrf.gov/). Gene ontology analysis indeed indicated that distinct classes 
of proteins are overrepresented in sperm and spermatids (see Table S2 for terms enriched 
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with a p-value < 0.05). GO analysis for biological processes (BP) for sperm-specific proteins 
showed a significant enrichment for terms associated with chromatin and nuclear changes, for 
example nucleosome organisation, nucleosome assembly or DNA packaging. This likely 
reflects the high degree of sperm nucleus specialisation that occurs during spermiogenesis 
(incorporation of protamines and global chromatin remodelling). In agreement with that, such 
terms were not enriched in the list of the spermatid proteins. Among the spermatid proteins 
the only significantly enriched BP terms were related to cellular homeostasis. Similarly, the 
BP terms enriched among the proteins present in both cell types were related to basic 
metabolism, such as glycolysis, oxidation reduction or anion transport. 
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Fig. 10. Experimental design for 2-D Fluorescence Difference Gel Electrophoresis (2-DIGE) 
analysis 
(A) The same quantity of proteins isolated from sperm or spermatids was labelled with Cy5 
(red) or Cy3 (green) dye. (B) After labelling, proteins were mixed and separated in the first 
dimension electrophoresis in the pH range, according to isoelectric points of proteins. 
Subsequently, the proteins were run in the second dimension electrophoresis, according to the 
molecular weight of proteins. These two runs allowed separation of proteins into spots of 
three colours: in this example the red spots were sperm-specific; the green ones spermatid-
specific and the yellow ones were proteins present in both cell types. 
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Fig. 11. 2-DIGE electrophoresis of proteins isolated from sperm and spermatids 
Proteins isolated from spermatids and sperm were labelled with Cy3 (green) and Cy5 (red) 
dyes, respectively, and subsequently separated in two dimensions. Examples of sperm- and 
spermatid-specific proteins identified are indicated with arrows: red arrows for sperm-
specific proteins and green arrows for spermatid-specific proteins. (A) Laser scanned image 
of a gel with the proteins separated in pH range 7-11 (basic range). (B) Laser scanned image 
of gel with proteins separated in the pH range 3-10 (broad range). 
 Chapter 4: Results 
 
74 
 
 
Fig. 12. Silver staining of 2-DIGE gels for spot excision 
Gels from figure 11 were silver-stained to allow protein visualisation and spot excision. 
Protein examples from Fig. 11 are also indicated with arrows. (A) proteins separated in pH 7-
11; (B) proteins separated in pH 3-10. 
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4.3. Sperm and spermatids bind distinct egg factors 
 
I next tested whether differences in the reprogramming potential between sperm and 
spermatids could be a result of their differential ability to attract and bind egg factors after 
fertilisation. One cell embryo contains only one set of maternal and paternal chromosomes, 
making the analysis of chromatin-bound proteins challenging for two reasons. First, there is 
an equimolar amount of paternal and maternal chromosomes, which therefore does not allow 
the analysis of the factors bound only to the paternal chromosomes. Second, just one set of 
chromosomes per embryo limits the material availability. Therefore, I took advantage of the 
availability of egg extracts in Xenopus laevis. Extracts from activated eggs can recapitulate 
the whole first embryonic cell cycle: global protamine to histone exchange in the sperm 
nucleus, DNA synthesis and chromosome condensation for mitosis (Lemaitre et al. 2001, 
Gillespie et al. 2012). Incubating large number of sperm/spermatids in extracts prepared from 
activated egg overcomes the problem of limited amount of material in 1-cell stage embryos 
and mimics the events happening after fertilisation. Therefore, to test whether sperm and the 
spermatids attract different egg factors, I incubated permeabilised sperm and spermatids in 
egg extracts. Subsequently, chromatin and chromatin-bound proteins were isolated, followed 
by extensive washes to enrich for proteins bound to chromatin (Fig. 13 and Experimental 
procedures). Proteins were then isolated, labelled with Cy3 and Cy5 dyes and subjected to 2-
DIGE analysis. Since only two samples can be simultaneously compared on one gel, and 
there were four samples to be compared (sperm, sperm-extract treated, spermatid, spermatid-
extract treated), I first compared sperm with sperm-extract treated and spermatid with 
spermatid-extract treated (Fig. 14A and 14B, respectively). Interestingly, it turned out that 
virtually all the detectable proteins changed after the egg extract treatment (almost no 
‘yellow’ spots, see fig. 14A and 14B). This can be explained by two possibilities: 1. the great 
majority of the donor nuclear proteins are removed (and/or modified post-translationally) 
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upon the incubation with egg extract or 2. egg-derived proteins are in such excess over the 
donor cell-derived proteins that the donor cell-derived proteins become undetectable after the 
egg extract treatment. Therefore, I decided to perform a direct comparison of sperm-extract 
treated sample with the spermatid-extract treated sample to identify egg proteins that are 
specifically incorporated from extracts to the sperm or spermatid nuclei. 2-DIGE analysis 
identified numerous protein spots present specifically in the sperm extract-treated or in the 
spermatids extract-treated sample (Fig. 15A). Selected spots were excised and subjected to 
mass spectrometry-based identification (Fig. 15B). Mass-spectrometry based analysis of 
peptides isolated from the selected spots, led to the identification of 107 proteins bound 
specifically to sperm nuclei, 20 proteins bound to spermatid nuclei and 108 proteins 
incorporated from the egg into both cell types (Table S3). 
 
 
Fig. 13. Experimental design for mass spectrometry analysis of extract-treated sperm or 
spermatids 
Sperm or spermatids are separately treated with egg extracts. Subsequently, sperm or 
spermatid chromatin is purified and chromatin-bound proteins are isolated. Isolated proteins 
are then subjected to 2-DIGE and mass spectrometry identification. 
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Fig. 14. 2-DIGE electrophoresis of proteins from sperm and sperm-extract treated and of 
spermatid and spermatid-extract treated. 
(A) Proteins isolated from sperm (red) were run on 2-D gel together with proteins bound to 
the sperm chromatin after egg extract treatment (green). (B) Proteins isolated from spermatid 
(red) were run on 2-D gel together with proteins bound to the spermatid chromatin after egg 
extract treatment (green). Note the presence of numerous red or green spots on both gels (A 
and B) and the low number of yellow spots. The first dimension electrophoresis for both gels 
shown was carried in the pH 3-10 (broad range). 
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Fig. 15. 2-DIGE electrophoresis of sperm-extract treated and spermatid-extract treated. 
(A) Proteins bound to sperm chromatin after egg extract treatment (green) were run on a pH 
3-10 gel together with proteins bound to spermatid chromatin after egg extract treatment 
(red). Examples of proteins binding specifically to sperm, spermatid or to both types of cells 
are indicated with arrows. (B) The same gel as in (A) silver-stained to allow protein spot 
visualisation and excision. Examples of proteins are indicated with arrows. 
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Among the egg proteins that were bound to both types of nuclei, many proteins 
involved in global chromatin remodelling, for example, chromodomain helicase DNA 
binding protein 4 (Chd4) and Imitation Switch (ISWI) were identified. Both Chd4 and ISWI 
are ATP-dependent chromatin remodelling complexes that move nucleosomes. Nucleosome 
sliding can change the accessibility of the DNA and plays important roles in multiple 
biological process, like regulation of transcription mediated by polymerases I-III, DNA 
replication or DNA repair (Tong et al. 1998, Poot et al. 2005, Erdel & Rippe 2011). ISWI has 
been already reported to be recruited to chromatin of somatic cell nuclei incubated in egg 
extracts (Kikyo et al. 2000), thus its identification here validates the experimental setup 
applied. Another class of proteins abundantly detected in both types of cells after extract 
treatment are structural proteins that are important for the maintenance of the cell 
cytoskeleton and of the nucleus and nuclear structures, like actin, nucleoporin or nuclear pore 
complex proteins Nup98-Nup96 (Fontoura et al. 1999, Fontoura et al. 2001, Enninga et al. 
2003, Loiodice et al. 2004), which likely reflect pronuclear formation activities induced by 
the extract. An example of another highly represented group of proteins incorporated from 
the egg extract into sperm and spermatid nuclei are proteins directly involved in DNA 
replication: origin recognition proteins (Orc1), protein involved in unwinding and 
remodelling of the DNA (topoisomerase I and II, FACT complex subunit Spt16, DNA 
replication helicase Mcm2), but also proteins involved in stabilising the single stranded DNA, 
necessary for replication, like Replication protein A (RPA) (Henricksen et al. 1996, 
Bochkarev et al. 1997, Rowles & Blow 1997, Sible et al. 1998, Wang et al. 2002, 
VanDemark et al. 2006, Han et al. 2010). Identification of the types of proteins mentioned 
above confirms that the extracts used were functional and that they were able to recapitulate 
at least some of the events occurring in the first embryonic cell cycle. Last, a protein named 
Sal-like protein 4 (Sall4) was also identified as bound to both cell types after egg extract 
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treatment. This finding is a bit surprising, as Sall4 is a transcription factor, and transcription 
factors are usually not present at very high concentrations. Sall4 was highly abundant among 
the proteins incorporated into chromatin after the egg extract treatment, as it was identified as 
the fourth most abundant protein in all the groups analysed. Interestingly, Sall4 has been 
reported as a master regulator of the core pluripotency network, necessary for the early 
embryonic development (Elling et al. 2006, Zhang et al. 2006, Tan et al. 2013). This finding 
could suggest that factors important for the pluripotency in the early embryo are incorporated 
into the paternal chromatin immediately after fertilisation. 
Interestingly, some proteins that were identified in spots originating uniquely from 
extract-treated sperm or from extract-treated spermatids, turned out to be isoforms sharing a 
high degree of similarity, for example, a protein identified within sperm-extract treated 
(gi|27881711) was just 3 amino acid different from protein identified in spermatids-extract 
treated (gi|639691) and both of them were isoforms of High mobility group protein X (HMG-
X) (Kinoshita et al. 1994). Another such example is a protein name Hira (histone cell cycle 
regulation defective homolog A) (Ray-Gallet et al. 2002). One isoform of this protein (Hira-
A) was identified as specific for sperm-extract treated (gi|50416397) and another one (Hira) 
as present in both cell types after egg extract treatment (gi|14330670). There were also some 
cases in which the same protein was identified separately in sperm- and spermatid-extract 
treated. For example, Metastasis associated 1-like protein (mta2) (gi|5901733) was identified 
independently in sperm- and in spermatid-specific protein spots. This is likely a result of 
post-translational modification of the protein; however, due to the fact that the analysis 
performed did not discriminate between different post-translational modifications, such 
proteins were classified as present in both cell types after the egg extract treatment. 
 
 Chapter 4: Results 
 
81 
 
There were however also egg proteins that were bound exclusively to one chromatin 
type and not to the other. Many of the protein identified exclusively in sperm extract-treated 
were structural chromatin proteins, for example core histones: H2A, H2B, H3 and H4. 
Presence of core histones incorporated into the sperm chromatin likely reflects the 
remodelling of the paternal chromatin after fertilisation and the exchange of sperm-derived 
protamine-like proteins (sp1-6) to canonical type of histones derived from the egg. Another 
class of egg proteins binding specifically to the sperm chromatin are transcriptional 
repressors, for example heterochromatin protein 1 gamma (HP1γ), methyl-CpG binding 
domain protein 3 (Mbd3), histone deacetylase 1 and histone deactylase 2 (Hdac1 and Hdac2, 
respectively). HP1γ was shown to recognise and bind methylated lysine 9 of histone H3 
(Lachner et al. 2001). This binding is important for the regulation of gene expression (Kwon 
& Workman 2011, Smallwood et al. 2012) and also for cell reprogramming to pluripotency 
(Sridharan et al. 2013). Mbd3 does not recognise post-translational marks on histones, but 
binds to methylated DNA (Wade et al. 1999). Mbd3 was shown to be necessary for 
embryonic development in Xenopus (Iwano et al. 2004) and to be a roadblock for 
reprogramming to pluripotency (Rais et al. 2013). Hdac1 and Hdac2 are enzymes responsible 
for removal of acetyl marks from histones, which were shown to be involved in 
transcriptional repression (Laherty et al. 1997, Hassig et al. 1998). Furthermore, both Hdac1 
and Hdac2 are involved in DNA replication, for example by stabilising newly formed 
nucleosomes and also by directly interacting with topoisomerase II (Tsai et al. 2000, 
Bhaskara et al. 2013). Identification of many repressive egg proteins binding specifically to 
the sperm chromatin may seem somewhat surprising. However, during the rapid cell cycle 
phases of early Xenopus development, no transcription is observed (Newport & Kirschner 
1982). Therefore, the ability to recruit all the repressive proteins from the egg may reflect 
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programming of sperm to participate in the earliest phases of embryonic development – to 
support efficient replication and prevent premature transcription.  
Such a wide variety of chromatin remodelling proteins were not identified in 
spermatid-extract treated, with the exception of Baf57/Smarce1. Baf57 was shown to be 
important for cell cycle progression via transcriptional regulation of cell-cycle related genes 
(Hah et al. 2010). Furthermore, a couple of unique isoforms of structural proteins – tubulin 
and vimentin were identified as binding specifically to spermatid extract-treated (Table S3). 
 GO analysis of egg proteins binding specifically to sperm, to spermatids and to both 
cell types confirmed the observations made by looking at examples of proteins (Table S4). 
First, among the egg proteins incorporated specifically to the sperm chromatin, there was a 
significant overrepresentation of those belonging to BP (biological process) terms connected 
with chromosome and chromatin organization, chromatin modification, chromatin assembly 
and disassembly. Such BP terms were not enriched among proteins incorporated into 
spermatid-nuclei, and instead terms related to protein polymerisation and protein complex 
assembly were identified as significantly enriched. As expected, many cell cycle related BP 
terms were enriched among egg proteins incorporated into both cell types, such as DNA 
replication, mitosis, cell division, spindle assembly etc. This likely reflects the functionality 
of the extracts used for the experiments, and their ability to support the events happening 
during the first embryonic cell cycle. 
 
4.4. Validation of mass spectrometry results by immunobloting. 
 
 Next I wanted to validate the mass spectrometry approach. One possibility to validate 
the mass spectrometry results is to perform immunoblotting analysis for candidate, mass-
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spectrometry-identified proteins. For that I have chosen four proteins, Hdac1, Hdac2, Hp1γ 
and Mbd3, identified as binding preferentially from the egg to the sperm chromatin. Those 
particular proteins were chosen due to the availability of antibodies that recognise the 
Xenopus laevis proteins. Immunoblotting analysis confirmed that those proteins are 
preferentially incorporated into the sperm chromatin upon egg extract treatment (Fig. 16A 
and B), therefore validating the use of mass spectrometry approach. 
 
Fig. 16. Validation of mass spectrometry results by immunoblotting. 
(A) Immunoblotting results on proteins isolated from sperm and spermatids after extract 
treatment. ‘sperm’ - proteins bound to sperm chromatin after egg extract treatment; 
‘spermatid’ - proteins bound to spermatid chromatin after egg extract treatment. The antibody 
used is indicated on the left hand side of the blot inset. The same quantity of proteins was 
loaded on each lane. (B) Quantification of the blots shown in (A). Results are shown as fold 
difference between the band intensity in sperm-extract treated to spermatid extract-treated. 
Names of the proteins are indicated below the x axis. 
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4.5. Summary 
 
 To conclude, mass spectrometry analysis of sperm, spermatids and of egg extract-
treated sperm and spermatids allowed the identification of numerous proteins present 
specifically in these cell types. Some of these proteins were previously identified as present 
in these cell types, therefore validating the approach used, for example the presence of Sp1 
basic protein in sperm, Rsb-66 in spermatids or the incorporation of ISWI into chromatin 
after egg extract treatment. On the other hand, interesting novel findings were also made. For 
example, Wdr5 protein was found as present exclusively in sperm nuclei, which could 
indicate sperm programming for efficient embryonic development. Also, several proteins 
were identified as incorporated specifically to the sperm chromatin, for example HP1γ. This 
may reflect interplay between the sperm chromatin and the egg cytoplasm – unique features 
of sperm, but not of spermatid chromatin, may allow the binding of specific egg factors. 
 It is also important to note that the approach used here to identify the proteins has 
some limitations. First, proteins need to be sufficiently abundant in order to be identified by 
2-DIGE/mass spectrometry approach. Therefore, less abundant proteins may be missed in 
this approach. Second, only some of the spots (not all of them) were excised and analysed. 
This means that not all the proteins that are different between sperm and spermatids were 
analysed and also, not all the egg proteins preferentially binding to the sperm or spermatid 
chromatin were identified. Therefore, even though there are many interesting candidate 
proteins identified in the analysis (see above), one has to remember that this is only a subset 
of all the proteins changing between these different conditions. 
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Chapter 5 
Functional assessment of candidate 
reprogramming factors 
 
 
5.1. Introduction 
 
Mass spectrometry based approach allowed the identification of several factors which 
could potentially explain the developmental advantage of sperm over spermatids. My next 
aim was to functionally validate these factors. To do this, I first selected several sperm-
specific factors identified by mass spectrometry, as well as several egg factors specifically 
incorporated from the egg extract into the sperm chromatin. 
For the functional validation of the sperm-specific factors I have selected these factors 
which were abundantly detected in sperm, and which are implicated in the most dramatic 
nuclear changes between the spermatid and sperm nucleus. These were: sperm-specific basic 
nuclear proteins Sp1, Sp4 and Sp5 and sperm linker histone variant H1fx. Additionally, I also 
included a transcription factor Mlf1 for the following reasons. First, it was very abundant 
specifically in the sperm nucleus, and such high abundance is somewhat surprising for a 
transcription factor, especially in the transcriptionally silent sperm nucleus. Second, recent 
proteomic studies of human sperm also identified MLF1 as present specifically in the sperm 
(Wang et al. 2013), and the conservation of the presence of this protein in the sperm nucleus 
between Xenopus and human suggests that it could be functionally relevant. Third, 
microarray analysis identified mRNA encoding an interacting partner of Mlf1, Mlf1IP (Mlf1 
Interacting Protein) as present in the oocytes/eggs of three different animal species: mouse, 
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bovine and Xenopus laevis (Vallee et al. 2005). All these suggest that the presence of Mlf1 in 
the sperm could be important for the embryonic development, perhaps due to interaction of 
Mlf1 with its oocyte counterpart. I have additionally chosen another sperm factor, Brdt, based 
on published research indicating that Brdt was necessary during spermiogenesis to remodel 
the maturing sperm nucleus (Gaucher et al. 2012). Furthermore, chemical inhibition of Brdt 
caused infertility in mouse, suggesting that the presence of Brdt could be important for the 
developmental potential of sperm (Matzuk et al. 2012). 
For the functional validation of egg factors identified as binding specifically to the 
sperm chromatin I have selected 7 proteins. Four of them were previously reported as 
transcriptional repressors (Laherty et al. 1997, Hassig et al. 1998, Jiang et al. 2004, du Chene 
et al. 2007): Hdac1, Hdac2, Mbd3 and Hp1γ and their recruitment to the sperm chromatin at 
fertilisation could be important to maintain a transcriptionally silent state during the earliest 
phases of embryonic development, before the onsets of zygotic genome activation. Two other 
proteins incorporated to the sperm chromatin from the egg extract: Rbbp4 and Rbbp7, were 
selected for a functional validation due to their presence in repressive complexes with Hdac1 
and Hdac2 proteins, but also with Polycomb group proteins (they are both present in 
Polycomb Repressive Complex 2) and also because of their reported interactions with 
histones and roles in chromatin assembly (Vermaak et al. 1999, Nicolas et al. 2000, 
Kuzmichev et al. 2002, Yao & Yang 2003). Lastly, Lsf protein (Late SV40 Protein, also 
known as Cp2 or Tfcp2) was also selected for a functional validation, as it is an egg-derived 
transcription factor incorporated specifically to the sperm chromatin and it was reported to 
have oncogenic properties and to be important for the cell cycle entry and progression 
(Saxena et al. 2009, Yoo et al. 2010). These therefore suggest that binding of Lsf1 to the 
sperm chromatin could potentially facilitate the rapid cell cycles of early Xenopus laevis 
embryos and thus explain the developmental advantage of sperm over spermatids. 
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The functional tests of sperm-specific proteins were performed by a somatic cell 
nuclear transfer of donor cells ectopically overexpressing these factors, whereas tests of the 
functional importance of egg-derived factors were attempted by a knockdown of the egg 
factors. 
Unfortunately, none of the sperm-specific factors exogenously expressed in the donor 
cells led to an increase in the efficiency of nuclear transfer. Similarly unsuccessful was the 
attempt to knock down the egg factors, as even though the strategy used allowed to 
downregulate the expression measured at the mRNA levels, the protein levels of none of 
these factors were reproducibly downregulated. 
 
5.2. Functional assessment of sperm-specific proteins 
 
 
5.2.1. Experimental design 
 
 High condensation of the sperm nucleus makes it very inaccessible for any technical 
manipulations, for example for selective protein depletion. In order to test whether the 
presence of candidate sperm-specific factors makes the sperm better at supporting 
development, I have therefore chosen to use a different strategy than depleting these factors 
in the sperm itself and instead I decided to ectopically overexpress these factors in somatic 
cells and examine the ability of such cells to support embryonic development. To achieve 
this, mRNA encoding a factor of interest is first injected into a 1-cell stage Xenopus embryo. 
Such embryo is then allowed to develop and as the embryo develops, the injected mRNA 
becomes translated into the corresponding protein. Subsequently, when the embryo reaches a 
late blastula/early gastrula stage it is collected and disaggregated to obtain single cells that 
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overexpress the protein of interest and which can be used as donors for nuclear transfer 
experiments (Fig. 17). Late blastula/early gastrula stage embryos were used as cell donors, 
since cells coming from such early embryos proved before to be efficient donors in nuclear 
transfer experiments (Gurdon 1962). Successfully reconstructed embryos can develop into 
tadpoles and their developmental potential can be compared to the developmental potential of 
control reconstructed embryos. I have therefore used this experimental setup to functionally 
test the candidate sperm-specific factors. 
 
 
Fig. 17. Overexpression of sperm factors in donor cells for a nuclear transfer experiment. 
To test whether a sperm factor can increase the developmental potential of somatic cells, 
mRNA encoding the factor is first injected into a 1-cell stage embryo. During embryonic 
development, the mRNA is translated into protein. The resulting embryo expressing the 
protein of interest is then disaggregated and the cells, pre-loaded with the factor of interest 
are used as donors for nuclear transfer experiments. 
 
5.2.2. Cloning and ectopic expression of sperm-specific factors 
 
 Candidate sperm-specific factors (Sp1, Sp4, Sp5, H1fx and Mlf1) were first cloned 
from cDNA into pCS2 vectors that allow in vitro mRNA synthesis. They were additionally 
tagged with a hemagglutinin tag (HA-tag) to allow monitoring of protein expression in the 
absence of available antibodies. The construct encoding Brdt was tagged with a green 
fluorescent protein (GFP) and was a kind gift of Dr Saadi Khochbin and was sub-cloned into 
pCS2 vectors. At this stage, pre-testing of some of the constructs (Sp1, Sp4, Sp5 and Brdt) 
was performed by transiently transfecting cultured cells and checking whether the proteins 
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are targeted to the nucleus, since the nuclear localisation of these proteins was reported 
previously (Risley & Eckhardt 1981, Abe & Hiyoshi 1991, Pivot-Pajot et al. 2003). 
Microscopic observations of the transfected cells confirmed that all the tested proteins 
localised to the nuclei (Fig. 18A - D). Interestingly, ectopic expression of Brdt combined with 
TSA (Trichostatin A) treatment led to chromatin compaction (Fig. 19). TSA is an inhibitor of 
histone deacetylases, and therefore TSA treatment leads to an increase of histone acetylation 
levels (Yoshida et al. 1990). It was reported previously that Brdt protein can recognise and 
bind to acetylated histones via its bromodomains and that this leads to chromatin compaction 
(Pivot-Pajot et al. 2003, Govin et al. 2006, Moriniere et al. 2009). Therefore, my observation 
that expression of Brdt combined with TSA treatment led to the chromatin compaction 
validates the functionality of Brdt exogenously expressed in the transfected cells. 
 Subsequently, mRNAs encoding the candidate proteins were in vitro transcribed. The 
size and the purity of the synthesised mRNA was confirmed by an agarose gel electrophoresis 
and mRNAs were subsequently injected into 1-cell stage embryos to test whether they can be 
efficiently translated into proteins. Expression of Sp1, Sp4, Sp5, H1fx and Mlf1 was tested by 
immunoblotting (staining against the HA tag of the proteins), whereas the expression of Brdt 
was assessed by microscopic observations of whole embryos (Brdt protein was tagged with 
GFP). All the mRNAs tested allowed efficient protein synthesis in the embryos (Fig. 20). 
 
5.2.3. Validation of UV treatment length required for the nuclear transfer procedure 
 
 Since the embryonic cells used as donors for the nuclear transfer procedure are 
diploid, the recipient egg needs to be enucleated to allow the development of a diploid 
embryo. Enucleation is performed by first placing the eggs on a small piece of a blotting 
paper soaked in water and mounted on a microscope slide. The eggs are oriented with their 
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animal poles and the white spot (which indicates the position of the meiotic spindle and egg 
chromosomes) upwards. Subsequently, the eggs are placed for 30s under a Mineralite UV 
lamp for enucleation and finally, for 3-6s under a Hanovia UV lamp for dejellination (Gurdon 
1962) (Fig. 21). The latter treatment is used to soften the jelly that coats the egg and to make 
it penetrable by the injection needle. The length of the Hanovia lamp treatment has to be 
optimized every time a new batch of eggs is used. In general, too short a treatment does not 
allow the insertion of a needle into the egg, whereas too long a treatment is detrimental for 
the development of embryos (Fig. 22), therefore each time the nuclear transfer procedure is 
performed, the researcher has to determine the shortest length of Hanovia lamp treatment that 
allows the needle to penetrate the egg. 
 Next I validated whether 30s treatment of eggs with Mineralite UV lamp, which has 
been used in the nuclear transfer procedure in the past (Gurdon 1962), is sufficient to 
enucleate the eggs. If the eggs are successfully enucleated, the resulting embryos should be 
haploid (since the sperm that fertilises the egg is haploid and the maternal genetic content is 
destroyed). Haploid embryos in Xenopus laevis are viable, but differ from the diploid ones 
morphologically: haploid tadpoles are more vegetalised (shorter and thicker) than the diploid 
ones. It is also possible to assess the ploidy of the embryo by squashing its cells on a 
microscope slide and looking at their nuclei with a phase contrast microscope. In Xenopus 
laevis each set of parental chromosomes give rise to one nucleolus, visible as a black dot in 
the nucleus. Therefore, diploid cells have two nucleoli in each nucleus (two black dots), 
whereas haploid cell have just one nucleolus in each nucleus (one black dot). To test whether 
30s treatment with Mineralite UV lamp is sufficient to enucleate the eggs, I first enucleated 
them as described above (Fig. 21) and then fertilised them. The control embryos were 
fertilised without enucleation. Morphological observations of the embryos revealed that the 
Mineralite-treated eggs gave rise to haploid embryos (they were vegetalised as compared to 
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control, diploid embryos) (Fig. 23A). Furthermore, microscopic observations of squashed 
cells also confirmed that embryos obtained from Mineralite-treated eggs were haploid 
(evidenced by the presence of only one nucleolus/nucleus) (Fig. 23B). 
 
Fig. 18. Nuclear localisation of Sp1, Sp4, Sp5 and Brdt in transfected C2C12 cells. 
C2C12 myoblast cells were transfected with plasmids encoding selected sperm factors: Sp1 
(A), Sp4 (B), Sp5 (C) and Brdt (D). 48h after transfection cells were fixed and subjected to 
immunostaining revealing DNA (staining with DAPI, left column) and the overexpressed 
sperm factor (middle panel). Merge images (right column) show that the overexpressed 
proteins (green) localise to the nuclei (blue). Scale bars = 10um. 
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Fig. 19. Brdt-dependent compaction of chromatin upon TSA treatment. 
C2C12 myoblast cells were transfected with a plasmid encoding Brdt and treated with 
120ng/ml TSA or with an equivalent concentration of DMSO (control). 48h after transfection 
cells were fixed and subjected to immunostaining revealing DNA (staining with DAPI, left 
column) and Brdt (middle panel). Merge images (right column) show that control, DMSO-
treated cells do not compact chromatin upon Brdt overexpression (A), but cells treated with 
TSA and overexpressing Brdt, do compact the chromatin (B). Scale bars = 10um. 
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Fig. 20. mRNA injection into 1-cell stage embryos allows protein synthesis. 
One cell stage embryos were injected with mRNAs encoding various sperm-specific proteins. 
At gastrula stage the embryos were either collected for immunoblotting analysis against the 
HA-tag (A) or were photographed under the microscope equipped with a fluorescent lamp 
(B). (A) Immunoblotting analysis confirmed that all proteins encoded by the injected mRNAs 
(Sp1, Sp4, Sp5, H1fx and Mlf1) were translated in the embryos. Note that the predicted 
molecular weights are slightly different from the observed molecular weights of proteins, 
which could be due to their post-translational modifications. (B) Microscopic observations 
under fluorescent light of embryos injected with mRNA encoding Brdt-GFP, revealed that 
the protein is expressed in the embryos (merge image). Scale bar = 1mm. 
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Fig. 21. Diagram explaining recipient egg preparation for the nuclear transfer procedure. 
Eggs are first immobilised with the animal pole (white spot) facing upwards on a wet blotting 
paper. Subsequently, eggs are enucleated with a 30s treatment with a Mineralite lamp UV 
light and then the jelly coat of the eggs is softened by a 3-6s treatment with a Hanovia lamp 
UV light. 
 
 
 
 
Fig. 22. Prolonged Hanovia lamp treatment leads to abnormal development. 
Control fertilised embryos were treated with a Hanovia lamp for 4s - the shortest time 
allowing the needle penetration (A) or for a prolonged time – 8s (B). Note that a prolonged 
treatment with Hanovia lamp results in abnormal development of the embryos. 
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Fig. 23. Mineralite UV lamp treatment for 30s destroys the genetic material of the egg. 
Eggs were subjected to 30s Mineralite UV lamp treatment for enucleation and subsequently 
fertilised. Control eggs were directly fertilised, omitting the Mineralite treatment. (A) 
Microscopic observations of control embryos (non-enucleated) (left panel, ‘diploid embryos’) 
and of embryos obtained from Mineralite-treated eggs (enucleated) (right panel, ‘haploid, 
enucleated embryos’) reveals that haploid embryos are vegetalised and therefore confirms the 
successful egg enucleation. Note that the vegetalised phenotype is not apparent at the gastrula 
stage (upper panel) and only becomes visible when the embryo elongates (bottom panel). 
Scale bars = 1mm. (B) Microscopic observations of cells from control embryos (left panel) 
and from embryos obtained from Mineralite-treated eggs (right panel) confirms a successful 
egg enucleation. Note that in the nuclei of cells from diploid embryos two nucleoli (black 
dots) are visible (left panel), whereas in the nuclei of cells from haploid embryos only one 
nucleolus per nucleus can be detected (single black dots). Examples of nuclei in each cell 
preparation are inside the red circles. 
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5.2.4. Overexpression of candidate sperm factors does not increase the efficiency of nuclear 
transfer. 
 
 I next tested the effect of overexpression of candidate sperm factors in the donor cells 
on the efficiency of nuclear transfer. In this experimental setup the developmental capacity of 
embryos reconstructed with cells overexpressing the factor of interest was compared with the 
developmental capacity of embryos reconstructed with control cells, which did not 
overexpress the sperm factor. Reconstructed embryos were scored as the number of 
swimming tadpoles obtained to the total number of cleaved embryos. The reasoning behind 
this experimental design was that if the presence of some sperm-specific factors is beneficial 
for the sperm to support the embryonic development, its ectopic expression in a donor cell 
should increase the efficiency of the nuclear transfer. Some of the candidate sperm factors 
were therefore expressed as single factors: Brdt, Mlf1, H1fx. A combination of factors was 
also used for those which have similar functions: Sp1, Sp4 and Sp5 or Sp1, Sp4, Sp5 and 
H1fx altogether (as those factors are structuring the chromatin in the mature sperm). These 
experiments, which initially gave promising outcomes (tendency of sperm factor-
overexpressing cells to support higher efficiency of nuclear transfer than control cells) were 
independently repeated to validate whether initially promising outcomes are reproducible.  
Unfortunately, none of the sperm factors tested, alone or in combinations, 
reproducibly increased the efficiency of the nuclear transfer. Even those factors which 
initially gave a promising outcome (Brdt and the mixture of Sp1, Sp4, Sp5 and H1fx) did not 
show reproducible effects in the following experiments (Table 5). 
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Table 5. Summary of nuclear transfer experiments using cells overexpressing candidate 
sperm factors. 
Factor/combination of factors 
tested 
Number of embryos tested: 
total number of swimming tadpoles obtained (ST)/cleaved 
embryos (CE) 
Control cells (% ST/CE) Overexpressing cells (% 
ST/CE) 
Brdt – experiment 1 2/42 (4.8%) 3/46 (6.5%) 
Brdt – experiment 2 10/36 (27.8%) 8/31 (25.8%) 
Brdt – experiment 3 5/48 (10.4%) 1/49 (2.0%) 
Brdt – experiment 4 7/61 (11.5%) 1/30 (3.3%) 
Brdt – total from 4 
experiments 
24/187 (12.9%) 13/156 (8.3%) 
Mlf1 6/35 (17.1%) 5/42 (11.9%) 
H1fx 2/18 (11.1%) 2/19 (10.5%) 
Sp1, Sp4, Sp5 3/31 (9.7%) 2/28 (7.1%) 
Sp1, Sp4, Sp5 and H1fx – 
experiment 1 
0/44 (0%) 4/44 (9.1%) 
Sp1, Sp4, Sp5 and H1fx – 
experiment 2 
1/20 (5%) 6/27 (22.2%) 
Sp1, Sp4, Sp5 and H1fx – 
experiment 3 
2/21 (9.5%) 1/22 (4.5%) 
Sp1, Sp4, Sp5 and H1fx – 
experiment 4 
3/26 (11.5%) 2/38 (5.3%) 
Sp1, Sp4, Sp5 and H1fx – 
total from 4 experiments 
6/111 (5.4%) 13/131 (9.9%) 
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5.3. Functional assessment of egg factors preferentially associating with the 
sperm chromatin 
 
 
5.3.1. Experimental design 
 
 In order to test whether egg factors preferentially associating with the sperm 
chromatin have a function in early development, one would ideally remove such factors from 
the early embryos. The fact that the egg is a much more accessible cell for any type of 
manipulations than sperm makes it possible to try to downregulate the selected factors. The 
best characterised way of downregulating proteins in Xenopus laevis oocytes is by the 
injection of antisense deoxy-oligonucleotides (Hulstrand et al. 2010). In this approach, 
oligonucleotides complimentary to mRNA encoding the protein of interest are designed and 
injected into the GV stage oocyte. Such oligonucleotides form DNA-RNA heteroduplexes 
with the target mRNA, which are recognised and cleaved by endogenous oocyte-derived 
RNase-H activity. Cleaved mRNAs are subsequently degraded by oocyte-derived 
exonucleases. If the protein of interest is sufficiently unstable, then downregulation of the 
mRNA can lead to the reduction of the desired protein level (Fig. 24A). Such oocytes in 
which the protein is downregulated can be subsequently in vitro matured to eggs and injected 
with sperm (in ICSI procedure), which allows the assessment of the effects of the protein 
downregulation on embryonic development (Fig. 24B). Here I aimed to use this approach to 
assess the developmental function of egg-derived candidate factors binding specifically to the 
sperm chromatin after the egg extract treatment. 
  
 Chapter 5: Results 
 
99 
 
 
 
 
Fig. 24. Diagram explaining oligonucleotide-mediated knockdown of proteins in Xenopus 
laevis oocytes. 
(A) Antisense deoxy-oligonucleotides against mRNA encoding the protein X are injected into 
the GV stage oocyte. These oligonucleotides form DNA-RNA heteroduplexes with the 
mRNA in the region of the base pair complementarity. DNA-RNA heteroduplexes are 
recognised and cleaved by endogenous, oocyte-derived RNase-H. The cleaved mRNA is then 
degraded by endogenous exonucleases. In the absence of mRNA, protein X becomes 
degraded. (B) GV stage oocytes depleted for protein X can be in vitro matured into eggs and 
injected with sperm (by ICSI procedure) to generate embryos depleted for the protein X. The 
effect of protein X depletion on embryonic development can be subsequently assessed. 
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5.3.2. Validation of the antibodies 
 
 I have first tested whether the proteins I want to downregulate (Hdac1, Hdac2, Rbbp4, 
Rbbp7, Mbd3, Hp1γ and Lsf) are detectable with commercially available antibodies. To do 
this I have treated sperm with egg extracts to test whether bands of correct sizes are detected. 
All antibodies recognised bands of approximately the expected size (Fig. 25), therefore 
validating their use for assessing the knockdown efficiency of the oligonucleotides. Next, I 
tested whether the proteins I want to downregulate are also detectable by immunoblotting in 
the oocytes, as the knockdown itself is performed in the oocytes. All proteins apart from 
Mbd3 and Lsf were detected in the oocyte lysates. Due to the fact that the oocyte is pre-
loaded with a lot of proteins, it is difficult to load more than one oocyte per a gel lane. The 
ability to detect the protein in the oocyte is crucial for the assessment of knockdown 
efficiency. Therefore, I tested whether I could detect these proteins if instead of the whole 
oocyte lysate I would use germinal vesicles (nuclei) isolated from the oocytes. The advantage 
of using the nuclei is that one can load many nuclei per one lane and in this way focus the 
analysis on nuclear proteins. I have therefore tried to detect Mbd3 and Lsf proteins in lysates 
from 20 germinal vesicles. Unfortunately, even the use of this approach did not allow me to 
detect the proteins of the correct size (Fig. 26). The anti-Mbd3 antibody recognised a band of 
around 45kDa instead of 33kDa. This antibody was reported to also recognise Mbd2, which 
was reported to migrate at 45kDa (Zhu et al. 2011), therefore the observed band could be 
Mbd2 and not Mbd3. Alternatively; the 45kDa band could be a post-translationally modified 
form of Mbd3. For Lsf protein a band of around 35kDa was detected instead of expected 
57kDa. This again could be the effect of post-translational clipping of the protein in the 
oocyte and not in the egg, or of unspecific recognition of another protein by anti-Lsf 
antibody. Due to the uncertainty about the detection of Mbd3 and Lsf proteins in the oocyte, 
which could impede the validation of the knockdown effect, I have decided to exclude these 
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two proteins from the list of candidate egg factors to be downregulated and for the further 
steps I focused on the downregulation of the five remaining proteins: Hdac1, Hdac2, Hp1γ, 
Rbbp4 and Rbbp7. 
 
5.3.3. Downregulation of the mRNA encoding the selected factors 
 
 I next tested whether deoxy-oligonucleotides injected into the oocytes can degrade the 
mRNAs encoding the target proteins. I have designed antisense deoxy-oligonucleotides 
complimentary to Hdac1, Hdac2, Hp1γ, Rbbp4 and Rbbp7, following the guidelines 
described before (Hulstrand et al. 2010). Three different oligonucleotides targeting each of 
the mRNAs were designed, whereas scrambled oligonucleotides were designed for control 
experiments. Oligonucleotides were injected into GV stage oocytes. Injected oocytes were 
collected 48h after the oligonucleotide injection and processed for reverse-transcription 
quantitative PCR analysis (RT-qPCR). Amount of transcripts present in the oligonucleotide-
injected oocytes were normalised to the amount of transcript present in the control, 
scrambled-oligonucleotide injected oocytes. qPCR results showed that all the 
oligonucleotides allowed a significant downregulation of the target mRNAs (Fig. 27). 
Subsequently, the most efficient oligonucleotides at degrading the mRNAs (oligonucleotide 3 
for Hdac1, Hdac2 and Rbbp7, oligonucleotide 1 for Hp1γ and oligonucleotide 2 for Rbbp4), 
were chosen to assay the degradation of the target proteins. 
 Chapter 5: Results 
 
102 
 
 
Fig. 25. Validation of the antibodies on sperm-extract treated samples. 
(A) Immunoblotting for Hdac1, Hdac2, Hp1γ (Hp1g), Rbbp7, Rbbp4, Lsf and Mbd3. ‘S-E’ 
indicates the position of sperm-extract treated sample and the arrow indicates the protein 
band of interest. (B) Table presenting the expected molecular weights of the proteins tested. 
Note that the protein bands detected in (A) are of similar weight to the expected molecular 
weight (B), suggesting that the antibodies recognised the correct proteins. 
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Fig. 26. Mbd3 and Lsf proteins are not detected in the oocyte. 
Proteins isolated from 20 germinal vesicles (oocyte nuclei) were loaded on each gel. 
Subsequently gels were stained for Mbd3 (left panel, green) and for Lsf (right panel, red). 
Detected proteins were not migrating at the expected molecular weights (observed before in 
the lysate from egg extract-treated sperm chromatin): Mbd3 should be detected at 33kDa (not 
at 45kDa) and the expected molecular weight of Lsf is 57kDa (not 35kDa). 
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Fig. 27. Assessment of mRNA degradation by oligonucleotide-mediated knockdown. 
Oocytes were injected either with scrambled oligonucleotides (control) or with three different 
oligonucleotides (oligo1, oligo2, oligo3) designed to target the mRNA of interest (name of 
the target mRNA indicated above the graph). All samples were normalised against a 
housekeeping mRNA pwp1 and the amount of mRNA in the control sample was set to 100% 
(the other samples were normalised accordingly). All oligonucleotides tested led to a 
significant downregulation of the mRNA levels (p < 0.05, t-tests). Error bars show ±SEM. 
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5.3.4. Protein levels of the candidate egg factors are not reproducibly downregulated by the 
antisense oligonucleotides 
 
 I have subsequently tested whether the injection of the most efficient oligonucleotide 
affects the target protein levels in the oocyte. For each candidate factor oocytes were injected 
either with the oligonucleotide against the mRNA or with the control scrambled 
oligonucleotide. Oocytes were collected for protein extraction and immunoblotting analysis 
48h, 96h and 144h after the injection. Only the injection of the oligonucleotide against Hp1γ 
led to a downregulation of the protein level in the oocyte, whereas the expression level of 
other proteins tested was not affected (Fig. 28A). I have therefore repeated the experiments 
with the oligonucleotide against Hp1γ. Unfortunately; the initial downregulation of the 
protein level observed after injection of the oligonucleotide 1 was not reproduced in 
independently repeated experiments. One of the reasons for that could be a sequence 
polymorphism between different frogs (animals in our frog colony are not from an inbred line 
and can therefore have slightly different DNA sequence which could prevent targeting by the 
oligonucleotide). I have therefore tried to inject the two other oligonucleotides against Hp1γ: 
oligonucleotide 2 and 3; which however did not result in a protein knockdown (Fig. 28B). I 
have then also tried a higher dose of the oligonucleotide 1: 2 times more than initially, the 
same amount and 2 times less; however, none of the concentrations led to the protein 
downregulation (Fig. 28C). The lack of knockdown could have been also caused by the fact 
that the oocytes used in the initial experiments were fully grown and therefore already ceased 
RNA transcription, whereas the oocytes used for the repeat experiments were still 
transcribing mRNAs and therefore the knockdown was not efficient. Alternatively, 
oligonucleotides could have degraded during the storage period and could have become less 
efficient at the mRNA degradation. To shed light on the discrepancy in the results obtained, I 
have treated non-injected oocytes with cycloheximide, which inhibits protein translation. 
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Treatment with cycloheximide therefore allows monitoring of the half-life of proteins. 
Immunoblotting of proteins from cycloheximide-treated oocytes revealed that the level of 
Hp1γ protein was not reduced during 48h of cycloheximide treatment (Fig. 28D) (longer 
treatment with cycloheximide is toxic to the oocytes and therefore cannot be applied). This 
result is contradictory to the initial result that demonstrated a knockdown of Hp1γ already 
after 48h from the oligonucleotide injection. The reason for the discrepancy between the 
results remains therefore unclear; however, since all the follow-up experiments suggest no 
knockdown of Hp1γ, it is unlikely that the oligonucleotide-mediated route can lead to a 
reproducible depletion of this protein. 
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Fig. 28. Assessment of protein degradation by oligonucleotide-mediated knockdown. 
(A) Oocytes were injected either with scrambled oligonucleotides (s) or with oligonucleotides 
against the mRNA of interest to achieve a protein knockdown (k) (indicated below the lanes). 
Oocytes were collected 48h (2d), 96h (4d) or 144h (6d) after injection for immunoblotting 
analysis. The protein detected on each blot is indicated above the blot. Red rectangle in the 
Hp1γ blot indicates the position of the Hp1γ protein band. (B) Assessment of Hp1γ level 
upon injection of various oligonucleotides. Oocytes were injected with three different 
oligonucleotides against Hp1γ (lanes 1, 2, 3) or with scrambled oligonucleotides (s). Samples 
were collected 48h after injection. Red rectangle indicates the position of the Hp1γ protein 
band. (C) Assessment of Hp1γ level upon injection of various doses of oligonucleotide 1. 
Oocytes were injected with three different doses of oligonucleotide 1 against Hp1γ mRNA 
(2x, 1x and 0.5x times of the amount injected in panel A) or with scrambled oligonucleotides 
(s). Samples were collected 48h after injection. Red rectangle indicates the position of the 
Hp1γ protein band. (D). Assessment of Hp1γ level upon cycloheximide treatment of oocytes. 
Cycloheximide-treated oocytes are labelled with ‘cyc’ below the lane, whereas the control 
oocytes, are labelled ‘ctrl’. Samples were collected 48h after the addition of cycloheximide to 
the media. Red rectangle indicates the position of the Hp1γ protein band. 
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5.4. Summary and discussion 
 
 
In this section I described the effect of the overexpression of candidate sperm factors 
on the efficiency of nuclear transfer and my attempts to downregulate the egg factors that 
bind specifically to the sperm chromatin upon egg extract treatment. 
In the first part I have tested the effect of several candidate sperm factors and several 
combinations of sperm factors on the efficiency of nuclear transfer. However, none of the 
factors/combinations of factors led to a reproducible improvement of the nuclear transfer 
efficiency. There could be several explanations for that, for example: wrong factors were 
selected, essential co-factors were not co-expressed with the candidate factors, over-
expressed factors were not functional or they were expressed at inappropriate levels. Also, it 
is likely that introduction of sperm factors could have rescued some aspects of the 
development, but not all. In order to address this in the future a more detailed molecular 
analysis of the nuclear transfer embryos (for example, qPCR analysis for candidate gene 
expression) would be needed. 
I have also attempted to downregulate several candidate factors which were identified 
as binding specifically to the sperm chromatin upon egg extract treatment. Knockdown was 
performed with the use of oligonucleotides antisense to mRNA encoding the protein of 
interest. All the oligonucleotides tested led to a significant downregulation of mRNA targets, 
as evidenced by a qPCR. However, none of the candidates tested was reproducibly 
downregulated at the protein level. This suggests that even though mRNA levels decreased, 
the target proteins were stable and did not degrade. In the future it would be worth 
performing a simple test with cycloheximide treatment before choosing the candidate 
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proteins to be downregulated. In this way one could eliminate those proteins, whose levels 
are unlikely to be affected by the oligonucleotide-mediated knockdown. 
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Chapter 6 
Characterisation of the developmental 
defects of spermatid-derived embryos 
 
Replication assays described in this chapter were performed in collaboration with Dr Vincent 
Gaggioli. Preparation of libraries and sequencing of two RNA-seq samples was done in 
collaboration with Dr Taejoon Kwon and Dr Edward Marcotte. Bioinformatic analyses 
described in this chapter were performed by Dr Angela Simeone, Dr George Allen and Dr 
Charles Bradshaw. 
 
 
6.1. Introduction 
 
 
 Comparison of the developmental potential of sperm- and spermatid-derived embryos 
revealed that sperm-derived embryos develop significantly better than spermatid-derived 
embryos to a swimming tadpole stage. Since the mass spectrometry analysis and further 
functional testing of sperm proteins and of sperm-binding factors failed to unravel the source 
of the developmental advantage of sperm, I modified my strategy. Instead of directly looking 
for potential factors conferring developmental benefits to sperm, I have decided to first 
characterise the developmental defects of spermatid-derived embryos. Understanding what 
processes occur abnormally in spermatid-derived embryos could help to identify in what 
respects sperm is better at supporting embryonic development. 
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Early Xenopus embryo development starts with rapid cell divisions (fast DNA 
replication cycles) in the absence of transcription from the zygotic genome. Only around the 
12
th
 cell cycle division, at the time called mid-blastula transition (MBT), cell divisions slow 
down and the zygotic genome activation occurs (Newport & Kirschner 1982, Kimelman et al. 
1987) (Fig. 29). I have therefore tested whether these major events during embryonic 
development: DNA replication accompanying cell divisions and gene transcription needed 
for further embryonic development occur normally in spermatid-derived embryos. My results 
demonstrate that spermatids are equally good as sperm at supporting DNA replication. 
Furthermore, I showed that developmental failure of spermatid-derived embryos is not due to 
RNA carried over to the embryo. I also showed that zygotic rRNA transcription is initiated 
normally in spermatid-derived embryos. Interestingly, RNA sequencing (RNA-seq) analysis 
of spermatid- and of sperm-derived embryos revealed that one hundred developmentally-
important mRNAs are misregulated in spermatid-derived embryos, which can reflect 
developmental programming of sperm to support correct regulation of gene expression in the 
embryo. 
 
 
Fig. 29. Rapid cell divisions precede zygotic genome activation in Xenopus. 
In the very early stages of embryonic development in Xenopus rapid cell divisions (fast DNA 
replication cycles) occur in the absence of zygotic transcription. Only when the embryo 
reaches the mid-blastula transition stage, the zygotic genome is activated, which is concurrent 
with slowing down of cell divisions. 
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6.2. Spermatids replicate their DNA as efficiently as sperm 
 
 
All replication studies described below were performed with great help and 
supervision from Dr Vincent Gaggioli from the Gurdon Institute, at the University of 
Cambridge, UK. 
 
Cell divisions occurred normally in spermatid-derived embryos (Fig. 8); however, it is 
not known whether accompanying DNA replication was also normal. Experiments in which 
sperm and somatic cells (erythrocytes) were incubated in Xenopus egg extracts showed that 
the sperm chromatin was better suited for supporting DNA replication that the chromatin of 
somatic cells (Lemaitre et al. 2005). DNA replication starts from the origins of replication 
and spreads in both directions from the origins (Fig. 30A). The first cell cycle in Xenopus 
lasts for only about 2h (at 18ºC). During this 2h the sperm needs to remodel its chromatin 
(exchange the protamines for histones) and initiate and timely complete DNA replication 
before the onsets of the cell division. It was shown that DNA replication in the sperm 
chromatin is initiated from multiple origins of replication spaced on average every 23.4kb of 
DNA. This was in sharp contrast to what was seen in erythrocyte chromatin in which the 
origins of replication were much sparser and positioned on average every 120.9kb of DNA 
(Lemaitre et al. 2005). This could prevent the erythrocytes from completing the replication 
before the onset of the cell division (Fig. 30B). Indeed, it was shown that after 2h of egg 
extract treatment, erythrocytes replicated less than 10% of DNA, whereas 80% of sperm 
DNA was replicated in this time (Lemaitre et al. 2005). This led to the hypothesis that 
inefficient replication is a roadblock to embryo development after somatic cell nuclear 
transfer in frogs (Laskey 2005). It was also shown that pre-treatment of mammalian donor 
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cells with Xenopus egg extracts increased the efficiency of mouse nuclear transfer and that it 
was correlated with an increased replication efficiency (Ganier et al. 2011). I have therefore 
hypothesised that the developmental failure of spermatid-derived embryos might be related to 
inefficient DNA replication. I have therefore decided to test the ability of sperm and 
spermatids to undergo replication with the use of in vitro Xenopus egg extracts. 
 
 
Fig. 30. Multiple origins of replication allow timely finishing of DNA replication in egg 
extracts. 
Figure based on results from (Lemaitre et al. 2005). (A) DNA replication occurs in both 
directions from the origin of replication. (B) Sperm has multiple origins of replication, 
densely positioned on the DNA fiber (left panel), whereas the erythrocyte has sparse origins 
of replication (right panel). Multiple origins of replication ensure timely finishing of 
replication after the egg extract treatment in sperm, but not in erythrocytes. 
 
To be able to assess the replication efficiency and at the same time to look into the 
initiation of replication I decided to use the technique of molecular combing. Help with this 
technique was kindly provided by Dr Vincent Gaggioli. I have prepared extracts from 
activated eggs, which are able to replicate DNA (Blow & Laskey 1986). Permeabilised sperm 
or spermatids nuclei were incubated in extracts at a concentration of 200 nuclei per a 
microliter of extract. Extracts were supplemented with biotin-dUTP, which is a DNA 
precursor incorporated into DNA upon replication (Fig. 31A). Newly synthesised (replicated) 
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DNA can be then revealed by biotin detection with fluorescently tagged streptavidin. In 
molecular combing procedure DNA fibers are isolated, spread on a microscope slide and then 
stained for DNA, to visualise all DNA fibers, and for biotin, to reveal those fibers/fragments 
of fibers that were replicated (Fig. 31B). 
 
Fig. 31. Diagram explaining the experimental design for the replication assessment in sperm 
and spermatids. 
(A) Permeabilised sperm or spermatids are incubated in egg extracts supplemented with 
biotin-dUTP. Subsequently, replicated DNA is revealed by molecular combing. (B) Diagram 
explaining the results of molecular combing. DNA fibers are stretched on the microscope 
slide and revealed with anti-DNA staining (shown in green). Replicated DNA is revealed 
with anti-biotin staining (shown in red). Replicated DNA in the merged image is shown in 
yellow. 
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 The initial experiment was designed to get an idea as to whether the cells can replicate 
and how they initiate replication (what is the spacing of the origins of replication in each cell 
type). For that I have incubated sperm or spermatids in freshly prepared egg extracts, 
supplemented with biotin-dUTP, for short time periods: 30mins and 40mins. Then the DNA 
fibers were isolated and subjected to molecular combing and immunostaining. Interestingly, 
immunostaining results revealed that both samples were able to initiate replication with very 
similar spacing of origins of replication; however, initiation of replication in sperm was 
approximately 10mins delayed as compared with spermatids. At 30mins from the start of 
extract treatment some fibers in spermatids already started to initiate replication (Fig. 32). At 
the same time the replication was not yet detectable in sperm. At 40mins most of the fibers in 
spermatids were replicating, whereas only some fibers in the sperm sample initiated 
replication (Fig. 32). This suggests that sperm is not better than spermatids at initiating DNA 
replication. If anything, the sperm is delayed as compared with spermatids, which is likely 
due to the fact that it has to remodel its chromatin (replace protamines for egg-derived 
histones) before the onset of replication. 
 No major differences between sperm and spermatids were found at the initiation of 
replication, which however does not mean that both cell types are capable of timely 
completing the replication. It could be that the speed of the replication fork is different in 
both cell types (for example due to differences in the chromatin structure, which could 
interfere with the replication progress). If that was the case it could be that even though the 
cells started the replication similarly, they would not be able to complete replication at the 
same time. I have therefore incubated sperm or spermatids in egg extracts, supplemented with 
biotin-dUTP) for 2h – the time which is equivalent to the length of the first embryonic cell 
cycle. Also, not to miss any potential differences between the samples, this time I have 
precisely quantified the extent of replication. Quantification of the replication extent was 
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performed by measuring with ImageJ the length of replicated DNA in each fiber (staining 
anti-biotin) to the total length of the fiber (staining against DNA). Measurements were 
performed on at least 125 independent DNA fibres (22000kb of DNA for each sample) (Fig. 
33A). Data acquired from all the measurements were then exported to Microsoft Excel for 
calculations with the use of a macro created and shared by Dr Vincent Gaggioli. At 120mins 
from the start of the egg extract treatment both cell types replicated more than 80% of the 
total DNA length. There was no difference in the replication extent between sperm and 
spermatid fibers, suggesting that replication problems are unlikely to be the explanation of 
the developmental defects of spermatid-derived embryos (Fig. 33B). 
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Fig. 32. Spermatids initiate replication earlier than sperm and show similar spacing of origin 
of replication to that of sperm. 
Sperm or spermatids were incubated in egg extracts supplemented with biotin-dUTP for 30 or 
for 40mins. Antibody staining against DNA reveals the total length of the fiber (green) and 
antibody staining against biotin reveals the replicated DNA (red). Replicated regions of the 
fibers are yellow in the merged images. (A) Examples of fibers isolated from the sperm 
sample. (B) Examples of fibers isolated from the spermatid sample. Note that spermatids 
initiate replication earlier than sperm (30mins for spermatids and 40mins for sperm) and that 
the spacing of origins is similar in both samples. 
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Fig. 33. Spermatids replicate DNA as efficiently as sperm 
(A) Examples of DNA fibers after immunostaining procedure. Antibody staining against 
DNA reveals the total length of the fibre (green) and antibody staining against biotin reveals 
the replicated DNA (red). The bottom panels show representative examples of replication 
staining from sperm and from spermatids incubated in egg extracts. (B) Replication extent 
measured as the proportion of DNA that incorporated biotin-dUTP to the total fiber length. 
Results are from at least 125 independent DNA fibers (22000kb of DNA for each sample). 
Error bars show ±SEM. Samples were not significantly different (p-value = 0.37, t-test).  
Panel ‘A’ of this figure was created and kindly shared by Dr Vincent Gaggioli. 
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6.3. Spermatid-derived RNA is not deleterious for embryonic development 
 
 
 Since my results showed that problems with DNA replication are unlikely to be the 
cause of developmental defects of spermatid-derived embryos, I next investigated other 
possible reasons which could explain their defects. I first tested whether carried-over RNA 
can be a problem for development of spermatid-derived embryos. All the RNAs present in 
sperm are also present in spermatids; however, during spermiogenesis the maturing 
spermatozoon reduces its cytoplasmic contents together with the vast majority of RNAs. It 
has been estimated that mature sperm contains only about 10-100fg of RNA compared to 10-
50pg of RNA typically found in a somatic cell (Pessot et al. 1989, Krawetz 2005), which is 
about 1000 times reduction in the RNA content. Since there is no transcription in the nucleus 
of the mature sperm, spermatids contain all RNAs which are required for sperm maturation, 
for example mRNAs encoding sperm basic proteins 1-6, which are the functional equivalents 
of mammalian protamines in Xenopus laevis (Abe & Hiyoshi 1991, Hiyoshi et al. 1991). 
Translation of these mRNAs into proteins and their further incorporation into chromatin is 
thought to be important for the acquisition of the highly specialised, almost crystalline 
structure of the sperm nucleus. One could imagine that delivery of all these spermiogenesis-
specific RNAs by the spermatid to the egg at fertilisation could lead to the illegitimate 
translation of spermiogenesis-specific mRNAs in the embryo after fertilisation. Presence of 
such translated proteins could then interfere with the embryonic development, for example by 
altering the chromatin architecture of the spermatid-derived embryos. Interestingly, when 
mRNAs encoding the sperm-specific factors Sp4 or Sp5 were injected into 1-cell stage 
embryos at high concentrations (9.2ng of mRNA per embryo), embryos died around the 
gastrulation stage, suggesting that illegitimate expression of spermiogenesis-related proteins 
can indeed be deleterious for embryonic development (Fig. 34). 
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 I have therefore tested whether the potential carried-over RNA from spermatids can 
have any effects on embryonic development. I have injected fertilised embryos (at 1-cell 
stage) with 50pg (corresponding to the maximum amount of RNA found in a typical somatic 
cell) of either total RNA isolated from testis (isolated with Trizol, therefore recovering all 
different RNA types) or with 50pg of the mRNA encoding the mixture of sperm basic 
proteins (Sp1, Sp4 and Sp5 – mRNAs which were shown to be toxic for embryonic 
development when injected at high doses). None of the injections had any detrimental effects 
on embryonic development (Fig. 35) suggesting that carried-over RNA from spermatids is 
not the cause of developmental failure of spermatid-derived embryos. 
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Fig. 34. Injection of high doses of mRNAs encoding spermiogenesis-related proteins is toxic 
for embryos 
Embryos were injected at 1-cell stage with water or with 9.2ng of mRNAs encoding Sperm 
basic protein 1 (Sp1), Sperm basic protein 4 (Sp4) or Sperm basic protein 5 (Sp5). Injection 
of Sp4 or Sp5 was toxic to the embryos. 
 
 
 
Fig. 35. RNA carry-over is not the cause of developmental defects of spermatid-derived 
embryos 
Fertilised embryos (at 1-cell stage) were injected either with water, with 50pg of mRNAs 
encoding sperm basic proteins (Sp1, Sp4 and Sp5) or with 50pg of total testicular RNA 
(‘Total RNA’). Injections did not affect the normality of embryonic development, since all 
embryos developed into normal swimming tadpoles. 
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6.4. Haploid paternal embryos as a tool for a specific assessment of 
transcription from the paternally-derived chromatin 
 
 
 Another major challenge that the embryo needs to accomplish to develop successfully 
is the zygotic genome activation (Newport & Kirschner 1982). Therefore, I decided to assess 
the ability of sperm- and spermatid-derived embryos to support embryonic transcription. 
After ICSI, embryonic transcription occurs from both the paternal and the maternal genome. 
In order to specifically assess the ability of the paternally-inherited chromatin to drive 
transcription, I decided to use haploid paternally-derived embryos. Haploid paternally-
derived embryos are typically generated by first enucleating the egg with a Mineralite UV 
lamp treatment, followed by in vitro fertilisation. Developing embryos are haploid and their 
genetic material is inherited solely paternally (Gurdon 1960, Hamilton 1963) (Fig. 23). Since 
here I wanted to generate haploid sperm- or spermatid-derived embryos, I had to slightly 
modify this protocol to compensate for the fact that a spermatid cannot fertilise the egg: 
sperm or spermatids were injected into enucleated eggs (instead of performing the in vitro 
fertilisation) (Fig. 36A).  
I have first tested whether haploid embryos recapitulate the developmental 
phenotypes of diploid sperm- and spermatid-derived embryos. I have allowed the generated 
haploid embryos to develop and scored them in the same way as diploid embryos were 
scored: as a number of gastrula embryos and as a number of swimming tadpoles to the total 
number of cleaved embryos. The results obtained with haploid embryos agreed with the 
findings obtained with diploid embryos – there was no significant difference in the embryo 
development to the gastrula stage, but sperm-derived embryos developed significantly better 
to the swimming tadpole stage compared to spermatid-derived embryos (p-value < 0.05) (Fig. 
36B). This therefore validates the use of haploid embryos for the assessment of transcription 
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originating specifically from sperm- or spermatid-derived chromatin at the time of embryonic 
gene activation. 
 
 
 
Fig. 36. Developmental advantage of sperm over spermatid is maintained in haploid embryos 
(A) Diagram explaining ICSI into enucleated eggs. Eggs are first enucleated with the 
Mineralite UV lamp treatment and subsequently injected with sperm or spermatids. (B). 
Haploid sperm-derived embryos developed better than haploid spermatid-derived embryos. 
Embryos were scored as the % of embryos reaching a gastrula stage and a swimming tadpole 
stage to the total number of cleaved embryos. Numbers of embryos analysed are indicated 
above the bars. N = 3 independent experiments. Error bars show ± SEM. * indicates p-value 
= 0.008 (z-test). 
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6.5. rRNA synthesis occurs normally in spermatid-derived embryos 
 
 
I next tested whether spermatid-derived embryos are equally suited to support 
embryonic transcription of rRNA as sperm-derived embryos. It was reported that mouse 
nuclear transfer-derived embryos aberrantly expressed rRNAs when compared to in vitro 
fertilised embryos (Suzuki et al. 2007) and that this correlated with their poor developmental 
outcomes (Zheng et al. 2012). I have therefore hypothesised that sperm is programmed to 
support efficient rRNA synthesis, whereas the spermatid is not. To test this hypothesis, 
enucleated eggs were injected with sperm or spermatids and with BrUTP. BrUTP was co-
injected with sperm or spermatids in order to label only the newly synthesised transcripts 
(Core et al. 2008) and to distinguish them from rRNA maternally accumulated during 
oogenesis (Roger et al. 2002). This procedure allowed generation of haploid sperm- or 
spermatid-embryos which were collected at the gastrula stage. Subsequently, newly 
synthesised RNA was pulled down and quantified by reverse transcription quantitative PCR 
(RT-qPCR) for 18S and 28S rRNA (Fig. 37A). The results of the RT-qPCR analysis revealed 
that there are no significant differences in the amount of 18S or 28S rRNA synthesised 
between the sperm- and spermatid-derived haploid embryos (Fig. 37B). This suggests that 
problems with correct activation of embryonic rRNA synthesis are unlikely to be the cause of 
developmental defects of spermatid-derived embryos. 
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Figure 37. Spermatid-derived embryos are as good as sperm-derived embryos at synthesising 
rRNAs. 
(A) Diagram explaining newly synthesised RNA isolation from sperm- and spermatid-
embryos. Haploid sperm- and spermatid-embryos are obtained by ICSI to enucleated eggs 
and are co-injected with BrUTP to label newly synthesised RNA. Embryos develop to a 
gastrula stage when they are collected. Subsequently, BrUTP-labelled, newly synthesised 
RNA is pulled down. (B) Spermatid-derived embryos synthesised rRNA as efficiently as 
sperm-derived embryos, as evidenced by RT-qPCR quantification of 18S and 28S rRNAs. 
Values are shown as a percentage of pulled down RNA to the total input RNA. Error bars 
show ± SEM. N=20 sperm-derived embryos and N=14 spermatid-derived embryos. Samples 
were not significantly different (p-value = 0.82 for 18S rRNA and p-value = 0.36 for 28S 
rRNA, t-test). 
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6.6. Developmentally-important mRNAs are misexpressed in spermatid-
derived embryos 
 
 
 Zygotic rRNA activation was not different between sperm- and spermatid-derived 
embryos, therefore I next hypothesised that spermatid-derived embryos may show aberrant 
mRNA transcription. In order to investigate the potential mRNA expression changes in a 
global way, I decided to perform RNA sequencing analysis of sperm- and spermatid-derived 
embryos. To focus my analysis on the transcription originating from the paternal chromatin, I 
again used haploid sperm- and spermatid-derived embryos. In order to eliminate technical 
variation between experiments and to facilitate the identification of the biologically 
meaningful differences, I collected the embryos (pools of 5 sperm- or spermatid-derived 
embryos) in seven independent experiments: experiments were conducted on different days, 
with eggs obtained from seven independent frogs and from three independent sperm and 
spermatid cell preparations. I generated haploid embryos as described above (Fig. 36A) and I 
collected them at the gastrula stage, before the onset of developmental defects. Subsequently, 
I isolated RNA from the embryos and generated sequencing libraries for five out of seven 
experimental replicates and sequenced them at the sequencing facility at the Cambridge 
Research Institute. Two remaining RNA samples were sent to our collaborators, Dr Taejoon 
Kwon and Dr Edward Marcotte at the University of Texas, USA, for independent library 
preparation and sequencing. 
Bioinformatic analyses performed by Dr Angela Simeone, Dr Charles Bradshaw and 
Dr George Allen identified 255 out of 18,340 transcripts as abnormally expressed in 
spermatid-derived embryos (compared to sperm-derived embryos) with a false discovery rate 
(FDR) below 0.05 (Table S5). When applying more stringent filtering criteria (selecting only 
those transcripts which were consistently up- or down-regulated in at least 6 out of 7 separate 
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experiments), a final list of 100 transcripts differentially expressed in spermatid-derived 
embryos was obtained. From now on I refer to these 100 transcripts as ‘misregulated’ (Fig. 
38A and Table S5). The majority of these misregulated transcripts (82 out of 100) were found 
to be upregulated, while only 18 out of 100 were downregulated in spermatid-derived 
embryos, as compared with sperm-derived embryos. The RNA-seq results were confirmed by 
RT-qPCR analysis (Fig. 38B). 
In order to further characterise the misregulated genes, gene ontology (GO) 
enrichment analysis was performed by Dr George Allen. The analysis revealed that several 
developmentally-important terms are significantly enriched in the misregulated gene list (p-
value < 0.05) (Fig. 39A). Indeed, more than 25% of the misregulated transcripts are known 
transcriptional regulators essential for embryonic development, for example gata2, gata3, 
hes1 and fos (Zon et al. 1991, Kelley et al. 1994, Maeno et al. 1996, Kim et al. 1998, Read et 
al. 1998, Nardelli et al. 1999, Jouve et al. 2000, Friedle & Knochel 2002, Nakazaki et al. 
2008, Lee et al. 2011). Furthermore, other misregulated transcripts, such as bmp2, bmp7 or 
dhh, are morphogens with crucial roles in the induction of germ layers and cell signalling 
(Bitgood & McMahon 1995, Reversade & De Robertis 2005, Reversade et al. 2005, Wills et 
al. 2008). 
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6.7. mRNAs misexpressed in spermatid-derived embryos are Polycomb 
targets in human sperm 
 
 
Interestingly, I noticed that the GO terms enriched in the misregulated set of 
transcripts (Fig. 39A) are very similar to those enriched for genes bearing trimethylated 
lysine 27 on histone H3 (H3K27me3) in the mature sperm in human (Brykczynska et al. 
2010) (Fig. 39B). I therefore tested whether human orthologues of the Xenopus misregulated 
transcripts identified here may also be H3K27me3-modified in human sperm. Orthology 
search was performed by Dr Charles Bradshaw and the cross comparison of H3K27me3-
modifed genes in human sperm to their Xenopus orthologues was performed by Dr Angela 
Simeone. It was found that among the Xenopus misregulated genes that have human 
orthologues, 41% were enriched for H3K27me3 in human sperm (Fig. 39C). This is a 
significant overrepresentation of H3K27me3-modified genes (p-value < 0.05), since of all 
human orthologues of Xenopus genes, only 16% are enriched for H3K27me3 in sperm (Fig. 
39C and Table S6). 
Concluding, 100 developmentally-important transcripts were identified as 
misregulated in spermatid-derived embryos, of which the majority of transcripts was 
upregulated. Furthermore, orthologues of these misregulated genes are enriched for the 
H3K27me3 mark in human sperm. This result supports the hypothesis that the nucleus of the 
sperm, but not of a spermatid, can be a subject of epigenetic programming to regulate the 
transcription of developmentally-important genes in the future embryo. 
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Fig. 38. Legend on the subsequent page 
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Fig. 38. Identification of 100 transcripts misregulated in spermatid-derived embryos 
(A) Heatmap of transcripts misregulated in spermatid-embryos. Haploid sperm- and 
spermatid-embryos were collected in seven experimental replicates and subjected to RNA-
seq analysis. Heatmap shows 100 misregulated transcripts in spermatid-embryos: transcripts 
in red were upregulated, whereas transcripts in blue were downregulated (FDR < 0.05). 
Columns represent expression values in counts per million of reads (cpm) for each transcript 
(rows) obtained in seven independent experiments (columns 1-7). Transcripts are sorted by 
average log2 of fold difference in expression levels between spermatid- to sperm-embryos. 
Examples of interesting misregulated transcripts are indicated on the right hand side of the 
heatmap (B) RT-qPCR validation of misregulated transcripts identified by RNA-seq analysis. 
Ten randomly selected transcripts from the fifty lowest FDR, upregulated transcripts, and 
four randomly selected out of eighteen downregulated transcripts were selected for RT-qPCR 
validation. Expression values for each gene were normalised to the housekeeping gene pwp1. 
Bars show average log2 of fold change (FC) of expression values obtained for spermatid-
derived embryos to values obtained for sperm-derived embryos. Red bars show transcripts 
which were identified as upregulated in spermatid-derived embryos in RNA-seq, and blue 
bars show transcripts identified as downregulated in RNA-seq. N=6 independent experiments 
for all transcripts, apart from Mn1 and Chd3 for which N=5 independent experiments. P-
values below 0.1 are shown above the bars (t-test). 
Panel ‘A’ of this figure was created and kindly shared by Dr Angela Simeone and Dr George 
Allen. 
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Fig. 39. Human orthologues of Xenopus misregulated genes are marked by H3K27me3 in 
sperm. 
(A) Developmentally-important gene ontology terms are enriched in the list of misregulated 
genes in spermatid-derived embryos (p-value < 0.05). (B) Top 6 gene ontology terms 
enriched within genes having H3K27me3 mark in human sperm (Brykczynska et al. 2010). 
(C) Number of Xenopus laevis orthologues of genes enriched for H3K27me3 and H3K4me2 
in human sperm (Brykczynska et al. 2010). * - p-value=0.000009 and p-value=0.00006 
(proportion test and hypergeometric test, respectively), demonstrating that H3K27me3-
positive genes are significantly overrepresented in the list of human orthologues of Xenopus 
misregulated genes. Statistical analysis of the enrichment was performed by Dr Angela 
Simeone. 
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6.8. Summary 
 
 Results described in this chapter aim at the identification of abnormalities observed in 
spermatid-derived embryos, as compared with sperm-derived embryos. I showed that DNA 
replication problems, carry-over mRNA or problems with the activation of the zygotic rRNA 
transcription are unlikely to be the cause of developmental defects of spermatid-derived 
embryos. On the other hand, RNA-seq analysis of sperm- and spermatid-derived embryos 
allowed the identification of 100 developmentally-important mRNAs which are misexpressed 
in spermatid-derived embryos, as compared with sperm-derived embryos. Interestingly, the 
majority of these mRNAs (82/100) turned out to be upregulated in spermatid-derived 
embryos. Misregulation of these mRNAs is a plausible explanation for the developmental 
defects of spermatid-derived embryos, especially since many of them are important 
transcriptional regulators of embryonic development. 
 Another interesting and unexpected finding is that the gene ontology terms enriched 
in the misregulated gene list in spermatid-derived embryos were strikingly similar to the gene 
ontology terms enriched within H3K27me3-positive genes in mature human sperm. More 
detailed analysis of human orthologues of Xenopus genes revealed a significant enrichment 
for genes positive for H3K27me3 in the list of human orthologues of the Xenopus 
misregulated genes. This finding suggests that perhaps sperm, but not the spermatid, is 
epigenetically programmed to regulate transcription of embryonic genes. 
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Chapter 7 
Epigenetic profiling of sperm and 
spermatids 
 
 
Experiments with enzymatic removal of H3K27me3 mark in in vitro matured/ICSI embryos 
were performed under the supervision and with a great help from Dr Kei Miyamoto and Dr 
Jerome Jullien. I was trained and supervised on how to perform MNase digestions and ChIP-
seq analyses on the chromatin from sperm and spermatids by Dr Serap Erkek and Dr Antoine 
Peters (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland), who 
collaborated with our laboratory on this project and who allowed me to visit their laboratory 
to obtain a technical training vital for this project. Bioinformatic analyses described in this 
chapter were performed by Dr Angela Simeone. 
 
7.1. Introduction 
 
 The results discussed in the previous chapter show that the expression of one hundred 
developmentally-important genes is misregulated in spermatid-derived embryos, as compared 
with sperm-derived embryos. Interestingly, human orthologues of these genes are enriched 
for H3K27me3 mark in the mature sperm. This result prompted me to hypothesise that 
perhaps sperm, as opposed to spermatids, is epigenetically programmed to regulate 
expression of embryonic genes in the embryo after fertilisation. Indeed, it was shown in many 
species that mature sperm retains post-translationally modified histones on chromatin 
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(Hammoud et al. 2009, Brykczynska et al. 2010, Wu et al. 2011). It has been suggested that 
such histones can be delivered to the embryo at fertilisation (van der Heijden et al. 2008). If 
the epigenetic marks on the chromatin could be delivered to the oocyte at fertilisation, then 
they could pattern the gene expression in the future embryo. Any differences in the chromatin 
structure between sperm and spermatids could potentially result in differences in the gene 
expression patterns. I have therefore decided to test the hypothesis that sperm, but not 
spermatids, may be epigenetically suitable to support embryonic transcription. 
In this chapter I describe my results that characterise the epigenetic status of the 
chromatin of sperm and spermatids in Xenopus laevis. I first tested whether the presence of 
H3K27me3 mark on the paternal chromatin at fertilisation is important for the regulation of 
the gene expression in the embryo. The results obtained showed that this is indeed the case – 
enzymatic removal of H3K27me3 marks from the parental chromatin at fertilisation led to 
gene misexpression in the embryo. This confirmed that the presence of epigenetic marks on 
the parental chromatin is important for the future regulation of embryonic gene expression. I 
therefore hypothesised that differential gene expression between sperm- and spermatid-
derived embryos could result from differences in epigenetic marks between sperm and 
spermatids. To interrogate the possible epigenetic differences between sperm and spermatids 
I first performed a brief general characterisation of sperm and spermatids chromatin by 
micrococcal nuclease digestion, which allowed the identification of unique chromatin 
structures in sperm, but not in spermatids. Subsequently, I performed ChIP-seq analyses for 
H3K27me3 and for H3K4me2 and H3K4me3. Interestingly, my results suggest that the 
overexpression of genes in spermatid-derived embryos is not explained by the lack of 
H3K27me3 in spermatids, but instead by a higher abundance of H3K4me2/3 marks in 
spermatids than in sperm. 
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7.2. Parentally-derived H3K27me3 is necessary for correct gene expression 
in embryos 
 
Cross-comparison of genes modified by H3K27me3 in human sperm with the 
misregulated genes suggested that sperm might be epigenetically programmed by H3K27me3 
to support a proper embryonic gene transcription. Before embarking on a detailed 
characterisation of the epigenetic marks in sperm or spermatids, I wanted to test whether 
epigenetic marks on the parental chromatin are of any importance for the regulation of gene 
expression in the early embryo. In other words, I first wanted to test the functional 
importance of parentally-derived H3K27me3 in the regulation of embryonic gene expression. 
To interfere with H3K27me3, I used Kdm6b (K6B), an enzyme that specifically demethylates 
H3K27me3, and as a control I used K6B mutant, which is catalytically inactive (K6B-mut). 
Constructs encoding these enzymes were kindly provided by Dr Jerome Jullien. First, by 
injecting mRNA encoding K6B or K6B-mut into 1-cell stage embryos I confirmed that K6B 
enzyme, but not its mutant version, removed H3K27me3 from embryonic chromatin (Fig. 
40). 
I designed my experiments in a way that allows H3K27me3 removal from both 
parental chromatin sets immediately at fertilisation. For that purpose I adapted the technique 
of in vitro maturation of prophase-arrested oocytes (Miyamoto et al. 2013) and I was 
supervised and assisted in performing these experiments by Dr Kei Miyamoto and Dr Jerome 
Jullien. Firstly, mRNA encoding K6B is injected into immature, GV stage oocytes to allow 
for protein overexpression. Such oocytes, pre-loaded with K6B or K6B-mut enzyme, are 
subsequently in vitro matured into eggs and injected with sperm (via ICSI procedure) to 
generate embryos (Figure 41A). In this experimental setup, with the currently available 
protocols, it is not technically possible to enucleate the oocyte and to obtain haploid embryos 
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derived from paternal genome only. Instead, in the conditions used here, both maternal and 
paternal chromatins contribute to development of the embryo and the enzyme accumulated in 
the oocyte prior to fertilisation acts on both parental chromatin sets. Embryos derived in such 
way were allowed to develop and were collected at the gastrula stage for RT-qPCR analysis. I 
assessed the expression levels of five genes misregulated in spermatid-derived embryos 
(gata3, plod2, hes1, mn1 and c19orf26), and of two control genes: hoxb1 and wasf1. 
Expression of hoxb1 is regulated by H3K27me3 (Agger et al. 2007). Therefore, hoxb1 serves 
as a positive control for the experiment, since the expression level of this gene should be 
affected by the removal of H3K27me3. Wasf1 does not have H3K27me3 around its genomic 
region (Akkers et al. 2009), so its expression levels should not change upon H3K27me3 
removal. As expected, in this experimental setup K6B overexpression had pronounced effects 
on gene expression (Figure 41B). Hoxb1 expression was upregulated 20-fold. Importantly, 
expression of 4 out of 5 misregulated genes tested was also upregulated (statistically 
significant upregulation was observed for plod2 and gata3, p-values < 0.05, t-test). I 
concluded from this experiment that the presence of H3K27me3 on parental chromatin is 
required for the proper regulation of embryonic gene expression. 
To determine whether the upregulation of gene expression observed was a result of 
H3K27me3 removal immediately at fertilisation or at a later point during development, I 
tested the effect of H3K27me3 removal during embryogenesis (after fertilisation). For that I 
injected fertilised 1-cell embryos with mRNA encoding K6B (Fig. 41C). In that way the 
enzyme is absent at fertilisation and becomes translated and modifies the chromatin only as 
the embryo develops. I again collected the embryos for RT-qPCR analysis at the gastrula 
stage and performed the analysis for the same genes as described above. Interestingly, in this 
experimental setup I observed that control genes, as well as genes identified as misregulated 
in spermatid-derived embryos were similarly transcribed in embryos expressing K6B or 
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K6B-mut (Fig. 41D). I therefore concluded that H3K27me3 removal during embryogenesis 
does not affect early embryonic gene expression. 
Summarising, these two sets of experiments (the removal of H3K27me3 at 
fertilisation and the removal of H3K27me3 later during embryonic development) demonstrate 
that the presence of H3K27me3 on parental chromatin at fertilisation is required for the 
proper regulation of expression of embryonic genes. Removal of the H3K27me3 marks 
during embryogenesis does not affect the expression levels of the tested genes. 
Results of these experiments support the hypothesis that the epigenetic marking in the 
sperm may be required for a proper embryonic development. 
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Fig. 40. Overexpression of K6B leads to a removal of H3K27me3 mark. 
(A) One-cell embryos were injected either with mRNA encoding K6B or K6B-mut (MUT). 
Non-injected embryos were used as a control (WT). Embryos were collected for a western 
blot analysis 1 day (1d, gastrula stage), 2 days (2d, tailbud stage) or 4 days (4d, early tadpole) 
after mRNA injection. Membrane is stained with an antibody against H3K27me3. 
H3K27me3 is removed upon overexpression of K6B, but not upon overexpression of K6B-
mut. (B) Quantification of H3K27me3 removal based on the results of immunoblots from 
three independent experiments. Error bars show ±SEM. 
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Fig. 41. Removal of H3K27me3 at fertilisation leads to gene misexpression. 
(A) H3K27me3 mark removal at fertilisation. Immature, prophase-arrested germinal vesicle 
(GV) stage oocytes are injected with mRNA encoding K6B or K6B-mut. mRNA is translated 
into protein and subsequently the oocytes, pre-loaded with K6B or K6B-mut, are in vitro 
matured into eggs. Sperm is then injected into such eggs and the resulting embryos are 
collected for RT-qPCR analysis at the gastrula stage. (B) Gene expression levels in in vitro 
matured and sperm injected (IVM/ICSI) embryos expressing K6B or K6B-mut. Gene 
expression was normalised to the housekeeping gene pwp1. Expression levels are shown as 
fold differences in gene expression between embryos expressing K6B to embryos expressing 
K6B-mut. Error bars show ± SEM. N=5 experimental replicates. * indicates p-value < 0.05 
(t-test). (C) H3K27me3 mark removal during embryonic development. 1-cell stage embryos 
are injected with mRNA encoding K6B or K6B-mut. In this way the proteins are absent at 
fertilisation and they become expressed only as the embryo develops. Embryos are collected 
for RT-qPCR analysis at the gastrula stage. (D) Gene expression in in vitro fertilised (IVF) 
embryos expressing K6B or K6B-mut. Gene expression was normalised to the housekeeping 
gene pwp1. Expression levels are shown as fold differences in gene expression between 
embryos expressing K6B to embryos expressing K6B-mut. Error bars show ±SEM. N=3 
experimental replicates. 
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7.3. General characterisation of chromatin structure in sperm and 
spermatids 
 
Removal of H3K27me3 marks from the parental chromatin at the time of fertilisation 
showed that they are important for the correct regulation of embryonic gene expression. I 
have therefore decided to further characterise the structure of chromatin in sperm and 
spermatids. I initially decided to see whether the chromatin is any different in sperm or 
spermatids in terms of its accessibility or its global structure. One simple way to test this is to 
treat the isolated chromatin with micrococcal nuclease (MNase). MNase is an endo-
exonuclease enzyme that digests DNA at regions which are not protected from digestion. 
Protection from digestion can be mediated for example by the presence of nucleosomes on 
DNA. The nuclesome protects DNA fragment of around 150bp, therefore after the MNase 
digestion of chromatin isolated from somatic cells, one usually obtains a so called 
‘nucleosome ladder’ – a DNA ladder of band sizes which are a multiplication of 150bp, for 
mono-, di- trinucleosomes etc. (Fig. 42). To establish a protocol for Xenopus laevis sperm 
and spermatids chromatin preparation and MNase digestion, a collaboration with the lab of 
Dr Antoine Peters (FMI, Basel) has been initiated, in order to benefit from the expertise of Dr 
Peters in this methodology (Brykczynska et al. 2010, Erkek et al. 2013, Hisano et al. 2013). 
 Chromatin from sperm and spermatids was isolated and subjected to MNase digestion 
for 30mins at 37ºC (using 2.5 units of MNase per chromatin isolated from 1 million of cells). 
As a control for MNase digestion, I have also prepared and digested chromatin from Xenopus 
laevis cell line XL177. Subsequently, DNA has been isolated and run on an agarose gel. 
Somatic cells and spermatids displayed a typical ‘nucleosome ladder’ digestion pattern (Fig. 
43). Spermatids were more digested than XL177 cells (more mononucleosomes and less of 
the higher order chromatin structures observed after digestion). Unexpectedly, it turned out 
that the sperm has a very unique pattern of nuclease-protected DNA regions. Three fragments 
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of different sizes were observed after MNase digestion: ~75bp, ~110bp and ~150bp long 
fragments (Fig. 43). Interestingly, mouse sperm digested with MNase displays a digestion 
pattern typical for any other somatic cells (150bp size nucleosomes) (Brykczynska et al. 
2010), which therefore suggests that Xenopus sperm is very unique in its chromatin 
composition. 
 
 
Fig. 42. ‘Nucleosome ladder’ after MNase digestion 
Drawing showing an example of a ‘nucleosome ladder’ when DNA isolated from chromatin 
from somatic cells digested with MNase is run on a gel. Note that the size of the bands of the 
‘ladder’ is approximately a multiplication of 150bp, which is a size of DNA protected by a 
single nucleosome. 
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Fig. 43. MNase digestion reveals that sperm chromatin has a unique structure 
Chromatin isolated from 1 million of sperm, spermatids or XL177 cells was digested with 2.5 
units of MNase for 30mins at 37ºC. Subsequently, DNA was isolated and run on the agarose 
gel. Spermatids and XL177 cells digestion pattern displays a typical ‘nucleosome ladder’ 
(mononucleosome band size indicated), whereas digestion of sperm revealed a unique 
structure of sperm chromatin, consisting of three bands of approximately 150bp, 110bp and 
75bp (bands are respectively numbered 1, 2, 3 and indicated on the gel). The lowest band (4) 
is digested DNA, which was also observed when mouse or human sperm is digested with 
MNase (Brykczynska et al. 2010). 
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 It is known that mature sperm in Xenopus laevis retains core histones H3 and H4, but 
has a reduced amount of histones H2A and H2B (Abe & Hiyoshi 1991, Yokota 1991, 
Shechter et al. 2009). My immunoblotting results on Xenopus leavis sperm and spermatids 
agreed with the published observations – I could detect similar amounts of H3 and H4 by 
immunoblotting in sperm and spermatids and reduced amounts of histones H2A and H2B 
(Fig. 44). I next hypothesised that perhaps at least some of the chromatin structures that I 
observed in the sperm, but not in the spermatid chromatin after MNase digestion are due to 
the incorporation of sperm basic proteins into the sperm chromatin. Sperm basic proteins in 
Xenopus are more basic than histones, as evidenced by theoretical isoelectric point 
calculations (calculations performed using online Expasy tool http://web.expasy.org/cgi-
bin/compute_pi/pi_tool): the least basic of the sperm basic proteins (Sp1) is still more basic 
than any canonical histone (Table 6). I have therefore reasoned that if any of the sperm 
chromatin structures observed after MNase digestion have sperm basic proteins as their 
components, they could be preferentially disrupted upon heparin treatment of chromatin. 
Heparin is a molecule of high negative charge and is therefore able to displace positively 
charged proteins from chromatin (Hildebrand et al. 1977). Treatment of permeabilised 
Xenopus sperm with heparin leads to chromatin dispersal and DNA release. Dispersal os 
sperm chromatin increased with the increasing concentration of heparin used (Fig. 45). Since 
the sperm basic proteins are more basic than histones, they should be displaced from sperm 
chromatin by the heparin treatment earlier than histones. Therefore, if some of the structures 
on sperm chromatin that protect the DNA from the MNase digestion are composed with the 
sperm basic proteins to a higher extent than the others, they could be displaced from the 
chromatin first. I have therefore decided to test the effect of sperm chromatin treatment with 
increasing doses of heparin on the pattern of MNase digestion. I have treated permeabilised 
sperm nuclei with increasing doses of heparin and subsequently performed MNase digestion. 
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Interestingly, ~110bp band (number 2) generated by MNase digestion is the first one to 
disappear upon increased heparin concentration (Fig. 46). This suggests that the band number 
2 (~110bp long) could be composed of sperm basic proteins or be a mixture of sperm basic 
proteins and histones. Alternatively, the second band could also be composed of unstable 
histones. Regardless of the reason for the preferential displacement of the 2
nd
 band, the 
important information is that these three chromatin structures in the sperm are not equally 
stable. The exact identity of these three bands and the nature of the DNA protected by these 
structures is a subject of follow-up studies currently conducted in the Gurdon laboratory. 
 
Table 6. Theoretical isoelectric point of nuclear proteins in Xenopus laevis. 
Name H2A H2B H3 H4 Sp1 Sp4 Sp5 
Isoelectric point 10.17 10.31 11.27 11.36 11.89 12.57 12.62 
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Fig. 44. Immunoblotting analysis for histone H2A, H2B, H3 and H4 on sperm and 
spermatids. 
Immunoblotting analysis for core histones H2A, H2B, H3 and H4 on the protein lysates from 
sperm and spermatids. The number of cells from which the proteins were isolated is indicated 
above each lane (numbers represent thousands of cells, for example, ‘8’ stands for proteins 
isolated from 8000 cells). Note that sperm and spermatids contain similar amount of histones 
H3 and H4, and that mature sperm has a reduced amount of histones H2A and H2B. 
  
 Chapter 7: Results 
 
146 
 
 
 
Fig. 45. Heparin treatment leads to chromatin dispersal in sperm. 
Permeabilised sperm were treated with increasing doses of heparin and stained with DAPI. 
Three representative images are shown for each of the heparin treatment doses. Note that the 
higher the heparin dose, the more decondensed the sperm. Scale bar = 20um. All images were 
taken with the same magnification. 
 
  
 Chapter 7: Results 
 
147 
 
 
 
Fig. 46. Heparin treatment first releases the ~110bp structure from sperm chromatin. 
Sperm chromatin was treated with increasing concentrations of heparin (0.0025 – 0.125 
mg/ml) and subsequently digested with 2.5U MNase for 30mins. DNA was isolated and run 
on the gel. Note that the chromatin structure protecting a ~110bp DNA fragments (number 2) 
disappears as the first one with the increasing dose of heparin treatment. This is concomitant 
with the appearance of digested DNA (band number 4). Further increase of the heparin 
concentration leads to a loss of all the protective chromatin structures and digestion of all 
DNA in sperm. 
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7.4. ChIP-seq analysis for H3K27me3 does not reveal differences between 
sperm and spermatids 
 
 
ChIP experiments were performed according to the advice provided by Dr Serap Erkek and 
Dr Antoine Peters. All the bioinformatic analyses were performed by Dr Angela Simeone. 
 
 My results obtained so far demonstrated that parentally-derived H3K27me3 marks 
regulate embryonic gene expression. Furthermore, I have shown that sperm and spermatids 
differ in their chromatin structure. I therefore reasoned that perhaps the misregulation of gene 
expression in spermatid-embryos, as compared to sperm-embryos, might be a consequence of 
improper epigenetic marking in the spermatid. As the majority of the misregulated genes are 
upregulated in spermatid-embryos, I hypothesised that the spermatid may lack the repressive 
H3K27me3 marks as compared with sperm. To address this, I performed chromatin 
immunopurification followed by a genome-wide sequencing (ChIP-seq) analysis for 
H3K27me3 mark on mononucleosomal chromatin isolated from Xenopus laevis sperm and 
spermatids. I have chosen the mononucleosomal chromatin fraction for the ChIP analysis, 
since this fraction is a canonical chromatin structure observed in both cell types and the 
identity of the other chromatin structures in sperm is currently unknown. I performed the 
ChIP experiments in three independent replicates (three different cell preparations from 
different frogs and ChIP experiments performed on different days). To assess the variability 
between the experiments, Dr Angela Simeone performed a Pearson correlation coefficient 
analysis for the replicates. The three biological replicates for the H3K27me3 mark showed an 
average Pearson correlation coefficient of 0.9 between replicates in sperm and 0.72 in 
spermatids. The ChIP-seq data was analysed first by looking at overall methylation levels and 
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second, by looking at localised regions of enrichment for histone marks (peaks) (see Fig. 47 
for a detailed explanation). 
 
7.4.1. Overall methylation levels analysis 
 
I first wanted to test whether the misregulated genes have different histone 
H3K27me3 methylation levels than the genomic average. Quantification of methylation 
levels was performed by Dr Angela Simeone. Methylation levels were calculated as the total 
number of reads obtained for H3K27me3 (normalised to the number of reads obtained in the 
input sample) at the region around the transcriptional start site and also in the region 
encompassing the gene bodies, as H3K27me3 was shown before to spread in broad domains 
across the genes (Fig. 47) (Barski et al. 2007). The analysis of the H3K27me3 methylation 
levels at misregulated genes as compared with the genomic averages revealed that in Xenopus 
laevis misregulated genes are significantly more methylated (have more reads) for 
H3K27me3 in both sperm and in spermatids (p-values<0.05) (Fig. 48A). This confirms the 
previous finding made by cross-species comparison to human sperm (Fig. 39) – the 
misregulated genes in Xenopus indeed have more of H3K27me3 mark. Unexpectedly 
however, it seems that H3K27me3 cannot on its own explain the difference in gene 
expression between sperm- and spermatid-derived embryos, since it is enriched at 
misregulated genes in both cell types. 
To make sure that meaningful differences in H3K27me3 methylation levels are not 
overlooked in the bioinformatic analysis described, I also decided to compare H3K27me3 
levels at misregulated genes between sperm and spermatids. Therefore, in addition to the 
comparison of the methylation levels between the misregulated genes and the genomic 
averages (see above), Dr Angela Simeone also directly compared the methylation levels at 
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the misregulated genes between sperm and spermatids. The reasoning behind performing this 
additional analysis is that the mark could be overrepresented in both samples, but still be 
more abundant in sperm than in spermatids. The results of the comparison between sperm 
and spermatids showed H3K27me3 levels at misregulated genes was not significantly 
different between sperm and spermatids (p-value = 0.7) (Fig. 48B and Fig. 49A). The same 
was true also when looking at individual gene tracks – no significant differences in 
H3K27me3 methylation patterns were observed between sperm and spermatids (Fig. 49B). 
To conclude, the quantification of overall methylation levels at misregulated genes 
showed a similar level of enrichment over the genome-wide average for H3K27me3 in both 
cell types. 
 
7.4.2. Peak analysis 
 
To further characterise any potential differences in H3K27me3 level between sperm 
and spermatids, regions of enrichment (peaks) for histone marks were identified in the gene 
regulatory regions and in the gene bodies by Dr Angela Simeone (Fig. 47). In agreement with 
the findings for the overall methylation levels, genes with H3K27me3 peaks were 
significantly enriched within the misregulated gene list in both cell types, as compared to the 
genomic averages (p-values < 0.05) (Fig. 50A). It was also assessed (analysis by Dr Angela 
Simeone) how broad were the H3K27me3 peaks, as it could be that peaks for H3K27me3 
differ in size between sperm and spermatids. Again, H3K27me3 peaks were of similar size in 
sperm and in spermatids (Fig. 50B), therefore the peak size of H3K27me3 could not explain 
the difference in gene expression between sperm- and spermatid-derived embryos. 
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7.4.3. Summary – H3K27me3 marks are not different between sperm and spermatids 
 
 
To summarise, both the quantitative assessment of methylation levels and the peak-
oriented analysis led to the conclusion that H3K27me3 is enriched at misregulated genes 
above the genomic average both in sperm and spermatids. This suggests that, even though 
H3K27me3 is necessary for proper gene expression (Fig. 41), presence of this mark alone 
cannot explain differences in gene expression between sperm- and spermatid-derived 
embryos, as the mark is enriched in both cell types. 
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Fig. 47. Legend on the subsequent page. 
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Fig. 47. Schematic representation of ChIP-seq analysis of histone marks: overall methylation 
level versus localised enrichments (peaks).  
(A) Quantification procedure is explained on the example of tbx3 gene for H3K4me2 ChIP. 
Firstly, all the reads obtained from sequencing of ChIP samples were normalised to the reads 
obtained from sequencing of the corresponding input samples and to the total number of 
sequencing reads. Normalised methylation tracks are shown as ‘Sperm methylation’ and 
‘Spermatid methylation’. Regions of read enrichment for each mark (‘peaks’) were identified 
with the use of MACS2 (Zhang et al., 2008) and are depicted as horizontal bars spanning the 
regions of significant read enrichment and are visualised as tracks named ‘Sperm peaks’ and 
‘Spermatid peaks’. (B) Subsequently, overall methylation levels were quantified by summing 
up the normalised read number in the regions spanning -10kbp to +2kbp of gene 
transcriptional start sites (TSSs) for H3K4me2 and H3K4me3 and in the regions spanning  
-10kbp of TSS and the entire gene body for H3K27me3 (Bernstein et al. 2005, Barski et al. 
2007, Akkers et al. 2009, van Heeringen et al. 2014). (C) Example of the results of 
quantification of normalised read number for tbx3. (D) The presence of peaks was evaluated 
in the same regions as above: -10kbp/+2kbp from TSS for H3K4me2/3 and -10kbp + gene 
body for H3K27me3. Table shows an example of the results of the peak presence assessment 
for tbx3. 
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Fig. 48. Cumulative distribution curves for H3K27me3 in sperm and spermatids. 
(A) Cumulative distribution curves of overall methylation levels for H3K27me3 compared 
between misregulated genes and the genome-wide averages in sperm or spermatids. Curves 
for the misregulated gene methylation level in sperm are shown in blue, for the spermatid – in 
red, and for the genome-wide average – in grey. P-values for the difference between the 
methylation level at misregulated genes and the genome-wide average are indicated in the 
graphs (Kolmogorov-Smirnov, KS-test). (B) Cumulative distribution curves of H3K27me3 
methylation level at misregulated genes between sperm (blue) and spermatid (red). P-values 
for the difference between the methylation levels are indicated in the graphs (KS-test). 
Analysis for this figure was performed by Dr Angela Simeone. The figure was generated and 
kindly shared by Dr Angela Simeone. 
  
 Chapter 7: Results 
 
155 
 
 
 
Fig. 49. H3K27me3 at misregulated genes is not different between sperm and spermatids. 
(A) A heatmap showing the average normalised number of reads for misregulated genes in 
sperm and spermatids for H3K27me3. Genes (rows) are sorted from the most methylated to 
the least methylated in spermatids. (B) Methylation patterns of a representative misregulated 
gene in sperm and spermatids for H3K27me3. Track shows read numbers in the bound 
fraction, normalised to the input and to the total number of sequenced reads. Analysis for this 
figure was performed by Dr Angela Simeone. The panel ‘A’ of this figure was generated and 
kindly shared by Dr Angela Simeone. 
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Fig. 50. Peak analysis for H3K27me3 reveals no differences between sperm and spermatids. 
(A) Peaks were counted in the upstream regions and in the gene bodies for H3K27me3. 
Statistical analysis shows a significant enrichment for H3K27me3-positive genes amongst 
misregulated ones in sperm and spermatids (as compared to genome-wide average) (B) Box 
plot analysis of the H3K27me3 peak width in sperm and spermatids reveals that peaks are of 
similar size in both cell types. The analyses for this figure were performed by Dr Angela 
Simeone, who also created and kindly shared the panel ‘B’ of this figure. 
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7.5. Misregulated genes have more H3K4me2/3 activating marks in 
spermatids than in sperm 
 
 
My ChIP-seq results for H3K27me3 revealed that this repressive mark is not different 
between sperm and spermatids; therefore, it cannot explain the difference in gene expression 
between sperm- and spermatid-derived embryos. I next hypothesised that since the majority 
of misregulated genes are upregulated in spermatid-embryos, perhaps the spermatid has more 
activating epigenetic marks than the sperm. To address this, I performed ChIP-seq analysis 
on mononucleosomal chromatin isolated from sperm and spermatids for two histone marks 
associated with gene activation: histone H3 lysine 4 dimethylation (H3K4me2) and histone 
H3 lysine 4 trimethylation (H3K4me3). Average Pearson correlation coefficient analysis 
performed by Dr Angela Simeone confirmed the reproducibility of the results (the exact 
average Pearson correlation coefficient values were: 0.9 for sperm H3K4me2; 0.55 for sperm 
H3K4me3; 0.95 for spermatid H3K4me2 and 0.8 for spermatid H3K4me3). 
The ChIP-seq data were again analysed by two different approaches: first, looking at 
the overall methylation levels and second, by looking at the localised regions of enrichment 
for histone marks (peaks) (Fig. 47). 
 
7.5.1. Overall methylation levels analysis 
 
In the initial analysis histone methylation levels were compared at the misregulated 
genes with the genomic average. Methylation levels were again quantified (by Dr Angela 
Simeone) as the total number of reads obtained for H3K4me2 and H3K4me3 in the regions 
around the transcriptional start sites (TSS) (Fig. 47). Interestingly, there was a slight 
enrichment of H3K4me2 reads at misregulated genes over the genome-wide average in 
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spermatids (p-value = 0.1) (Fig. 51A), suggesting that the presence of high levels of 
H3K4me2 might be responsible for the gene upregulation in spermatid-embryos. 
To further characterise this difference, histone methylation levels were compared at 
the misregulated genes between sperm and spermatids. Interestingly, misregulated genes had 
a significantly higher methylation in spermatids than in sperm for H3K4me2 and H3K4me3, 
(p-values < 0.05) (Fig. 51B and Fig. 52A). At individual gene tracks, H3K4me2 and 
H3K4me3 showed mainly quantitative differences in the methylation levels between sperm 
and spermatids (Fig. 52B). Interestingly, for some genes H3K4me2 additionally showed a 
different distribution of methylation between sperm and spermatids: in such genes 
H3K4me2-positive regions in spermatids were broader than in sperm and often contained 
several enriched regions close to the TSS (Fig. 52B). 
To conclude, quantification of H3K4me2/3 levels at misregulated genes between 
spermatids and sperm revealed significantly higher levels of H3K4me2/3 in spermatids. 
Higher levels of H3K4me2/3 in spermatids correlate with the observed upregulation of genes 
in spermatid-derived embryos. 
 
7.5.2. Peak analysis 
 
Subsequently, peak analysis for H3K4me2 and for H3K4me3 was performed (by Dr 
Angela Simeone). Interestingly, in sperm, but not in spermatids, there was a two-fold 
decrease in the number of H3K4me3-positive genes among the misregulated ones as 
compared to the genomic average (Fig. 53A). Next, the size of peaks for H3K4me2 and 
H3K4me3 was analysed in sperm and spermatids. Interestingly, peaks for H3K4me2 and for 
H3K4me3 in spermatids were broader than in sperm (Fig. 53B). 
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7.5.3. Summary – H3K4me2/3 marks are more abundant in spermatids 
 
To summarise, the activating marks H3K4me2 and H3K4me3 are more abundant in 
spermatids and depleted in sperm at misregulated genes. Enrichment of activating 
H3K4me2/3 in spermatids, as compared sperm, correlates well with the fact that the majority 
of misregulated genes (82/100) are overexpressed in spermatid-derived embryos, as 
compared to sperm-derived embryos. This suggests that sperm, as opposed to the spermatid, 
is epigenetically programmed for proper embryonic gene expression. 
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Fig. 51. Cumulative distribution curves for H3K4me2 and for H3K4me3 in sperm and 
spermatids. 
(A) Cumulative distribution curves of overall methylation levels for H3K4me2 and 
H3K4me3 compared between misregulated genes and the genome-wide averages in sperm or 
spermatids. Curves for the misregulated genes methylation levels in sperm are shown in blue, 
for the spermatid – in red, and for the genome-wide averages – in grey. P-values for the 
difference between the methylation level at misregulated genes and the genome-wide 
averages are indicated in the graphs (Kolmogorov-Smirnov, KS-test). (B) Cumulative 
distribution curves of H3K4me2 and H3K4me3 methylation levels at misregulated genes 
between sperm (blue) and spermatids (red). P-values for the difference between the 
methylation levels are indicated in the graphs (KS-test). Analysis for this figure was 
performed by Dr Angela Simeone. The figure was generated and kindly shared by Dr Angela 
Simeone. 
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Fig. 52. H3K4me2 and H3K4me3 marks are more abundant in spermatids than in sperm at 
the misregulated genes. 
(A) Heatmaps showing the average normalised number of reads for the misregulated genes in 
sperm and spermatids for H3K4me2 and for H3K4me3. Genes (rows) are sorted from the 
most methylated to the least methylated in spermatids, separately for each mark. (B) 
Methylation patterns of representative misregulated genes in sperm and spermatids for 
H3K4me2 and for H3K4me3. Tracks show read numbers in the bound fraction, normalised to 
the input and to the total number of sequenced reads. Analysis for this figure was performed 
by Dr Angela Simeone. The panel ‘A’ of this figure was generated and kindly shared by Dr 
Angela Simeone. 
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Fig. 53. Peak analysis for H3K4me2 and for H3K4me3 reveals depletion of H3K4me3 peaks 
in sperm and also shows that peaks for H3K4me2 and H3K4me3 are broader in spermatids. 
(A) Peaks were counted in the upstream regions for H3K4me2 and for H3K4me3. Note a 
two-fold depletion of H3K4me3-positive genes amongst misregulated ones in sperm (as 
compared to the genome-wide average) (B) Box plot analysis of the H3K4me2 and 
H3K4me3 peaks width in sperm and spermatids reveals that peaks are broader in spermatids 
than in sperm. The analyses for this figure were performed by Dr Angela Simeone, who also 
created and kindly shared the panel ‘B’ of this figure. 
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7.6. Summary 
 
 
 In this chapter I investigated the roles of epigenetic signatures in the parental 
chromatin for the embryonic development. I first showed that the presence of H3K27me3 on 
the parental chromatin at fertilisation (but not afterwards) is needed for a proper regulation of 
embryonic gene expression. Then I looked into the chromatin structure of sperm and 
spermatids. It turned out that the sperm of Xenopus laevis has a uniquely structured 
chromatin, which is evidenced by unusual patterns of DNA bands released after the MNase 
digestion (DNA bands pattern are different from the canonical ‘nucleosome ladder’ and they 
are also different from the patterns observed in mouse or human sperm). Subsequent ChIP-
seq analysis of mononucleosomal chromatin from sperm and spermatids for the repressive 
H3K27me3 and activating H3K4me2 and H3K4me3 revealed that sperm and spermatids do 
not differ in the abundance of H3K27me3, but that H3K4me2/3 was higher in spermatids 
than in sperm at misregulated genes. Interestingly, the average width of peaks for 
H3K4me2/3 was also higher in spermatids than in sperm. These results support the 
hypothesis that the upregulation of developmentally-important genes in spermatid-derived 
embryos is a consequence of the presence of H3K4me2 and H3K4me3 at higher levels in 
spermatids than in sperm. These also suggest that during spermiogenesis the spermatid has to 
epigenetically mature (lose H3K4me2/3 marks) in order to be correctly programmed to 
support embryonic development. 
 
 Chapter 8: Discussion 
 
164 
 
Chapter 8 
Discussion 
 
 
In this thesis I described my results investigating the nature of sperm programming 
for embryonic development. To address this question, I compared the sperm with its 
precursor cell, a spermatid. The results obtained support the hypothesis that programming of 
sperm is related to the acquisition of chromatin signatures that support a correct gene 
expression in the embryo. Specifically, I showed that spermatids, as opposed to sperm, retain 
on the chromatin activating H3K4me2/3 marks. Presence of these activating marks at 
misregulated genes in spermatids correlates with upregulation of these genes in spermatid-
derived embryos. Therefore, my results suggest that sperm, as opposed to spermatids, are 
epigenetically mature to support normal embryonic development. There are however certain 
limitations to the conclusions that can be drawn from the results presented. Also, there are 
experiments, which are now carried in the Gurdon laboratory, that can potentially extend the 
findings presented in this thesis. Therefore, below I thematically group these matters and 
discuss them. I finish this section by explaining how the results presented in this thesis 
broaden our current understanding of sperm programming and how they relate to the 
phenomena of transgenerational inheritance of the phenotypic changes through paternal 
epigenetic marks. 
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8.1. Are the defects of spermatid-derived embryos a consequence of gene 
misexpression? 
 
 
 In order to understand the nature of sperm programming, I investigated the 
developmental defects of spermatid-derived embryos. Identifying the defects of the 
spermatid-derived embryos, not observed in sperm-derived embryos, allowed me to narrow 
down the aspects of development in which the sperm-derived embryos are better. I showed 
that replication problems, carry-over RNA or inefficient activation of rRNA transcription are 
unlikely to explain the developmental defects of spermatid-derived embryos. Interestingly, I 
identified 100 developmentally-important mRNAs as misregulated in spermatid-derived 
embryos (compared to sperm-derived embryos). Is this however the real cause of the 
developmental defects of spermatid-derived embryos? 
 The experiments presented in this thesis do not directly answer this question. Results 
shown allow correlating the developmental effects with the misexpression of these mRNAs. 
However, the presented results do not provide the functional evidence that could prove the 
hypothesis that misexpression of these mRNAs is indeed causative for the defects of 
spermatid-derived embryos. Experiments that could functionally test the relationship between 
the misexpression of these mRNAs and the occurrence of developmental defects in 
spermatid-derived embryos could be potentially designed in two different ways. First, one 
could try to overexpress the misregulated mRNAs in sperm-derived embryos to test whether 
developmental defects similar to those observed in spermatid-derived embryos would be 
induced. Alternatively, one could also downregulate proteins encoded by these mRNAs in 
spermatid-derived embryos to rescue their defects. Unfortunately however, none of these 
strategies are technically possible for multiple reasons. First, transcription factors need to be 
present at the correct concentrations and at very precise developmental time windows and 
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their expression should be limited only to specific tissues. Currently available protocols 
aiming at overexpressing or downregulating the proteins utilise mRNA or morpholino 
oligonucleotides injection, respectively. Injections are performed into 1-cell stage embryos; 
therefore the effects would happen in all the embryonic tissues and would not be limited to 
the desired tissues only. Secondly, the majority of these misregulated mRNAs are 
embryonically expressed with a precisely controlled time of expression. Injecting mRNAs or 
morpholinos into 1-cell stage embryos does not allow one to have control over the 
developmental timing of the expression. Last, but not least, it is difficult to imagine how one 
would express all the factors of interest at the precisely desired concentration. This would be 
even more problematic in the morpholino knockdown strategy, as for this strategy one would 
also need to precisely measure how the mRNA concentration encoding a given factor is 
reflected in the final concentration of the translated protein. 
 Interestingly, it has been demonstrated that about a 2-fold difference in the protein 
concentration of the transcription factor Xbra prevented nucleocytoplasmic hybrid embryos 
between Xenopus laevis and Xenopus tropicalis from the correct convergence/extension 
movements during gastrulation, which resulted in their failure to gastrulate successfully. 
These defects were partially rescued by correcting for the Xbra protein concentration 
(Narbonne et al. 2011). Therefore, if inappropriate concentration of a single transcription 
factor can be responsible for at least some gastrulation defects of the nucleocytoplasmic 
hybrid embryos (Narbonne et al. 2011), it is very likely that misregulation of 100 different 
mRNAs, which are developmentally-important and amongst which many are transcription 
factors, is indeed responsible for the developmental failure of spermatid-derived embryos. 
However, as mentioned before, the definite experimental evidence to support this statement is 
lacking and it is highly unlikely it would be technically possible to provide such evidence, at 
least with the currently available protocols. 
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8.2. Model for epigenetic programming of the sperm nucleus 
 
 
 My results show that expression of developmentally-important mRNAs is altered in 
spermatid-derived embryos as compared to sperm-derived embryos and that the majority of 
these mRNAs are upregulated in spermatid-derived embryos. With the help of Dr Kei 
Miyamoto and Dr Jerome Jullien I showed that the presence of H3K27me3 marks at 
fertilisation is necessary to prevent gene overexpression in embryos. This led me to the 
hypothesis that perhaps sperm has on its chromatin repressive H3K27me3 marks, which are 
absent on the spermatid chromatin, hence gene overexpression is observed in spermatid-
derived, but not in sperm-derived embryos. However, ChIP-seq results showed that 
upregulation of genes in spermatid-derived embryos could not be explained by the absence of 
repressive H3K27me3 marks in spermatids, since these marks were enriched at misregulated 
genes in both sperm and spermatids. Instead, upregulation of misregulated genes correlated 
with the presence of higher levels of activating H3K4me2/3 marks in spermatid than in 
sperm.  
These findings suggest that proper regulation of embryonic gene expression is 
ensured in the sperm chromatin by two separate epigenetic layers: the presence of repressive 
H3K27me3 marks and a simultaneous depletion of activating H3K4me2/3 marks (Fig. 54). 
The spermatid already has the repressive H3K27me3, but does not yet lose activating marks 
from the misregulated genes (Fig. 54). Therefore, spermatids, as opposed to sperm, are not 
epigenetically mature to support correct gene expression in the embryo due to the retention of 
activating marks on their chromatin. These findings are in agreement with reports in mouse: 
in contrast to H3K27me3, which is similar between sperm and spermatids, H3K4me3 levels 
are reduced in sperm (Erkek et al. 2013). 
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Curiously, the results described in this thesis show a similar low efficiency of normal 
development between spermatid-derived embryos and nuclear transfer-derived embryos (as 
compared with sperm-derived embryos). In others words, spermatid had a similarly low 
developmental potential as an early embryonic cell. Furthermore, it was shown in nuclear 
transfer experiments conducted in Xenopus laevis that ectopic expression of donor-cell genes 
in nuclear transfer-derived embryos was associated with the presence of H3K4me3 at these 
gene promoters in such embryos (Ng & Gurdon 2005, Ng & Gurdon 2008), as compared to 
control fertilised embryos. This is again similar to our observations that spermatids, as 
compared to sperm, had more of activating H3K4me2/3 marks on chromatin which correlated 
with the overexpression of embryonic genes in spermatid-derived embryos. All these results 
support the hypothesis that sperm is epigenetically-programmed to regulate the expression of 
embryonic genes. 
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Fig. 54. Model for epigenetic programming of sperm nucleus for embryonic development. 
The presence of H3K27me3 and the absence of H3K4me2/3 in sperm is important for a 
proper regulation of embryonic gene expression. Model is explained on examples of several 
misregulated genes (gata3, hes1 and plod2), which are upregulated in spermatid-derived 
embryos. In spermatids, these genes have H3K27me3 and H3K4me2/3 marks. Repressive 
H3K27me3 marks are retained in the chromatin of mature sperm, but activating marks 
H3K4me2/3 are lost. Aberrant retention of activating marks at the misregulated genes in 
spermatids correlates with overexpression of these genes in spermatid-derived embryos and 
with abnormal development of spermatid-derived embryos. 
 
The remaining question is why the activating H3K4me2/3 marks were present at 
misregulated genes in the spermatid chromatin. As discussed earlier, misregulated genes were 
enriched for developmentally-important ones and many of them were transcription factors 
important for embryogenesis. Therefore, it is unlikely that those genes would be expressed in 
spermiogenesis. However, to exclude this possibility, I have performed a qRT-PCR analysis 
for selected misregulated genes (mn1, hes1, gata3 and sfrp2) to test whether they were 
expressed in spermatids. These genes were identified by ChIP-seq as having H3K4me3 peaks 
exclusively in spermatids and also as having lower quantity of H3K4me2 methylation level in 
sperm than in spermatids. As expected, the results of the qRT-PCR analysis confirmed that 
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these genes were not expressed in spermatids (data not shown). Therefore, active expression 
of these genes in spermatids cannot explain the presence of H3K4me2/3 in spermatids. 
Interestingly, it was shown that in spermatids, a global acetylation of histones is 
observed (Hazzouri et al. 2000), which was suggested to be involved in chromatin 
rearrangements that allow its ultimate compaction in several of ways. First, it was shown that 
acetylated histones can be recognised and bound by Brdt – bromodomain, testis-specific 
protein, and it was shown that such binding by Brdt leads to the chromatin compaction 
(Pivot-Pajot et al. 2003, Govin et al. 2006, Moriniere et al. 2009). Secondly, acetylation (but 
not their polyubiquitination) triggered degradation of core histones during spermiogenesis by 
testis-specific proteasomes (Qian et al. 2013), presumably facilitating protamine deposition 
on chromatin, which are the main chromatin component of the mature mammalian sperm. 
Last, it was also suggested that global acetylation increases the instability of the canonical 
histone-structured chromatin during spermiogenesis, therefore facilitating the incorporation 
of protamines (Gaucher et al. 2010). Therefore, it is plausible to think that the presence of 
activating H3K4me2/3 marks at genes in spermatids, similarly to what was reported for 
histone acetylation, does not necessarily reflect their transcriptional activity, but that it is 
important for structural changes occurring during spermatid to sperm transition. For example, 
analogously to what has been suggested for histone acetylation, methylation of H3K4 could 
create a more open chromatin structure in the spermatid, which in turn could facilitate the 
access of sperm basic proteins to chromatin and as a result, lead to a chromatin remodelling 
which allows its compaction in sperm. Then, if such H3K4me2/3-modified chromatin of 
spermatid is delivered to an egg, the egg, which does not have sperm basic proteins in the 
cytoplasm and other machinery required for remodelling of the chromatin to the sperm-like 
state, could interpret the H3K4me2/3 as transcriptionally-activating marks. This in turn 
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would lead to overexpression of genes having such marks, as indeed observed in spermatid-
derived embryos. 
 
8.3. How are the epigenetic marks transmitted to the embryo? 
 
 
 Another interesting aspect emerging from this study, which was only partially 
addressed in this thesis, is how the epigenetic marks present on sperm are transmitted to the 
embryo. In collaboration with other members of the Gurdon laboratory, I showed that the 
experimental removal of H3K27me3 marks at fertilisation had a pronounced effect on gene 
expression, whereas removal of the very same mark later during embryonic development did 
not have such effect (Fig. 41). In early Xenopus embryos the first twelve cell cycles are rapid, 
with no gene transcription. Only after reaching the mid-blastula transition stage, is the 
zygotic genome activated (Newport & Kirschner 1982). It was shown that in species in which 
such rapid cell cycle phases precede zygotic genome activation, histone post-translational 
modifications, such as H3K4me3 or H3K27me3 were not detected on chromatin during these 
rapid cell cycles (Akkers et al. 2009, Vastenhouw et al. 2010, Lindeman et al. 2011). Post-
translational epigenetic marks were established again on chromatin only around the time of 
zygotic genome activation (Lindeman et al. 2011). It is possible that the presence of post-
translational histone marks and the need for their re-establishment after each cell cycle would 
impede rapid DNA replication phases. During S-phase in Drosophila embryos H3K4me3 and 
H3K27me3 marks disappear completely from the chromatin; to re-appear again only in G2 
phase. Interestingly, in Drosophila the enzymes that carry out these modifications: Trithorax 
and Enhancer-of-Zeste, respectively, remain associated with chromatin during S-phase. This 
suggests that the enzymes that modify histone tails (chromatin ‘writers’) also act as 
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placeholders for the actual histone marks (Petruk et al. 2012). Nascent chromatin capture 
experiments (performed by a pull down of chromatin at different phases of replication) 
showed that the enzymatic machinery associated with deposition of H3K27me3 mark on 
chromatin is indeed stably bound to chromatin in all cell cycle phases (Alabert et al. 2014). 
Interestingly, it was reported that Ezh2 (enhancer of zeste homolog 2), the enzyme that 
catalyses H3K27me3 deposition, was associated with chromatin in Xenopus tropicalis 
embryos and that this preceded H3K27me3 deposition (van Heeringen et al. 2014). This 
could suggest that writers of epigenetic marks could be, at the same time, their placeholders 
during the rapid cell cycle phases in the early embryo. A placeholder model fits well with the 
experimental data reported in this thesis – removal of epigenetic marks at fertilisation, but not 
after the mark has been already recognised by the placeholder, leads to the misregulation of 
gene expression (Fig. 41). It is also important to note that the removal of H3K27me3 marks 
late in embryogenesis, does not affect gene expression (Fig. 41). It is likely that in those 
conditions egg-derived Ezh2 is correctly targeted to genes, via binding to parentally-inherited 
H3K27me3, and can later on exert repression of these genes through an H3K27me3-
independent mechanism. 
 An alternative possibility to the one described above is that the marks are present in 
the embryo all the time, faithfully recapitulated from the parental chromatin even in the rapid 
cell cycle phases, and the only time when they are absent from the chromatin is the S-phase 
itself. Then, due to the fact that the cell cycle phases in the early embryos are rapid, with 
almost no G1 and G2 phases (almost exclusively S-phases followed by mitoses) (Newport & 
Kirschner 1982), by probing the chromatin isolated from the early embryo, one would almost 
always look into the chromatin undergoing active DNA replication, and therefore devoid of 
epigenetic marks. Furthermore, it has been also shown that during the rapid cell cycle phases 
in zebrafish, the nucleosomes are not well positioned. Canonical nucleosome organisation 
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was only achieved around the time of zygotic genome activation (Zhang et al. 2014). 
Therefore, a globally low amount of well-positioned nucleosomes, plus the fact that early 
embryos are most of the time in S-phase, would prevent post-translational epigenetic marks 
from being detected at the earliest stages of embryogenesis, even if they were indeed present 
on the chromatin. 
 How to distinguish between the two hypotheses? One would ideally probe for the 
presence of the marks at different phases of the cell cycle. In vitro egg extracts in Xenopus 
laevis make such experiments possible. With the use of such egg extracts it was demonstrated 
that DNA methylation from the sperm chromatin is faithfully recapitulated after DNA 
replication and the molecular mechanism of DNA methylase targeting to newly replicated, 
hemimethylated DNA was revealed (Nishiyama et al. 2013). It would be important to 
perform such experiments to examine what is happening with histone marks. The use of egg 
extracts would allow one to test for the first time what happens to sperm-derived 
epigenetically marked histones after fertilisation. So far the only experimental data providing 
hints that sperm-derived modified histones may be retained after fertilisation come from 
immunostainings in mammalian systems (van der Heijden et al. 2006, van der Heijden et al. 
2008), which however do not provide any information about the localisation of the retained 
marks or how global is this retention. A substantial advantage of using the Xenopus laevis 
egg extracts is the possibility of precisely controlling and monitoring the progression of the 
cell cycle – one could collect the samples at various time points from the start of the egg 
extract treatment (various phases of the cell cycle). Also, with the use of egg extracts it is 
possible to perform ChIP-qPCR and ChIP-seq analyses, to identify the localisation of the 
retained marks on the paternal chromatin. Currently it is not known whether at the time of 
fertilisation the egg replaces all sperm-derived nuclear proteins (including post-translationally 
histones) with its own, maternally-stored histones, or whether sperm-derived, epigenetically 
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marked histones are retained after this global chromatin remodelling. Also, even if such 
sperm-derived modified histones would survive the chromatin remodelling after the 
fertilisation, it is not known whether their marks would be reproduced after the DNA 
replication. Therefore, a precise timing of egg extract treatment would not only allow one to 
provide answers to these questions but also would enable discrimination between the two 
processes. Furthermore, the use of egg extracts creates the opportunity of a relatively easy 
examination of mechanisms allowing the possible retention of histone marks. One could 
perform immunodepletion of certain candidate factors from the extracts and examine the 
effects of their removal on the retention of histone marks. Experiments with the use of egg 
extracts aiming to determine what happens to H3K4me3 and H3K27me3 marks after 
fertilisation and during the first cell cycle, together with uncovering the underlying 
mechanisms of possible histone mark retention, are currently being designed in the Gurdon 
laboratory as follow-up studies on the results described in this thesis. 
It would be also extremely important to track the epigenetic marks during the early 
phases of embryonic development in vivo. Even though egg extracts were shown to be able to 
recapitulate the early cell cycle events, a demonstration that the same events occur in 
embryos in vivo would be still required. Using Xenopus as a model system provides the 
advantage of almost unlimited material available for ChIP (or ChIP-seq) experiments. My 
preliminary experiments with ChIP for H3K4me3 followed by qPCR using Xenopus laevis 
gastrula stage embryos revealed that as little at 10 embryos give one a sufficient amount of 
material to reliably detect this histone mark (data not shown). Therefore, it would be 
interesting to test whether the marks observed on the chromatin of sperm and spermatids are 
indeed retained in the developing embryos (and whether the differences observed between 
sperm and spermatids between them are maintained between sperm- and spermatid-derived 
embryos). 
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Last, in the experiments that were designed to functionally test the importance of 
H3K27me3 by a K6B-mediated removal of these marks at fertilisation, the enzyme removed 
the marks from both the maternal and the paternal chromatin sets. Furthermore, the effects of 
H3K27me3 removal had apparent effects on gene expression only when it was present in the 
egg already at the time of fertilisation (Fig. 41). The mRNA was injected into fully-grown 
oocytes (isolated from PMSG-treated frogs), which are transcriptionally silent (Gilbert 2010), 
therefore it is unlikely that any major transcriptional events in the oocyte were disturbed by 
the H3K27me3 removal from the maternal chromatin before the sperm injection. However, 
this possibility cannot be excluded. Therefore, in order to be able to state precisely that the 
observed changes in transcription are due to the epigenetic mark removal at fertilisation, one 
would ideally examine the effects of delivering to the egg a paternal chromatin devoid of 
such marks. Also, in an ideal situation, such experiment would be performed in haploid 
embryos. As mentioned in the results section (Chapter 7.2), with the currently available 
protocols involving in vitro maturation of mRNA-injected oocytes, followed by ICSI, it is not 
possible to generate haploid, paternally-derived embryos. Therefore, the use of IVM/ICSI 
procedure does not allow the assessment of the effects of the histone mark removal at 
fertilisation solely on the paternal chromatin. However, a new experimental strategy is 
currently being designed in the Gurdon laboratory as a follow up of these experiments, in 
which recombinant histone demethylases are used. Such enzymes are able to remove histone 
marks from synthetic methylated peptides in vitro, therefore in theory they should be also 
able to remove such marks from a chromatin template. It is still technically impossible to 
remove the marks from the sperm chromatin, as it is highly condensed and any attempts of 
chromatin loosening lead to DNA dispersal (data not shown). However, Dr Jerome Jullien 
from the Gurdon laboratory is currently optimising the treatment of spermatids with histone 
demethylases in vitro. If such approach gives promising results, it should be possible to test 
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in the future whether the removal of histone marks solely on the paternal (spermatid) 
chromatin affects gene expression in the embryo. It would be especially interesting to test 
whether removal of H3K4me2/3 activating marks from the spermatid chromatin would be 
able to rescue (downregulate) the upregulation of misregulated genes in spermatid-derived 
embryos. 
In the future (when a better annotation of the Xenopus laevis genome is available) it 
would be worth trying to target the enzymes that modify the chromatin (for example 
demethylases that remove H3K4me2/3 marks) to specific loci in the genome with the use of 
CRISPR-Cas9 system (Mali et al. 2013). This system is naturally used by bacteria as a 
defence mechanism against foreign nucleic acids. It is based on guide RNAs that bring the 
Cas9 nuclease to the foreign nucleotides for their degradation (Mali et al. 2013). Such guide 
RNAs can be custom designed to target any desired sequence in the genome and therefore 
this strategy has been widely applied to obtain gene knock-outs in many different systems 
(Cho et al. 2013, Cong et al. 2013, Friedland et al. 2013). Interestingly, it has been shown 
that using custom-designed targeting RNAs and nuclease-dead Cas9 fused to the proteins of 
interest it was possible to modify the levels of gene expression of the desired gene. For 
example, it was shown that by creating a fusion between a nuclease-dead Cas9 and a 
transcriptional transactivator protein and by simultaneously expressing in human cells 
appropriate guide RNAs, it was possible to selectively activate desired endogenous target 
genes (Perez-Pinera et al. 2013). Conversely, it was also shown that a another type of Cas9 
modification can result in gene repression in bacteria, human and yeast by blocking 
transcriptional initiation and/or elongation (Gilbert et al. 2013, Qi et al. 2013), confirming 
that Cas9 system can be successfully applied not only for genome editing, but also for 
modulating gene expression. It would be therefore interesting to fuse epigenetic modifiers 
(for example H3K4me2/3 demethylase) to nuclease-dead Cas9 to try rescuing 
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(downregulating) the gene expression in spermatid-derived embryos. Doing such experiment 
in a targeted way (targeting all the 100 misregulated genes by injecting appropriate guide 
mRNAs into 1-cell stage embryos), would eliminate side effects which would occur if the 
enzyme would act on the whole chromatin. 
 
8.4. What are the epigenetic changes occurring during spermiogenesis in 
Xenopus laevis? 
 
 
 ChIP-seq experiments described in this thesis probed for repressive H3K27me3 and 
for activating H3K4me2/3 marks in sperm and spermatids. Even though this experiments 
provided interesting and unexpected findings (H3K27me3 did not change between spermatids 
and sperm, whereas the activating H3K4me2/3 marks were more abundant in spermatids, 
which correlated well with the gene upregulation observed in spermatid-derived embryos), 
one has to realise that the picture obtained is far from complete. As mentioned in the 
introduction chapter, there are multiple epigenetic modifications known on DNA: DNA 
methylation, DNA hydroxymethylation, DNA formylation, DNA carboxylation; and even 
more histone modifications: methylation, acetylation, phosphorylation, ubiquitylation, 
sumoylation, ADP ribosylation, crotonylation and many others. Moreover, histone 
modifications occur on many different residues and different histones, for example both 
serine and threonine can become phosphorylated, or histones H3 and H4 can both be 
acetylated (Dawson & Kouzarides 2012). Plus, there are many histone variants existing and 
also, the positioning of histones itself can affect the chromatin structure. All these epigenetic 
changes affect each other and they can also attract different binding partners, which can 
further alter the transcriptional outcome of the target gene (Kouzarides 2007). On top of that, 
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it has been shown that protamines in mammalian sperm are also subjected to post-
translational modifications (Brunner et al. 2014). All these suggest that the possible 
combination of various epigenetic marks that could affect the chromatin and the 
transcriptional state of a given gene is enormous. It is for sure not possible to probe for all the 
known DNA modifications, histone marks and histone variants. However, the more 
epigenetic profiles of spermatids and sperm are obtained, the more data can be utilised as an 
input into the model aiming at predicting gene expression status in the embryo based on the 
epigenetic states of the paternal chromatin. 
 Experiments currently conducted in the Gurdon laboratory aim to obtain epigenetic 
profiles of DNA methylation and also trimethylation of lysine 9 of histone H3 (H3K9me3) in 
sperm and spermatids. Investigations into these marks are of a particular interest, as the 
proteomic analysis of egg factors binding specifically to sperm, and not to the spermatid 
chromatin, identified HP1γ and Mbd3 proteins (Fig. 15). These proteins recognise and bind to 
H3K9me2/3 modification and to methylated cytosine in DNA, respectively. This therefore 
suggests that those two epigenetic marks: H3K9me3 and DNA methylation are likely to be 
different between sperm and spermatids. Furthermore, finding the functional connection 
between the epigenetic marks in sperm and spermatids and their readers from the egg side 
will provide a valuable addition to the current understanding of the inheritance of the 
epigenetic marks via the gametes. 
 The results described in this thesis also identify a unique chromatin structure in 
Xenopus laevis sperm. I showed that MNase digestion of chromatin leads to a release of DNA 
of three different sizes: ~75bp, ~110bp and ~150bp (Fig. 43). I also showed that ~110bp 
structure is the most unstable one, as it disappears first upon a treatment with an increasing 
concentration of a heparin (Fig. 46). What is the identity of these three different structures? 
What are they composed of? Are the main components of these structures histones, sperm 
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basic proteins or perhaps a mixture of both? Do they contain any specific sequence features? 
For example, the canonical nucleosome size, ~150bp structure could contain gene promoters 
or developmentally-important genes; or, the ~75bp structure could have mostly intronic 
sequences or housekeeping genes. The experiments currently ongoing in the Gurdon 
laboratory (in collaboration with Dr Angela Simeone and Dr Jerome Jullien) aim to address 
these questions by performing sequence analysis of DNA contained in each of these 
fragments and by chromatin immunopurifications against histones. 
 
8.5. How the results obtained add to the current knowledge on sperm 
programming? 
 
 It is currently known that sperm of different species can bear epigenetic marks on 
DNA and also on histones (Hammoud et al. 2009, Brykczynska et al. 2010, Wu et al. 2011). 
It was correlated that genes bearing the repressive marks tend to be repressed during the 
earliest developmental stages (Brykczynska et al. 2010), whereas those with activating marks 
tend to be expressed early in embryogenesis (Wu et al. 2011). What is the novelty of the 
findings described in this thesis? First, it is not possible to manipulate the sperm nucleus to 
change the histone marks on chromatin. Therefore, comparing sperm and spermatids in the 
same type of assay allows bypassing the problem of inaccessibility of the sperm chromatin. 
By using these two different cell types, coming from the same lineage, having the same DNA 
and chromosome content, but differing in their developmental potential I was able to assess 
for the first time what is the source of developmental advantage of the sperm. I showed that 
the developmental advantage of sperm over the spermatids is likely related to the ability to 
correctly regulate embryonic gene expression. I also managed to link this ability to 
underlying differences in histone marks between sperm and spermatids: spermatids, which 
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overexpress the misregulated genes, have more of activating H3K4me2/3 marks. These 
results largely extend the currently available knowledge in the field, since even though I was 
not able to directly manipulate the epigenetic status of the sperm chromatin, I was able to 
compare the sperm to its direct precursor, that has a different epigenetic state. Furthermore, 
enzymatic removal of H3K27me3 marks from the parental chromatin at fertilisation proved 
for the first time that the presence of an epigenetic mark on the parental chromatin is indeed 
required for a correct regulation of embryonic gene expression. As such, the experiments 
presented in this thesis significantly advance our current understanding of the sperm 
programming. Furthermore, presented experiments became a basis for many follow-up 
projects currently carried in the Gurdon laboratory (as discussed above), therefore I strongly 
hope that the obtained results will also have interesting future implications. 
 
8.6. Results described in this thesis in the context of the current knowledge 
on transgenerational inheritance of epigenetic information. 
 
Concluding, the results described in this thesis provide experimental evidence 
supporting the hypothesis that the sperm is epigenetically programmed to regulate embryonic 
gene expression. This hypothesis is further strengthened by the fact that an incorrect pattern 
of histone modifications or DNA methylation was associated with cases of idiopathic 
infertility in humans (Hammoud et al. 2010, Hammoud et al. 2011). Furthermore, it was 
reported in mammals that epigenetic traits can be transgenerationally inherited from the 
father to the offspring (Braunschweig et al. 2012, Daxinger & Whitelaw 2012, Lambrot et al. 
2013, Padmanabhan et al. 2013, Vassoler et al. 2013, Dias & Ressler 2014). For example, it 
was shown in mice that offspring of males fed on a low-protein diet had elevated expression 
of many hepatic genes, which was linked to changes in DNA methylation at the promoters of 
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these genes (Carone et al. 2010). In another example it was shown that paternal obesity in 
mice is transgenerationally inherited up to F2 generation and that this phenomenon was 
correlated with global changes in DNA methylation patterns and with altered expression 
profiles of mRNAs and microRNAs in the testes of the F0 obese male mouse (Fullston et al. 
2013). There is therefore growing evidence for the existence and importance of 
transgenerational inheritance of epigenetic traits via the gametes. Not surprisingly, this 
subject receives more and more of the media attention, as the possibility that the 
environmental cues acting on the sperm/sperm progenitors can be transmitted and affect the 
phenotype of the offspring is revolutionising the current view based on genetic mutations as 
the main source of evolutionary adaptation (Grossniklaus et al. 2013, Hughes 2014, Kaiser 
2014, Szyf 2014). Further research into the subject is needed not only because of its impact 
on the basic biology and our understanding of the non-genetic inheritance, but also because it 
is necessary to get insight into the potential effects of various environmental cues on the 
future fitness of the offspring from the perspective of human health. This is especially 
important as many of the reports on the transgenerational inheritance of epigenetic traits in 
animals point to the inheritance of metabolic adaptations. For example, it is crucial to 
understand the consequences of the diet on the health of the future offspring, especially in 
light of the growing numbers of obesity cases in humans. Furthermore, it was also reported 
that exposure of pregnant female rats to commonly used environmental toxins: vinclozin 
(fungicide) or methoxychlor (insecticide) induced transgenerational inheritance of reduced 
male fertility (complete infertility in 8% of the cases) in male mice in all subsequent 
generations tested, which was correlated with changes in global DNA methylation patterns 
transmitted through the male germline (Anway et al. 2005). Therefore, a better understanding 
of agents causing the heritable changes in the germline epigenome, as well as the 
mechanisms of the inheritance of such changes is clearly needed. 
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I hope that the results presented in this thesis will help our understanding of the 
mechanisms of transgenerational inheritance of epigenetic traits in general. I believe that 
Xenopus, in which it is possible to generate haploid sperm- and spermatid-derived embryos, 
to assess their developmental potential, transcriptional capacity, and manipulate the 
epigenetic state of chromatin, is a well suited model organism for further investigations of the 
nature of the sperm programming. 
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